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SUMMARY
The initial rationale of this thesis was to conduct an extensive investigation into the 
circadian rhythms of blind subjects. An epidemiological study of registered blind 
subjects (N = 388) established that 58% had a sleep disorder as assessed by the 
Pittsburgh Sleep Quality Index (PSQI > 5). The incidence and severity of sleep disorder 
was greater in subjects with no conscious light perception (NPL) (78%, PSQI mean ± 
sem = 8.1 ± 0.5, n = 58) compared to subjects with some degree of light perception (LP) 
(54%. PSQI mean = 5.8 ± 0.2, n = 330). In order to investigate whether the high 
incidence of sleep disorder was due to circadian rhythm abnormality, a detailed 
evaluation of circadian rhythms in the blind was conducted. A total of 49 blind subjects 
(30 NPL and 19 LP) with varying degrees of severity of visual loss were studied for at 
least four weeks. Subjects were required to keep daily sleep and naps diaries and wear 
wrist-worn actigraphs continually. They were asked to complete four analogue mood 
scales and an auditory performance test every two hours whilst awake for 48 h each 
week. During the same 48 h each week, urine was collected (4-hourly and 8-hourly 
overnight) for analysis of 6-sulphatoxymelatonin (aMT6s), the major metabolite of 
melatonin and considered to be a reliable marker of circadian phase. The majority of LP 
subjects (14/19, 74%) had normally entrained aMT6s rhythms whereas the majority of 
NPL subjects had abnormal aMT6s rhythms (23/30, 76%). Free-running aMT6s 
rhythms were only found in NPL subjects (17/30, 57%) the incidence of which was 
greater in bilaterally enucleated subjects (11/12) compared to those with one (5/7) or 
both eyes (2/12) present. All of the NPL individuals with abnormally entrained rhythms 
(n = 5) had both eyes present.
The effect of the circadian system on sleep was investigated using both the subjective 
and actigraphically-derived sleep data. In group analysis of subjects with entrained 
aMT6s rhythms, there was a strong positive correlation between the timing of sleep and 
activity with the timing of the aMT6s acrophase. Regression analysis of sleep and 
activity showed that some individuals with a free-running aMT6s rhythm also had a 
free-running activity, sleep or nap rhythm although at a much reduced tau compared to 
the aMT6s rhythm. The effect of age on the timing of behavioural rhythms was also
measured in entrained subjects and found that increased age was associated with an 
advance in the timing of mean sleep onset.
The study also showed that there were significantly more naps of a longer duration in 
NPL subjects (mean ± sem = 0.6 ±0 .1  naps/day, 0.4 ±0 . 1  h/day) compared to LP 
subjects (0.3 ±0.1 naps/day, 0.2 ± 0 h/day). When analysed with respect to circadian 
rhythm type, the results showed that normally entrained subjects had significantly fewer 
naps per day compared to all other circadian rhythm types. The timing of the naps was 
not random; there were significantly more naps (65%) within a 5 h range before and 
after the aMT6s acrophase.
Further analysis of sleep, naps and activity with respect to circadian phase in free- 
running subjects showed that the number and duration of naps decreased when the 
aMT6s acrophase was in a normal phase position (24.00 - 06.00 h) and increased when 
the aMT6s acrophase was maximally out of phase. There were also significant effects of 
circadian phase on the timing and duration of night-time sleep with maximal night sleep 
duration occurring when the aMT6s acrophase was normal and minimal when the 
aMT6s acrophase was out of phase. The timing of sleep onset and offset also changed 
with circadian phase, being advanced when the aMT6s was advanced relative to normal 
(18.00 - 24.00 h) and delayed when the aMT6s acrophase was relatively delayed (06.00 
- 12.00 h). It was observed that sleep onset and offset did not vary in parallel with 
circadian phase and this may provide the basis of a model to investigate the effects of 
circadian influences on sleep.
Preliminary analysis of mood and performance did not reveal a robust rhythm as 
assessed by fitting cosine curves to the data. There was a significant effect of circadian 
phase on daily mean mood (calmness) and performance (% gaps) in group analysis of 
six free-running subjects although more detailed analysis is required before any 
conclusions can be drawn.
Comparisons were performed on the simultaneous subjective and actigraphic 
measurement of sleep for the whole study in all subjects. There was a high rate of
111
disagreement between the two methods in the measurements of absolute sleep 
parameters , especially when measuring the number and duration of day- or night-time 
sleeps. However, both methods gave comparable results when measuring changes in 
sleep over time and the effects of circadian phase on sleep.
These results of this thesis show that individuals with no light perception (NPL) are 
likely to have abnormal circadian rhythms. This is associated with increased incidence 
and duration of naps, the timing of which is associated with the timing of the aMT6s 
acrophase. In some free-running individuals, there are also distinct cyclical variations in 
the timing of sleep in relation to circadian phase.
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CHAPTER 1
INTRODUCTION
CHAPTER 1 - INTRODUCTION
1.1. Circadian rhythm production and control
1.1.1 The Phenomenon of Rhythmicity
The phenomenon of rhythmicity is universal and is inherent in all aspects of the world 
around us. From physiological processes in unicellular algae to the movements of 
planetary systems, everything is organised with respect to time. In physiological 
systems, rhythmicity is endogenous throughout all orders and therefore was developed 
at a very early stage of evolutionary development. The selective pressure to develop 
rhythms must have been applied by the environment in which can be observed so many 
different periodicities. Planetary movements around the sun ultimately determine annual 
rhythms, moon movements around the earth determine lunar and tidal rhythms and the 
speed at which the earth rotates determines daily rhythms. There are also other distinct 
natural périodicités such as ultradian rhythms (less than a day), infradian rhythms (more 
than a day) and multiannual rhythms that cycle with a periodicity of several years.
1.1.1.1 Circadian rhythms
Circadian rhythms, defined as those rhythms, generated internally, that take about a day 
to complete one full cycle (Latin: 'circa\ meaning ‘about’ and "dies’ meaning ‘day’), 
are one of many influences that control human physiology. In order to maintain a 
rhythm, three processes are required. Firstly, an oscillator or pacemaker is required 
which can generate a rhythm. Secondly, the pacemaker requires an input pathway to 
modify its rhythm and finally, an output pathway is required to allow expression of 
rhythmicity. The human circadian system has the required components: it has a major 
endogenous oscillator that can independently generate rhythmicity (the suprachiasmatic 
nucleus (SCN) of the hypothalamus) (Section 1.1.3.1), it receives input (e.g. 
environmental light-dark cycles via the eyes) to modify rhythms and imposes 
rhythmicity on other body systems (e.g. rhythmic production of the pineal hormone, 
melatonin).
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1.1.1.2 Input pathways - zeitgebers
Inputs influencing the pacemaker are called zeitgebers (time-givers) or time cues and 
modify its rhythmic parameters. In the absence of such time cues, circadian rhythms run 
at the endogenous period of the pacemaker. In humans, this period is usually greater 
than 24 h (Aschoff, 1965; Wever, 1979). In a normal environment, endogenous rhythms 
are entrained to 24 h by environmental time cues. The strongest time cue in humans is 
the light-dark (LD) cycle and this environmental cycle resets the endogenous clock on a 
daily basis (Wever, 1983). In normal conditions, via pacemaker control, different 
circadian rhythms run at identical periodicities and maintain constant phase 
relationships with each other, e.g. core body temperature (CBT) minimum occurs 
approximately one hour after plasma melatonin maximum. When rhythms remain in 
such a stable relationship, ‘internal synchronisation’ is said to occur (Wever, 1979). 
There are unusual conditions, however, where rhythms become ‘internally 
desynchronised’. For example, individuals kept in constant light (LL) or constant 
darkness (DD) and temporal isolation may show a splitting of the relationship between 
rhythms and have different rhythms running at different periods. These differences may 
be quite extreme and in humans, splitting primarily occurs between the sleep-wake 
rhythm (SW) and core body temperature. For example, the SW rhythm may run at 
periods > 50 h whilst core body temperature may remain at 25 h. Or, in the presence of a 
zeitgeber, some rhythms may free-run whilst some are entrained to the time cue (Wever, 
1979). Under such conditions, there may still be persistent relationships between 
rhythms despite having differing periods e.g. sleep periods are longer when occurring 
near to the CBT minimum (e.g. Czeisler et al., ; 1980).
There are limits to which some endogenous rhythms can be entrained. For example, 
CBT can only be entrained to periods between 23 - 27 h but if zeitgebers with periods 
outside these limits are imposed, the CBT rhythm reverts back to its endogenous 
periodicity (Wever, 1989). The SW or activity rhythm, however, appears to have much 
wider limits of entrainment (< 23 - >27 h) (Wever, 1989).
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The ability of different rhythms to run at different periods in the same organism has led 
to debate as to whether there is a complex multi-level system involving a single 
oscillator or whether separate multiple oscillators control rhythms (Section 1.1.2).
1.1.1.2.1 Photic zeitgebers
1.1.1.2.1.1 Entraining and phase-shifting effects
The circadian system must be able to change its timing in response to changes in the 
environment so that the organism can maintain an appropriate relationship with the 
environment. This is achieved by ‘phase shifting’ the circadian system forwards or 
backwards in response to a zeitgeber. The magnitude and the direction of any shift 
depends on the intensity and duration of the light signal (i.e. a dose-response curve). In 
addition to absolute light intensity, relative light intensity and photoperiodic history are 
also important in determining whether light phase shifts the system. The ability of light 
to shift circadian rhythms and the direction and extent of the shift (advance or delay) 
depends on the time of day the light pulse is given. The effects of light treatment as a 
function of time are predicted by the ‘phase response curve’ (PRC) for light in animals 
(Decoursey, 1964) and humans (Honma and Honma, 1988; Czeisler et al., 1989; Minors 
et al., 1991). It shows that light given in the subjective morning (advancing dawn) 
causes an advance in the circadian system and that light given in the subjective evening 
(delaying dusk) causes a delay in the circadian system. There are also parts of the day 
when light has no effect (the ‘dead’ zone of the PRC). The PRC depends on when the 
light pulse is given with respect to the endogenous pacemaker (circadian time (CT)), 
rather than the clock time of day. The PRC has extensive practical applications in 
ensuring that light treatment (for example in order to reentrain the circadian system to 
alleviate jet-lag or fatigue from shift-work) is given at the correct time to ensure the 
phase-shift is of the right magnitude and direction.
All zeitgebers should theoretically show a PRC and it is thought that two distinct types 
of PRC exist. One has a low amplitude and is therefore capable of phase shifts of only 
a few hours, mediating weak phase resetting and the other has a high amplitude and is
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capable of much larger phase shifts, mediating strong phase resetting. These ‘weak’ and 
‘strong’ classes of responses are also known as Winfree’s type 1 and Winfree’s type 0 
phase resetting, respectively (Winfree, 1980).
1.1.1.2.1.2 Complex effects of light
Light has some complex effects on the circadian system. As well as time-dependent 
effects on SCN rhythmicity and SCN-driven circadian rhythms, there are also intensity 
dependent effects. In constant light conditions, increased light intensity decreases the 
period of the endogenous rhythm in diurnal animals, increases the period in nocturnal 
animals (Aschoff s rule; Pittendrigh, 1960) and increases the incidence of rhythm 
splitting (Pickard et al., 1993). However in man, this relationship is not so distinct. 
Increasing light intensity may shorten, lengthen or have no effect on the period of 
rhythms (Wever, 1979). Group data suggests a trend for increased light intensity to 
cause increased tau (Wever, 1979; 1989). Similarly, increased light intensity may 
increase the occurrence of internal desychronisation in humans (Wever, 1979; 1989). In 
some humans (Wever, 1979; Czeisler et al., 1980) and certainly in animals (e.g. 
Pittendrigh and Daan, 1976; Pickard et al., 1993), light can cause ‘splitting’ of rhythms 
into two components which has led to the hypothesis that rhythmicity is controlled by 
more than one oscillator (Section 1.1.2.2).
There is evidence in animals and humans that the intensity of light required for 
entrainment is different from that required for suppression of melatonin. In animals 
(Nelson and Takahashi, 1991) and humans (Hashimoto et al., 1996), higher intensity 
light is required to entrain rhythms than to suppress pineal and plasma melatonin. These 
findings suggest that either the two actions of light are mediated by different receptors 
and pathways with differing sensitivities to light or that there is some difference in the 
thresholds required to stimulate action.
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1.1.1.2.1.3 Dark effects
Just as light has phase-shifting effects in constant darkness, dark pulses show phase 
shifting effects on animals kept in constant light (Boulos and Rusak, 1982; Van Reeth 
and Turek, 1989). The resulting PRC shows an opposite phase relationship to light in 
both nocturnal and diurnal animals (Smith et al., 1992). The shapes of the PRC’s, 
however, are reversed between nocturnal and diurnal animals so that changes in 
circadian behaviour, such as activity, are mediated by the appropriate stimulus.
1.1.1.2.2 Non-photic zeitgebers
1.1.1.2.2.1 Environmental zeitgebers
Zeitgebers other than light can also entrain and phase-shift rhythms. In animals, these 
include social interaction (Mrosovsky, 1988), opportunities to hoard food or feed 
(Boulos et al., 1980; Rusak et al., 1988), novelty-induced activity (Mrosovsky and 
Salmon, 1987; Reebs and Mrosovsky, 1989; Mrosovsky, et al., 1992; Mrosovsky, 
1995), handling (Mead et al., 1992; Sumova et al., 1996), saline injections (Hastings et 
al., 1992) and scheduled voluntary exercise (Edgar and Dement, 1991). Recently, Amir 
and Stewart (1996) have shovm that a non-photic stimulus (air movement) following 
conditional association with light onset, could phase-shift rat activity rhythms, 
following removal of the light signal. The Pavlovian conditioning was able to mimic the 
biological and presumably the biochemical effects of light on the SCN and therefore the 
circadian system.
Non-photic phase-shifts are often associated with arousal (Mrovosky, 1995; Hastings et 
al., 1995) although whether this is the cause of the phase shifts is not known. 
Serotoninergic pathways are stimulated by arousal (Jacobs and Azmitia, 1992), and 
serotoninergic inputs from the raphe nucleus to the SCN have been implicated in 
circadian entrainment (Section 1.1.3.2.3). The IGL is also implicated in mediating 
non-photic phase shifts as IGL lesions prevent such shifts (Section 1.1.3.2.2). In 
addition to the biochemical evidence that photic and non-photic stimuli may act on
1-5
similar SCN areas, there is also behavioural evidence that these stimuli may interact in 
order to control phase shifts; (Mrosovsky, 1991 ; Ralph and Mrosovsky, 1992).
Non-photic zeitgebers also affect the human circadian system and were once thought to 
be more important than light in humans (e.g. Aschoff et al., 1971). In two separate 
studies on human sleep rhythms in Antarctica during the winter (where light intensity 
did not exceed 1000 lux), one group of subjects led a 24 h scheduled day (O’ Conor and 
Arendt, unpublished observation, cited from Arendt, 1995) and the other led an 
unrestricted lifestyle (Kennaway and Van Dorp, 1991). The restricted group had 
entrained sleep-wake cycle, melatonin and cortisol rhythms whereas the unrestricted 
group had free-running sleep, melatonin and cortisol rhythms. Further indirect evidence 
of non-photic influences comes from a study of blind subjects who were tested for 
melatonin suppression by bright light (Czeisler et al., 1995a) (Section 1.2.2.3). Three 
subjects (one with both eyes and two bilaterally enucleated) did not demonstrate 
melatonin suppression (i.e. had no photic zeitgeber input) and maintained an entrained 
melatonin rhythm and sleep cycle. As the subjects were blind and light failed to 
suppress melatonin, the only assumption is that something other than light was able to 
entrain the rhythms. There have also been some preliminary experiments to attempt to 
entrain circadian rhythms in blind people using exercise and a strict social routine 
(Moog, 1995) although the results do not appear to suggest that entrainment had 
occurred (Section 1.2.5.2).
1.1.1.2.2.2 Drug effects
1.1.1.2.2.2.1 Non-melatonin effects
Many experiments have used drug interventions to entrain and phase-shift rhythms in
animals. For example, benzodiazepines (Ralph and Menaker, 1986; Turek and Losee-
Olson, 1986; Johnson et al., 1988b; Van Reeth and Turek, 1989; Joy and Turek, 1992;
Van Reeth and Turek, 1992), serotonin agonists (Edgar et al., 1993; Gillette et al.,
et al.,
1995), methamphetamine (Honma et al., 1987) and NPY agonists (Gillette/^ 1995) have 
been investigated. Benzodiazepines have been shown to have some phase-shifting
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effects in humans (e.g. Sack et al., 1987). Their effects are thought to be mediated in a 
similar manner to other non-photic zeitgebers, through stimulation of arousal via the 
serotoninergic raphe and the IGL (Section 1.1.3.2) as immobilisation prevents phase- 
shifts (Van Reeth and Turek, 1989). Their effects are predicted by a PRC which is 
dependent on previous lighting schedules (Van Reeth and Turek, 1992). The 
proliferation of GABA immunoreactivity throughout the SCN may provide a route 
through which benzodiazepines may exert a direct effect on rhythmicity (Redfem et al., 
1994).
1.1.12 .2 2 2  Melatonin effects
The ability of exogenous melatonin to entrain free-running activity rhythms was first 
demonstrated by Redman et al. (1983) who found that melatonin injections timed to 
coincide with the onset of activity entrained activity rhythms in rats kept in constant 
dark and constant light (Armstrong et al., 1986). Melatonin can also alter the phase of 
electrical rhythms in the SCN in vitro (McArthur et al., 1991). The phase shifting effects 
of pharmacological doses of melatonin are dose- and time- dependent and the direction 
and the extent of the phase shift are predicted by a phase response curve (PRC) 
(Armstrong, 1989). In humans, the melatonin PRC (Lewy et al., 1992; Zaidan et al., 
1994) has the opposite effect to the light PRC. Melatonin administration in the early 
subjective day causes phase delays in the rhythms (i.e. delaying the night-time signal) 
and administration in the late subjective day causes phase advances in the rhythms (i.e. 
advancing the night-time signal) (Arendt et al., 1985a). As in animals (Cassone et al., 
1986a), the size of any phase-shift is also dose-dependent (Deacon and Arendt, 1995) 
with larger doses of melatonin causing larger phase shifts. These effects are also 
associated with a simultaneous dose-dependent reduction in subjective alertness and 
CRT.
Although it is clear that exogenous melatonin does have phase-shifting properties in 
humans, the ability of melatonin to fully entrain a free-running circadian system remains 
ambiguous. The success of melatonin treatment in entraining free-running blind people 
has been variable (Section 1.2.5.1) and although sleep rhythms appear to become
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entrained during treatment (Arendt et al., 1988; Palm et al., 1991; Tzischinsky et al., 
1992; Sarrafzadeh et al., 1990; Jan et al., 1994), the rhythms of temperature and cortisol 
(Folkard et al., 1990) and endogenous melatonin (Sack et al., 1991) do not appear to be 
entrained.
Similar observations have been reported in sighted humans free-running in constant dim 
(< 8 lux) light (Middleton et al., 1996) although CBT appeared to be entrained in some 
individuals. There is some evidence in these studies that sleep onset and offset times can 
be differentially affected and entrained by melatonin, a result also described for the 
NAT rhythm in rats (Illnerova, 1991). Melatonin does not appear to entrain the free- 
running strongly endogenous rhythms of blind subjects as readily as the 
(experimentally-induced) free-running rhythms of sighted subjects but there is as yet 
insufficient data for valid comparisons.
1.1.2 Oscillator Theory
Whether the circadian system is under a single-oscillator or multi-oscillator control 
remains a contentious question. Most results can be explained using either theory and as 
yet, no experiment has been able to distinguish between either hypothesis. There is 
some ambiguity as to whether distinct time-dependent processes observed 
experimentally in vivo are independent oscillators or ‘downstream’ effects of one central 
oscillator (i.e. the hands of the clock or ‘slave’ oscillators). In order to be defined as a 
true oscillator or pacemaker, any organ or cell would have to be able to maintain a 
spontaneous endogenous rhythmicity in the absence of any time cues or other inputs.
1.1.2.1 Anatomically distinct oscillators
Most research points towards the SCN as the site for the main oscillator in higher 
animals (Section 1.1.3.1). In many lower animals, the pineal organ has oscillator 
properties (Cassone, 1990) and even unicellular algae maintain true circadian rhythms 
(Roenneberg, 1995). There is evidence for a distinct retinal oscillator that is thought to
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control rhythmic events within the eye as,m vitro, the retina can still maintain cyclic 
production of melatonin when kept in DD in mammals (Tosini and Menaker, 1996).
In addition to a photically sensitive, SCN oscillator model, there is evidence for non- 
SCN oscillators that may be independent of photic modification. There is a food 
entrainable oscillator in rats that is not influenced by light and is not located in the SCN 
(Clarke and Coleman, 1986; Kreiger et al., 1977; Stephan et al., 1979; Mistleberger, 
1992; Stephan, 1992). Other reports of rhythms that persist in SCN lesioned animals 
include temperature in squirrel monkeys (Fuller et al., 1981; Albers et al., 1984) and rats 
(Satinoff and Prosser, 1988), cortisol rhythms in rhesus monkeys (Reppert et al., 1981), 
hoarding rhythms in hamsters (Rusak et al., 1988) and methamphetamine-induced 
activity rhythms in rats (Honma et al., 1987). However, some of these studies may be 
misleading due to incomplete SCN lesions. There is also a photically entrainable but 
extra-SCN oscillator for photic sensitivity in rats (Terman and Terman, 1985). It is 
likely that these and all other extra-SCN oscillator are primarily coupled to and 
controlled by the SCN in normal conditions.
1.1.2.2 Functionally distinct oscillators
Throughout all orders of organisms, rhythms can be simultaneously expressed with 
different peroidicities within the same organism (‘internal desynchronisation’) or the 
same rhythm can be ‘split’ into two components (e.g. Pittendrigh and Daan, 1976). 
These observations suggest the existence of at least two distinct time-keeping 
mechanisms which may or may not represent distinct oscillators. The rhythm of 
production of the pineal enzyme, N-acetyltransferase (NAT) in rats, has been 
investigated extensively and suggests that there are at least two ‘clocks’ in mammalian 
circadian organisation. There is a dusk-sensitive or evening oscillator (EO) and a dawn 
sensitive or morning (MO) oscillator (for review, Illnerova, 1991). The EO may be more 
sensitive to delay phase-shifts by light whereas the MO may be more sensitive to 
advance phase-shifts. This hypothesis fits neatly with the effect of changing daylength 
on circadian systems; increasing daylength would advance the MO and delay the EO 
shortening the night-time melatonin profile (although there is an alternative explanation.
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see below). These oscillators are usually phase-locked and in normally entrained 
conditions, work in tandem to organise circadian variations. However, there are 
differences in the degree of phase shift shown by either oscillator when the same light 
signal is used: for example, phase-shifts of the EO are not necessarily paralleled by the 
MO and vice versa and in fact they can simultaneously shift in opposite directions. The 
oscillators may be “uncoupled” and manipulated independently to the point where the 
NAT rhythm is extremely short or completely abolished by simultaneously delaying the 
EO and advancing the MO until their phase relationship is non-existent. Further 
evidence for the independence of these oscillators comes from the effects of melatonin 
administration on NAT rhythms. Phase advances caused by melatonin administered to 
rats just before dark (and NAT) onset are larger for the NAT onset than NAT offset 
(Illnerova, 1991). Similarly, in humans, evening-administered melatonin advances the 
endogenous melatonin onset more than melatonin offset (Arendt et al., 1985a; Wright et 
al., 1986).
Instead of being controlled by two distinct oscillators, the duration of the melatonin 
profile could be mediated by two different properties of light on melatonin, namely the 
ability of light to immediately suppress melatonin production and its ability to phase 
shift the SCN (Lewy et al., 1985). In summer (i.e. long days), the onset of melatonin 
production is delayed and its offset is advanced, ensuring a short melatonin profile. This 
need not necessarily require phase shifts in both the MO and EO. The early onset of 
dawn would cause a phase advancing effect on the MO and would therefore advance the 
melatonin rhythm. A simultaneous advance of the EO would bring forward the onset of 
melatonin whereas it is known to be delayed. This apparent delay in melatonin onset 
could be caused by a direct light-suppressive effect on melatonin production, rather than 
a change in the EO (Lewy et al., 1985).
The observation of ‘internal desychronisation’ may also be explained by single or 
multiple oscillator theories. It is not easy to distinguish whether differing periodicities 
of rhythms result from multiple time-keeping mechanisms or alterations in the 
‘coupling’ between overt rhythms. Extensive humans experiments have demonstrated 
that rhythms of sleep and activity can often run at very different periods to those of the
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strongly endogenous variables such as CBT, melatonin and cortisol (Section 1.1.1.2). 
Such studies (e.g. Wever, 1979; 1983; Folkard et al., 1983) have suggested that different 
underlying oscillators control different rhythm periods. However, in an elegant 
mathematical model of such a system, Daan and Beersma (1992) have suggested that a 
single oscillator undergoing transition in phase due to an external phase shift, can 
explain different periodicities and apparent limits of entrainment and therefore such 
results cannot be attributed to multiple oscillator systems. This explanation may go 
some way toward explaining differential changes in EO or MO seen in NAT rhythms 
(Illnerova, 1991), on the onset and offset of human activity (Middleton et al., 1996) or 
the phenomenon of the ‘splitting’ of a rhythm into two distinct components due to an 
‘internal phase shift between two representations of the same oscillation’ (Wever, 
1979).
As stated by Daan and Beersma (1992) only ‘multiple frequencies in a free-running 
system’ or ‘persistence of a circadian oscillation following destruction of a known 
pacemaker’ can prove the existence of multiple oscillators and currently in humans, this 
has not been achieved. However, it is difficult to support these conclusions in the light 
of animal studies that have described extra-SCN oscillators.
1.1.3 Role of the SCN and related structures
The search for the anatomical site of the endogenous ‘clock’ has isolated the 
suprachiasmatic nuclei or SCN as the primary site of endogenous rhythm generation in 
mammals. Comparative studies in animals, in addition to a small amount of work on 
humans, have shown general agreement in the anatomical organisation of the circadian 
system between mammal groups (e.g. Moore, 1973; Cassone et al., 1988; Moore, 1993). 
The fundamental questions to be addressed are how the SCN perceives temporal 
information and how this is transduced and relayed to effector mechanisms controlling 
the circadian timing of overt rhythms.
1.1.3.TSCN rhythm production
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The SCN consists of two paired but autonomous nuclei located in the anterior 
hypothalamus at the base of the third ventricle and immediately above the optic chiasm 
in the brain. They contain cells that in vitro spontaneously generate circadian rhythms of 
electrical activity (Green and Gillette, 1982; Shibata et al., 1982), glucose uptake 
(Newman and Hospod, 1986) and vasopressin release (VP) (Earnest and Sladek, 1986). 
In vivo, SCN cells also demonstrate circadian rhythms in electrical activity (Inouye and 
Kawamura, 1979; 1982; Gillette and Reppert, 1987; Meijer and Reitveld, 1989), glucose 
utilisation (Schwartz and Gainer, 1977) and protein synthesis (Van den Pol, 1981). 
Lesions of the SCN abolish virtually all circadian rhythms, including endocrine (e.g. 
corticosterone) (Moore and Eichler, 1972) and behavioural (e.g. drinking and locomotor 
activity) (Stephan and Zucker, 1972; Rusak and Zucker, 1979) rhythms. Neural 
isolation of the SCN in vivo prevents other parts of the brain expressing diurnal 
variations in their electrical activity whilst it maintains its own circadian rhythm (Inouye 
and Kawamura, 1979; 1982). Transplantation of the SCN can restore circadian 
rhythmicity in activity and drinking behaviour to SCN-lesioned animals (Drucker- 
Colin et al., 1984; Lehman et al., 1987; LeSauter et al., 1996; Matsumoto et al., 1996) 
with the periodicity and circadian phase of the donor (Ralph et al., 1990). However, 
function is not restored completely as despite immunoreactivity to normal SCN 
peptides, the SCN graft hosts are not responsive to light (Lehman et al., 1987; 
Matsumoto et al., 1996), which indicates a lack of afferent input from the host.
The SCN consists of at least two subdivisions; the ventrolateral and dorsomedial regions 
and these have distinct differences in neural input, anatomy, immunoreactivity and 
function (Van den Pol and Tsujimoto, 1985; Gillette et al., 1993). There is a high degree 
of internal communication within the SCN; it is estimated that two-thirds of SCN 
neurons are intemeurons.
1.1.3.2 Afferent Projections to the SCN
The major environmental input to the SCN is the light-dark cycle but there are non- 
photic stimuli which can influence its rhythmicity (Section 1.1.1.2.2). These zeitgebers 
act via afferent input to the SCN and modify its activity. The main afferent
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projections to the SCN are the retinohypothalamic tract (RHT) (Section 1.1.3.2.1), the 
geniculohypothalamic tract (GHT) (Section 1.1.3.2.2) and the serotonergic input from 
the midbrain raphe nucleus (Section 1.1.3.2.3). They are distinguishable by the region of 
the SCN in which they synapse, the neurotransmitters they release and their afferent 
functions.
1.1.3.2.1 Retinohypothalamic tract
The RHT is the main afferent to the SCN. Signals from a distinct set of photoreceptors 
(Pickard, 1982; Foster et al., 1991; 1993) relay neural information via a distinct set of 
retinal ganglion cells (Card et al., 1991) which then primarily project directly into the 
ventrolateral region of the SCN (Hendrickson et al., 1972; Moore and Lenn, 1972; 
Cassone et al., 1988; Johnson et al., 1988b) (Figure 1.1). The integrity of the RHT is 
essential for the entrainment of circadian rhythms by the LD cycle (Moore and Card, 
1985); destruction of the RHT prevents LD entrainment of rhythms which revert to their 
endogenous period (Johnson et al., 1988a). The RHT also projects to many extra-SCN 
sites in the brain (Johnson et al., 1988b). which may be implicated in the control and 
production of “downstream” rhythms via retinal and SCN control.
The major neurotransmitter of the RHT is thought to be glutamate. In vitro, it has 
excitatory effects on hypothalamic slices (Liou et al., 1986a), it is released by optic 
nerve stimulation (Liou et al., 1986b) and mimics phase-shifts (Shibata and Moore, 
1989) induced by light pulses (Daan and Pittendrigh, 1976). Several other substances 
demonstrate immunoreactivity in the retinal ganglion cells and within the SCN (e.g. 
aspartate, y-aminobutyric acid (GABA), neurotensin (NT), corticotrophin releasing 
factor (CRF), Substance P (SP)) but their precise neourotransmitter role via the RHT is 
not known.
i. 1.3.2.2 Geniculohypothalamic tract
The GHT arises from a lamina of retinorecipient cells (intergeniculate leaflet, IGL)
lateral
between the ventral lateral and dorsal geniculate nuclei of the thalamus (Swanson et al.,
A
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Figure 1.1 shows the major known afferents of the SCN with their associated 
excitatory (+) and inhibitory (-) neurotransmitters and the immunoreactivity of the 
target cells. The pathways mediating non-photic input to the Raphe and IGL are 
unknown and therefore not shown.
KEY: SCN - suprachiasmatic nucleus, DMR - dorsomedial region, VLR - ventrolateral region, RHT - 
retinohypothalamic tract, GHT - geniculohypothalamic tract, IGL - intergeniculate leaflet, GABA - 
gamma-amino butyric acid, 5-HT - serotonin, GLU - glutamate, ASP - aspartate, NPY - neuropeptide Y, 
SP - substance P, VP - vasopressin, MT - melatonin, VIP - vasoactive intestinal peptide, PHI - peptide 
histidine isoleucine, GRP - gastrin releasing peptide
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1974; Ribak and Peters, 1975; Card and Moore 1982; Pickard, 1982; 1985). The GHT 
projects bilaterally and primarily to the same subdivision of the SCN as the RHT, 
namely the ventrolateral region,and has terminals which overlap with those of the RHT 
(Card and Moore, 1982; 1989). The GHT may also extend more dorsally to overlap with 
cells in the dorsomedial region,in both humans (Moore, 1993) and hamsters (Treep et 
al., 1995). The integrity of the GHT is not essential for the photic entrainment of 
rhythms as IGL lesions do not stop entrainment to LD cycles (Dark and Asdourian, 
1975; Pickard et al., 1987). However, it may play a large modulatory role in photic 
entrainment as these lesions do cause changes in circadian rhythmicity. Lesions slow the 
rate of reentrainment after phase-shifts, reduce the free-running period and ‘splitting’ of 
rhythms in constant light and reduce the magnitude of advance phase-shifts (Pickard et 
al., 1987; Harrington and Rusak, 1988; Johnson et al., 1989). It has also been suggested 
that the IGL/GHT may mediate non-photic entrainment (Section 1.1.1.2.2) as it has 
distinct neural connections to the SCN not stimulated by light (Mrosovsky, 1995). 
Lesions of the IGL/GHT prevent phase-shifts by non-photic zeitgebers including 
benzodiazepine (Johnson et al., 1988b) and activity (Mrosovsky, 1995).
The primary neurotransmitter of the GHT is thought to be neuropeptide Y (NPY) 
(Harrington et al., 1987; Moore and Speh, 1993) which shows a diurnal variation in the 
SCN (Jhanwar-Uniyal et al., 1990). Injection of NPY into the SCN (Albers and Ferris,
1984) or electrical stimulation of the GHT in vivo (Meijer et al., 1984) or in vitro 
(Shibata and Moore, 1993) produces phase-shifts that mimic the pattern of phase-shifts 
produced by dark pulses (Boulos and Rusak, 1982). Virtually all NPY immunoreactivity 
in the SCN arises from the GHT and is higher in the ventrolateral region. There are 
other immunoreactive substances in the IGL neurons (including retinorecipient neurons) 
which may also be afferent neurotransmitters of the GHT, for example SP, enkephalins 
and GABA which colocalise with NPY in SCN afferents (Mantyh and Kemp, 1983). 
The role of the GHT in photic information processing may depend on afferent 
projections to the IGL. The major afferent to the IGL is from collaterals of the RHT 
(Millhouse, 1977; Moore and Card, 1994) and there are other inputs from the 
contralateral IGL, raphe nucleus, SCN, anterior hypothalamic area, brainstem and 
retrochiasmatic area (Moore and Card 1994). The GHT may also be involved in
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mediating non-photic zeitgebers as NPY has been implicated with the induction of an 
immediate-early gene, c-fos in non-photic phase shifts in hamsters (Mrosovsky, 1995).
1.1.3.2.3 Raphe Nuclei
There are other afferent projections to the SCN which may also be involved in
processing photic and non-photic information. The midbrain raphe nucleus, which
receives retinal photic input projects primarily to the ventrolateral region of the SCN
and the IGL (Aghajanian et al., 1969; Moore et al., 1978; Mantyh and Kemp, 1983;
Meijer and Reitveld, 1989) (Figure 1.1) but, as with the GHT, it is not essential for
photic entrainment and may also play a modulatory role. Raphe lesions reduce the
and
amplitude and regularity of circadian rhythms, alter the free-running period^alter the 
phase angle of entrainment (Block and Zucker, 1976; Levine et al., 1986a; Morin and 
Blanchard, 1991; Morin, 1992; Prosser et al., 1992). It is thought that raphe neurons 
may specifically affect photically responsive SCN cells and may modulate the photic 
intensity perceived by the SCN (Liou et al., 1986a).
The neurotransmitter from the raphe is serotonin (Fuxe, 1965; Saavedra et al., 1974). 
Serotonin administration in vivo and in vitro is inhibitory to SCN and IGL neurons 
(Liou et al, 1986a; Zhang and Rusak, 1989) and can cause time-dependent phase shifts 
of neuronal activity in the SCN in vitro (Medanic and Gillette, 1992; Prosser et al.,
1993) and of behavioural rhythms (Edgar et al., 1993). Depletion of serotonin can also 
significantly disrupt circadian rhythmicity (Honma et al., 1979; Morin and Blanchard,
1991). The level of serotonin and possibly its effects within the SCN may be modulated 
by light exposure via retinal input to the raphe; the night-time peak of endogenous 
serotonin production in the SCN during DD is 180° out of phase with the pattern under 
a L/D cycle (Cagampang and Inouye, 1994). The Raphe may also modulate photic 
effects via the IGL and GHT through inhibitory serotonergic (Zhang and Rusak, 1989; 
Rusak et al., 1993) and SP-containing neurons from the Raphe to the IGL. Serotonin 
may mediate non-photic entrainment as the PRC for non-photic zeitgebers resembles the 
PRC for serotonin (Prosser et al., 1990) and serotonin regulation has also been
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implicated in the control of arousal (McGinty and Szymusiak, 1988) which may be 
involved in non-photic entrainment (Sumova et al., 1996).
1.1.3.2.4 Other afferents
There are afferent inputs to the SCN from other brain regions including the 
hypothalamus, basal forebrain and the thalamic PVN but their function is not known 
(Pickard, 1982).
1.1.3.3 SCN structure and anatomy
1.1.3.3.1 Ventrolateral region
The ventrolateral region of the SCN is the subdivision of larger cells where photic 
afferents from the retina (via the RHT and GHT) and raphe afferents terminate (Van den 
Pol and Tsujimoto, 1985) (Figure 1.1). They terminate on cells that demonstrate 
immunoreactivity to vasoactive intestinal polypeptide (VIP), peptide histidine 
isoleucine (PHI) and / or gastrin releasing peptide (GRP) and these make up the 
majority of cells in this region. The levels of these peptides are photically-sensitive and 
may relay information about the photoperiod, from afferent photic inputs (e.g. Laemle,
1992). Generally, VIP and PHI immunoreactivity is higher during the dark phase and 
significantly reduced by light. GRP levels may not vary in a similar way and therefore 
the ratio of VIP/PHI to GRP has been suggested as a way of relaying photic information 
(Albers et al., 1991).
1.1.3.3.2 The dorsomedial region
The dorsomedial region of the SCN does not appear to receive direct photic input 
although there are extensive local pathways between the ventrolateral and dorsomedial 
regions (Figure 1.1). Many cells in this region contain arginine vasopressin (VP) and 
there is also some neurophysin (NP) immunoreactivity. VP expression, release and cell 
number have a circadian rhythm that may correlate to the neural firing rate of the SCN
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seen in vitro with a rise just before dawn, peaking in the middle of the day and 
remaining low for most of the night (Gillette and Reppert 1987; Hofman and Swaab,
1993). However, in vitro studies on single SCN units suggest that the dorsomedial 
region cannot sustain circadian rhythmicity when separated from the ventrolateral 
region (Gillette et al., 1993). Administration of VP or an antagonist does not alter 
circadian rhythms (Albers et al., 1984; Reghunamdaman et al., 1987) and the excitatory 
effects of VP when applied to hypothalamic slices in vitro also do not show circadian 
variation (Shibata and Moore, 1988). This, coupled with the fact that Brattleboro rats, a 
strain unable to produce VP in the SCN, still maintain normal circadian rhythmicity 
suggests that these cells are not essential for circadian entrainment.
There is evidence that melatonin receptors may be localised in the dorsomedial region in 
hamsters (Maywood et al., 1995) suggesting that melatonin may directly influence SCN 
efferents. It is thought that these effects may be mediated by vasopressinergic cells. 
There are other subsets of cells and terminals within the SCN and these display 
immunoreactivity to various substances including NT (primarily in the ventrolateral 
region) SP, CRF, PRL, neurophysin, bombesin, NPY and GABA. Gamma-aminobutyric 
acid (GABA) is an inhibitory neurotransmitter and GABA-containing neurons are 
distributed locally throughout the SCN colocalised with both VP and VIP (Moore and 
Speh, 1993). Drugs (i.e. benzodiazepines) effecting GABA-receptors alter the SCN 
response to light-induced phase-shifts which suggests that GABA may mediate both 
SCN activity and photic input. NT and NPY appear to be widely spread throughout the 
human SCN in distinct regions but their function is unknown (Moore, 1993).
1.1.3.4 Efferent projections from the SCN
The majority (around 70%) of SCN efferents are internal which indicates a high degree 
of modulation within the SCN. The direct efferent projections from the SCN are 
therefore too few in number to be solely responsible for the all of rhythmic parameters 
that are SCN-dependent. It is likely that these efferents convey rhythmic information to 
extra-SCN sites that amplify these signals which ultimately control circadian expression 
of many behavioural and physiological parameters. The SCN conveys information on
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time and rhythmicity that is integrated into the homeostatic regulation of a variety of 
functions.
There are efferents arising from VIP-containing neurons (in the ventrolateral region 
receiving direct photic input) to the paraventricular nucleus (PVN) of the hypothalamus 
and the hypothalamic subparaventricular zone (sPVHz). Similarly, there are efferents 
from the VP-containing neurons of the dorsomedial region also to the hypothalamic 
PVN. Various techniques have located many SCN efferent targets including the 
periventricular nucleus, dorsomedial and ventromedial nucleus of the hypothalamus, 
retrochiasmatic area, lateral hypothalamic area, preoptic region, supraoptic nucleus, 
posterior hypothalamus, lateral septal nucleus and IGL.
The functional response of these pathways is largely unknown but may be predicted 
from knowledge of the function of the target area (Figure 1.2). The majority of SCN 
efferents appear to innervate the sPHVz of the hypothalamus (Watts, 1991). The sPHVz 
has immunoreactivity to VIP, VP and NT from SCN efferents that may innervate 
distinctly separate areas of the sPHVz. There is evidence that the sPHVz may play an 
integral role in circadian rhythmicity control. Efferent projections from the sPHVz 
innervate very similar areas of the brain to the SCN, sometimes with a greater density. 
There are also afferent inputs to the PVN and sPHVz that may modulate their actions 
for example, from the IGL and direct retinal projections (Johnson et al., 1988a) 
suggesting that the sPHVz may receive photic information (Watts, 1991). The extent of 
SCN efferents to the sPHVz suggest an important role for the sPHVz in conveying, 
amplifying and possibly modulating SCN control of other brain areas.
The PVN of the hypothalamus is a potentially important target for the SCN as the PVN 
integrates many neuroendocrine, autonomic and behavioural processes, for example 
photoperiodic control of reproduction. Its projections innervate both the anterior and 
posterior pituitary, the brainstem and spinal cord. Many hormones show SCN- 
dependent circadian variations and may be controlled indirectly by SCN projections
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to the PVN. The PVN is also integral to the SCN-pineal pathway and therefore 
melatonin production which may haveimplicationsin rhythm control (Section 1.1.4.1).
There is some evidence that SCN efferents are humoral as well as neuronal as circadian 
VP release is seen in SCN explants in vitro (Earnest and Sladek, 1986). Certainly, 
circadian time-keeping within the SCN is not completely dependent on intact neuronal 
networks, as blocking sodium-dependent action potentials with tetrodotoxin does not 
halt underlying circadian timing (even though rhythms are temporarily abolished 
(Schwartz et al., 1987), or prevent serotonergic phase-shifts in the SCN (Prosser et al., 
1992). However, whether SCN humoral products influence circadian rhythmicity in vivo 
is not known (Silver and LeSauter, 1993). Removal of the pituitary gland, and therefore 
many humoral signals, can alter circadian rhythmicity (Zucker et al., 1980) and pineal 
melatonin certainly has an effect on SCN rhythmicity (e.g. McArthur et al., 1991). 
Foetal circadian rhythms are entrained to maternal rhythms possibly humorally before 
the fetal neuronal mechanism has developed (Reppert and Schwartz, 1983).
1.1.3.5 Modification of SCN function
1.1.3.5.1 Neuronal mechanisms
Some of the SCN afferents from brain sites that may modulate circadian rhythmicity 
may feedback to the SCN to modify its actions. However, there is little known about 
how this occurs.
1.1.3.5.2 Endocrine mechanisms
The rhythmic production of the pineal hormone melatonin is dependent on an intact 
SCN (Section 1.1.4.1). Melatonin may also be involved in regulation of SCN function 
by a feedback mechanism which, in turn,may modulate other circadian rhythms i.e. act 
as an internal zeitgeber. The phase-shifting effects of exogenous melatonin (Section 
1.1.4.5) require an intact SCN (Cassone et al., 1986b) and melatonin is known to act 
directly on isolated SCN in vitro (McArthur et al., 1991). Pinealectomy, causing
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abolition of most circulating endogenous melatonin, severely disrupts circadian rhythms 
in many lower vertebtrates (Cassone, 1990). These effects are thought to be mediated by 
specific melatonin receptors that are found in the SCN in animals (Vanecek et al., 1987) 
and humans (Reppert et al., 1988; Weaver et al., 1993). The distribution of these 
receptors is not uniform throughout the SCN in all species but is concentrated in areas 
of the SCN that are not retinophotorecipient (Maywood et al., 1995).
1.1.4 Melatonin rhythm production and control
1.1.4.1 Melatonin synthesis
Melatonin (N-acetyl-5-methoxytryptamine) was first isolated by Lemer et al. (1958)
from bovine pineals. It is an uncharged indole found throughout all classes of organisms
including unicellular algae and plants. In mammals, melatonin is produced primarily in
the pineal gland by pinealocytes. Its precursor is tryptophan, a dietary amino acid which
is actively taken up by the pinealocyte from the blood and hydroxylated (by the
mitochondrial enzyme tryptophan-5-hydroxylase) to 5-hydroxytryptophan. It is then
decarboxylated (by the cytoplasmic enzyme aromatic amino acid decarboxylase) to
form 5-hydroxytryptamine (serotonin). Serotonin is acetylated to N-acetylserotonin
which is then finally 0-methylated to form N-acetyl-5-methoxytryptamine (melatonin)
(Figure 1.3). The key regulating factor of this pathway is the enzyme N-
acetyltransferase (NAT) which converts serotonin to N-acetylserotonin and is up to 100
times higher at night than the day (Klein and Weller, 1970). Its circadian rhythm mirrors
that of melatonin concentration which is at least ten times higher in the dark period than
the light period. These rhythms in NAT and melatonin levels persist in constant
darkness and are driven by the SCN as denervation of the pineal or SCN lesions abolish
the rhythms of NAT and melatonin (Moore and Klein, 1974). The efferent pathway
fi*om the SCN to the pineal is multisynaptic and first passes to the PVN of the
to occur
hypothalamus which must be intact for melatonin production^(Klein et al., 1983a). 
These cells then project to the superior cervical ganglion via preganglionic cells and 
then noradrenergic postganglionic cells project to the pinealocytes (Figure 1.4).
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These nerve endings primarily release the neurotransmitter noradrenaline (NA) which 
interacts with Pi-adrenergic receptors and -adrenergic receptors located on the 
pinealocytes. ai-adrenergic receptors, although not originally thought to be involved, 
are also stimulated by noradrenaline and potentiate the stimulation of pi-adrenergic 
receptors (Klein et ah, 1983b). This induces an increase in intracellular cyclic adenosine 
monophosphate (cAMP) levels via GTP- binding protein which then increases NAT 
activity and melatonin synthesis. The a  %-adrenergic receptors potentiate these effects via 
an increase in intracellular calcium, phosphatidylinositol and diaglycerol levels.
After cAMP is activated (up to 60-fold), NAT activity is induced and there is a time 
lag whilst new mRNA is synthesised before the increase in NAT levels. Continual 
stimulation of p^-receptors is required to keep NAT in an activated state and if the 
enzyme is deactivated, for example by light, melatonin production stops (Vanecek and 
Illnerova, 1980) (Figure 1.4).
Another site of melatonin production is the retina although the level of production is not 
sufficient to contribute to circulating plasma levels in mammals (Leino, 1984). It is 
thought that retinal melatonin may have a role in maintaining local circadian rhythms in 
the retina, in modulating transduction of photic information or be involved in the control 
of retinal oscillators (Besharse and luvone, 1983). Retinal melatonin binding sites have 
been demonstrated in a variety of species (review, Skene et al., 1993) including some 
postmortem human retinae (James, 1997).
1.1.4.2 Melatonin metabolism
Melatonin is metabolised primarily in the liver. It is hydroxylated to form 6- 
hydroxymelatonin and is then either conjugated with sulphate, to form 6- 
sulphatoxymelatonin (aMT6s) or glucuronide, forming 6-hydroxmelatonin glucuronide. 
In humans, aMT6s is the primary metabolite with approximately 60-80% of melatonin 
forming the sulphated metabolite. Other minor metabolites (N-acetyl-Nformyl-5- 
methoxykynuramine, N-acetyl-5-methoxykynuramine, N-acetyl serotonin sulphate or
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glucuronide, cyclic isomer 2-hudroxymelatonin) may have some physiological 
relevance as yet unknown.
Plasma melatonin and plasma or urinary aMT6s have been shown to be very well 
correlated in humans both in terms of their rhythmic production and 24 h outputs 
(Arendt et al., 1985b; Bojkowski et al., 1987b; Bojkowski, 1988). Urinary aMT6s has 
also been shown to be sensitive to light-induced melatonin suppression (Bojkowski et 
al., 1987a), atenolol-induced melatonin inhibition (Arendt et al., 1985b) and phase-shifts 
in melatonin by bright light in field (Broadway et al., 1987) and laboratory (Deacon and 
Arendt, 1994a) conditions. This makes urinary aMT6s an excellent index of melatonin 
production. The reliability of the urinary aMT6s rhythm, its small propensity to be 
masked and the ease with which urine samples can be obtained makes analysis of 
urinary aMT6s an excellent tool with which to measure underlying circadian 
rhythmicity for long term field studies.
1.1.4.3. Factors affecting melatonin production and amplitude
1.1.4.3.1 Light
Light has two primary effects on the production of melatonin. Firstly, light is the 
primary environmental zeitgeber entraining the SCN (Section 1.1.1.2.1) and therefore, 
the timing of the production of the melatonin rhythm is entrained to the environment LD 
cycle by light-mediated SCN activity. Secondly, melatonin is acutely inhibited by light 
of a sufficient intensity (Lewy et al., 1980) in a dose-dependent manner in humans 
(Bojkowski et al., 1987a; Brainard et al., 1988; McIntyre et al., 1989; 1992; Owen and 
Arendt, 1992). Suppression is wavelength-dependent whereby around 510 nm is the 
most suppressive (Brainard et al., 1985). This does not, however appear to be mediated 
by conventional rod and cone photoreceptors: light-suppression of colour-blind 
individuals shows no difference to normally sighted subjects (Ruberg et al., 1996).
1.1.4.3.2 Age
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Melatonin production decreases with increasing age (Armstrong and Redman, 1991; 
Touitou et al., 1981; Iguchi et al., 1982; Sack et al., 1986) as does its main metabolite, 
aMT6s (Bojkowski and Arendt, 1990; Haimov et al., 1994). There is a reduction in the 
amplitude of the rhythm (Iguchi et al., 1982) which may be associated with unstable 
circadian rhythmicity and sleep disorders in the elderly (e.g. Czeisler et al., 1992; 
Gislason et al., 1993; Haimov et al., 1994). It has been proposed that exogenous 
melatonin administration, elevating the amplitude of circulating melatonin, may halt 
age-related circadian desynchrony (e.g. Armstrong and Redman, 1991).
1.1.4.3.3 Drugs
A variety of drugs interfere with the production of melatonin. Alpha-adrenergic 
antagonists (e.g. clonidine, Lewy et al., 1986) and P-adrenergic antagonists (p-blockers) 
suppress melatonin production in humans (e.g. atenolol, Cowen et al., 1985). The 
suppression is faithfully reflected in its urinary metabolite, aMT6s (Arendt et al., 
1985b). A variety of other drugs can also decrease levels of circulating melatonin, such 
as steroids (dexamethosone, Demisch et al., 1988), non-steroidal antiinflammatory 
drugs (ibuprofen. Bird et al., 1986) and alcohol (Ekman et al., 1993).
Several drugs could potentially increase melatonin production. For example, in humans, 
antidepressant drugs such as monoamine oxidase inhibitors (MAO) (e.g. 
tranylcypromine, Oxenkrug et al., 1986) and tricyclic antidepressants (e.g. desipramine, 
Franey et al., 1986) may increase circulating plasma melatonin levels. Similarly, p- 
adrenergic agonists (Desir et al., 1983), noradrenalin-reuptake inhibitors (e.g; 
oxaprotiline, Palazidou et al., 1992) or serotonin-reuptake inhibitors (fluvoxamine, 
Demisch et al., 1987) may have similar effects. They may work through increasing the 
availability of the melatonin precursor or transmitter (Arendt, 1985). However, the 
effects are not consistent (Demisch et al., 1987).
Benzodiazepines phase-shift the rhythm of melatonin in humans (e.g. temazepam. Sack 
et al., 1987) and therefore implicate GABA-receptors, found throughout the SCN
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(Section 1.1.3.3.2) in the mediation of non-photic phase-shifts. They may also exert 
minor inhibitionon night-time plasma melatonin levels (alprazolam, Arendt, 1995).
1.1.4.3.4 Other factors
There does not appear to be any effects of sex, height or weight on plasma melatonin 
levels in healthy adults (Bojkowski, 1988).
1.1.4.3.5 Melatonin as a phase marker of the clock
The rhythm of melatonin is considered to be the most reliable phase marker of the 
circadian system. The rhythm of its production is minimally masked by other variables, 
for example stress or activity, unlike the rhythms of CBT and cortisol. For example, 
CBT rises during activity and falls during sleep in addition to circadian changes thus 
‘masking’ the true position of its endogenous phase. This is particulary important when 
using CBT minima or maxima to predict the timing of the rhythm in order to time any 
treatment (e.g. light or melatonin) as any inaccuracies may cause treatment to be given 
at an inappropriate phase. There are some factors which marginally influence melatonin 
production, such as posture (Deacon and Arendt, 1994b) and excercise (Ronkainen et 
al., 1986) but these are minimal compared to the larger effects on other variables.
1.1.4.4 Role of melatonin
1.1.4.4.1 Daylength information
As melatonin is found so widely across all classes of organism, its role must be 
fundamental and highly conserved through evolution. In virtually all species, its 
production occurs in the dark phase of the day, regardless of whether the organism is 
nocturnal or diurnal. The primary function of melatonin is to provide information about 
daylength in order to control the timing of seasonal physiology such as breeding, coat 
growth and milk production. The duration of melatonin production extends and retracts 
relative to daylength in animals (e.g. sheep, Arendt, 1985) and it is therefore produced
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for a longer period during the short days (and long nights) of winter and for a shorter 
period during the long days (and short nights) of summer. In humans, this seasonal 
effect is difficult to measure unless the LD cycle is strictly controlled (Wehr, 1991). 
There is also a seasonal phase change of melatonin production in humans such that there 
is an an advance of the acrophase during the summer in Polar and temperate regions 
(Illnerova et al., 1985; Broadway et al., 1987).
1.1.4.4.2 Role of melatonin in thermoregulation
The circadian rhythms of melatonin and CBT are phase locked in unmasked conditions
(constant routine) (e.g. Nakagawa et al., 1992) and during fractional desychronisation
(Arendt et al., 1985a; Wever, 1989). The melatonin peak occurs close to the nadir of the
et al.,
CBT rhythm (Cagnacci^ 1992). This suggests that they are controlled by the same 
oscillator. In addition, administration of exogenous melatonin causes an acute drop in 
CBT in a dose-dependent manner which is associated with a simultaneous drop in 
subjective alertness and a phase shift of both the melatonin and CBT rhythms (Deacon 
et al., 1994).
1.1.4.4.3 Melatonin as a zeitgeber
Melatonin may be involved in control of SCN timekeeping via specific melatonin 
receptors and therefore act as an internal zeitgeber. Evidence comes from the finding 
that removal of circulating melatonin, via pinealectomy, disrupts circadian rhythmicity 
(Cassone, 1992) and that administration of exogenous melatonin has phase-shifting 
effects on the SCN in vitro and on circadian rhythms in vivo (Section I.I.I.2.2.2.2.).
1.1.4.5 Melatonin administration
1.1.4.5.1 Circadian effects
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Exogenous melatonin has phase-shifting and entraining properties on endogenous 
rhythms (Section 1.1.1.2.2.2.2) which suggests that endogenous melatonin may fulfil a 
similar role in circadian physiology.
1.1.4.5.2 Acute effects of melatonin
One of the most striking effects of melatonin administration is the induction of 
sleepiness. In both pharmacological (Vollrath et al., 1981; Arendt et al., 1984; 
Lieberman et al., 1984; Macfarlane et al., 1991;. Dollins et al., 1993a; Deacon and 
Arendt, 1995 ; Hughes et al., 1994; Nave et al., 1995) and physiological (Dollins et al.,
1994) doses melatonin has a sleepiness-inducing effect at various times of the day 
although not in all cases (James et al., 1990; Deacon and Arendt, 1995). This sleepiness- 
inducing effect, coupled with research showing a close association between endogenous 
melatonin rhythms and sleep propensity in sighted (Akerstedt et al., 1979; Haimov et 
al., 1994) and blind subjects (Tzschinsky et al., 1991; Nakagawa et al., 1992) has led to 
the proposal that endogenous melatonin fulfils a sleep ‘gating’ role in controlling the 
onset of sleep. This might be mediated by melatonin onset or a ‘critical accumulation’ 
of melatonin (Tzischinsky et al., 1993).
However, any inferences drawn from such experiments using exogenous melatonin 
must take into account the fact that the circulating levels of melatonin following 
administration usually greatly exceed normal endogenous levels.
1.1.5 Sleep rhythm production and control
1.1.5.1 The sleep-wake cycle
The control of sleep and wake, although recognised to be under circadian control, is 
complex in that there is also a strong daily homeostatic influence on timing and duration 
of sleep in normal conditions. A further complication of sleep-wake (SW) control is 
seen in temporal isolation experiments. Such experiments have shown that sleep, as 
expected of a circadian rhythm, free-runs at an endogenous period (along with other
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circadian rhythms) usually greater than 24 h (Wever, 1979; 1989). However, the SW 
rhythm can spontaneously desynchronise from strongly endogenous parameters (e.g. 
CBT or melatonin) and run at a different period or may be entrained, using light-dark 
cycles, to much shorter or longer periods (e.g. 22 h - 48 h) than CBT or melatonin 
(Wever, 1989). The SW rhythm has a much larger range of entrainment and is under a 
distinctly different control than other circadian rhythms, although there may still be 
some ‘mutual interaction’ between sleep and other rhythms. This deviation of sleep 
from other circadian rhythms has led to several hypotheses about the organisation of the 
circadian system and the number of oscillators involved (Section 1.1.2.2).
There have been several models proposed for the control of sleep-wake. These have 
tried to model the interactions between an endogenous circadian influence on the ability 
to initiate and sustain sleep throughout a circadian cycle and the homeostatic influence 
on the ability to sleep determined by the length of time of wakefulness before the sleep 
period.
The circadian aspect of SW control has been demonstrated in several ways. In an 
extended constant routine sleep deprivation study (Akerstedt et al., 1979), individuals 
expressed a persistent circadian rhythm in self-rated fatigue or sleep propensity that was 
strongly associated with circadian rhythms in CBT and melatonin. This relationship has 
since been confirmed in sighted subjects (Tzschinsky et al., 1993) and a spontaneously 
free-running blind man (Nakagawa et al., 1992) using an ultrashort sleep-wake 
paradigm (7/13 minutes) which unmasks the circadian rhythm of sleep propensity 
(Lavie, 1986).
Isolation and constant routine studies of actual sleep-wake periods have also 
demonstrated a distinct circadian effect in the timing and duration of sleep (e.g. Czeisler 
et al., 1980a). The ability to initiate and sustain sleep shows a marked time-of-day effect 
and is closely linked to the CBT rhythm. Even if sleep and temperature rhythms are 
running at different circadian periods, there is still a ‘mutual interaction’ between the 
rhythms making sleep more likely to occur as the CBT rhythm is falling and wake more 
likely as the CBT rhythm is rising (Czeisler et al., 1980a; Wever, 1989; Dijk and
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Czeisler, 1994). There are so-called ‘wake maintenance zones’ or ‘forbidden zones’ 
when sleep is either seldom initiated or demonstrates a long latency and these are 
observed in a variety of different SW patterns (Czeisler et al., 1980, ; Lavie, 1986; 
Strogatz et al., 1987; Dijk and Czeisler, 1994; 1995). Sleep duration also tends to vary 
according to when sleep is initiated. Sleep initiated during the CBT maximum is longer 
as wakes are less likely to occur as the CBT falls. Conversely, sleep initiated near to the 
CBT minimum is shorter as wakes are more likely to occur as the CBT rhythm rises 
(Czeisler et al., 1980 '; Wever, 1989; Dijk and Czeisler, 1994). There also appears to be 
a window where ‘wake-up’ seldom occurs, namely around the CBT minimum (Winfree, 
1980; 1982). These observations led researchers to state that the ‘phase of the 
endogenous circadian system, rather than the duration of prior wakefulness, is the major 
determinant of the length of sleep in normal man’ (Czeisler et al., 1980 ).
A two-process model of sleep regulation described by Borbély (1982), proposed a more 
balanced relationship between circadian mechanisms and homeostatic mechanisms (i.e. 
the influence of prior sleep and wakefulness on initiating sleep) of sleep control. It 
stated that EEG-measured slow-wave activity represented an ‘intensity parameter of the 
sleep process’. This was based on observations that slow-wave sleep (SWS) 
predominates during the first part of sleep, is increased in sleep immediately following 
sleep deprivation and decreased in sleep immediately following extended sleep or day­
time naps (Borbely, 1982) (which has since been confirmed (Daan et al., 1987; 
Âkerstedt et al., 1992)). Borbély’s model combined a sleep-dependent homeostatic 
function of sleep and wake, represented by slow-wave activity (called Process S) and a 
sleep-independent circadian propensity to sleep demonstrated as described above (called 
Process C). Process S is lowest immediately following a sleep episode and rises 
exponentially until the next sleep episode, during which Process S decreases 
exponentially (Figure 1.5). Process C follows a continuous sinusoidal pattern which is 
maximal around the CBT minimum and minimal around the CBT maximum. The model 
suggested that sleep occurred when a threshold in the difference between the two 
processes was reached (i.e. Process S was large and Process C was at an appropriate 
phase) and that sleep ended as the difference decreased (i.e. because of a fall in Process 
S during sleep and a reduction in the circadian propensity to sleep) (Figure 1.5).
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Figure 1.5 shows the outline of the model for a two-process regulation of sleep. Figure 1.5A 
(taken from Borbely, 1982) shows how sleep timing and duration may be controlled by the 
interaction of two processes; Process C, an endogenous circadian influence and Process S, 
the level of which is dependent on the length of prior wakefulness. Process S becomes 
larger as a function of time since waking and declines exponentially during sleep periods. 
Figure 1.5B (taken from Daan et al., 1987) shows how Process C and S may be influenced 
by external factors. Sleep occurs when Process S reaches the upper threshold of Process C.
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The model has since been modified and analysed in more detail (Daan et al., 1984; 
1987; Dijk et al., 1987) but still forms the basis of what is generally thought to be multi­
process control of sleep requiring a single circadian oscillator which interacts variably 
with a number of homeostatic mechanisms. Modifications include the addition of upper 
(H) and lower (L) thresholds for Process C between which Process S rises and falls 
(Daan et al., 1984). Alterations in the amplitude of these thresholds or changes in the 
difference between them were found to predict sleep schedules shown in sleep 
deprivation and fractional desychronisation studies and sleep in shift-work schedules 
(Daan et al., 1984). These thresholds were first modelled with similar shapes (skewed 
sine curves) but more recently, Borbely et al. (1989) has ftirther adjusted the shape of 
the upper threshold (to a standard sine curve). This was to allow more accurate 
prediction of sleep propensity which is represented by the difference between the upper 
threshold (H) and Process S (i.e. the greater the time since waking, the shorter the sleep 
latency).
Following on from Borbely’s model (Borbely, 1982), Akerstedt and Folkard developed 
a three-process model for the regulation of sleepiness and alertness (Akerstedt and 
Folkard, 1990; Akerstedt et al., 1992; Akerstedt, 1996). They have added a further effect 
called Process W (‘wakeup process’ or sleep inertia), which predicts the effect of forced 
awakening on alertness. The process falls immediately after forced waking (when 
alertness is low) in a steep, exponential manner. Its effect is only predicted to last for a 
few hours after waking. Recently, a version of this model has been integrated into 
computer software that allows experimental data to be easily tested against the model 
(Akerstedt, 1996). Wider applications of the model to multiple data sets from a variety 
of experimental and field conditions will further test the validity of the model and 
provide insight into how it may need to be improved.
An alternative hypothesis to Borbely’s was proposed by Kronauer and colleagues 
(Kronauer et al., 1982; 1983) which suggested that two interacting oscillators controlled 
sleep. This was developed in the light of isolation studies which demonstrated 
desychronisation between SW, CBT and alertness rhythms and led to the proposal that 
the human circadian system was controlled by more than one oscillator (Wever, 1979;
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1983; Folkard et al., 1983). Two oscillators were proposed - one was considered a 
strong oscillator (type X, cf. Wever’s Type I oscillator) which controlled strongly 
endogenous variables such as CBT and melatonin and one was weaker (type Y, cf. 
Wever’s Type II oscillator) which controlled sleep and activity (e.g. Kronauer et al., 
1982; 1983). They were said to exhibit ‘mutual interaction’ and showed relative co­
ordination or ‘phase trapping’. By altering the relative influence of the oscillators on 
each other or of an external zeitgeber, the model was able to predict sleep patterns and 
desychronisation very similar to those observed in experimental data. However, Daan 
and Beersma (1992) have shown theoretically that similar predictions of sleep in 
isolated conditions can be modelled using a single oscillator.
1.1.5.2 Naps
The role of naps within the SW cycle is not fully understood. Anecdotal evidence 
suggests that napping is common in a normal environment and may increase in certain 
subsections of the population, for example in students or the elderly. There is also 
evidence to suggest a natural ‘post-lunch dip’ in alertness (Colquhoun, 1971) which 
may manifest as a nap or, in some cultures, a ‘siesta’. Naps were prohibited in early 
studies (e.g. Wever, 1979) and therefore sleep was generally monophasic. The 
difference in the rhythm of this monophasic sleep compared to the rhythm of CBT 
formed the basis for the theory of ‘internal desychronisation’ (Section 1.1.1.2). 
However, restricting naps may have led to artifactual results about the relationship 
between the SW cycle and other circadian rhythms. Zulley and Campbell (1985) 
reanalysed sleep data obtained from subjects exhibiting internal desychronisation who 
napped during the study despite being instructed not to do so. Their analysis revealed a 
biphasic sleep pattern. Most sleep episodes occurred around the endogenous CBT 
minimum but others occurred approximately 180° out of phase, around the CBT 
maximum. This coincided with the so-called ‘post-lunch dip’ seen in alertness 
(Colqhoun, 1971). This polyphasic sleep and sleep latency pattern has also been 
observed in other studies employing different protocols (e.g. Miles et al., 1977; Strogatz 
et al., 1987; Tzischinsky et al., 1993; Klein et al., 1993) and has led to further work on 
the possible role of naps within the circadian system. There is conflicting evidence
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about whether allowing naps in temporal isolation shortens the period of the free- 
running rhythms of SW and CBT (Campbell et al., 1993) or lengthens it (Aschoff,
1994). Similary, there is some ambiguity in whether naps and the time of day at which 
they are taken, affect the ‘main’ sleep duration (Dijk et al., 1987; Aschoff, 1994). The 
overriding conclusion from these studies is that naps are an integral part of the SW cycle 
and that further work is required to measure how and why naps occur and how they 
relate to other circadian rhythms.
1.1.6 Performance rhythms
Psychomotor performance has long been known to have a repeatable and sustainable 
time of day effect (e.g. Akerstedt et al., 1979; Folkard et al., 1983; Folkard and Monk
1985). Although originally thought to be phase-locked to CBT (Colquhoun, 1971), the 
variation in performance is comprised of a mixture of influences; endogenous and 
exogenous components that contribute to the diurnal variation observed (Dijk et al. 1992; 
Wever 1983). Various factors influence performance including sleep and memory-load 
(Folkard, 1983; Folkard and Monk 1985) and performance has been shown to be sensitive 
to bright light treatment (Campbell and Dawson, 1991; Dollins et al., 1993b) and 
melatonin treatment (Dollins et al, 1993a). These properties make the measurement of 
performance a potentially useful tool to measure the effect of any changes in the circadian 
system as shown in shiftwork studies (e.g. Folkard and Totterdell, 1993).
1.2 Effects of blindness on circadian systems
1.2.1 Animal studies
The entrainment of circadian rhythms requires an intact RHT which in turn requires an 
intact retina. Removal of the eyes or the RHT prevents circadian responses to light. The 
pathway required for circadian response to light is distinct from the neural pathways 
required for vision as lesioning visual pathways but leaving the RHT intact does not 
disrupt circadian rhythms (Stephan and Zucker, 1972). However, as the retina is 
essential for mediating light signals for both processes, it would be reasonable to expect
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that any disease of the retina causing visual loss would potentially disrupt light-induced 
circadian responses.
In a series of experiments, Foster and colleagues (Foster et al., 1991; Foster et al., 1993; 
Foster et al., 1997) have shown that mice with hereditary retinal disorders, destroying 
either rods, cones or both, maintain normal circadian rhythmicity and the ability to be 
phase-shifted by light. This has led to the proposal that a novel set of photoreceptors are 
present on the mouse retina that may utilise a novel opsin to mediate light responses. 
Such a novel opsin has recently been described (Soni and Foster, 1997).
Another important animal model for studying circadian effects of blindness is the mole 
rat {Spalox ehrenberghi) which lives all of its life underground and, presumably due to 
selective evolutionary pressure, has only vestigial eyes remaining (cryptophthalmos). 
Cooper et al. (1993) have shown that despite a complete redundancy of the eyes for 
visual function in Spalox, the circadian response to light remains intact.
It is therefore clear that visual blindness is not analogous to ‘circadian’ blindness. The 
thresholdsof light required for the two responses are not equal e.g. we know humans can 
see in very dim light (1 lux, Middleton et al., 1996) but this does not phase shift the 
clock. Anterograde and retrograde viral tracing techniques have shown that there are 
distinct retinal ganglion cells that innervate the SCN (Card et al., 1991) and do not 
innervate targets similar to other central retinal targets. These cells are few in number 
and appear to be located in the periphery of the retina (Pickard, 1980; 1982) although 
they are widely spread throughout the periphery. They have an extensive dendritic 
network which encompasses most of the retina. This would be inadequate for spatial 
orientation of light signals but suitable to convey irradiance information. The 
distribution of these ganglion cells suggests that the photoreceptors innervating them are 
also small in number and distributed widely throughout the retina. However, how light 
for circadian rhythms is perceived and translated into a signal is not knovm. Foster has 
proposed (Foster et al., 1993) that the anatomy described suggests a ‘photon averaging’ 
system of circadian light perception capable of being mediated by only a few 
photoreceptors rather than a ‘photon counting’ mechanism.
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1.2.2 Circadian rhythm studies in blind people
1.2.2.1 Longitudinal Studies
There have been few studies investigating several circadian rhythms isimultaneously' in 
the blind and the number of subjects assessed in these experiments is small. Although 
several studies had previously investigated metabolism and circadian rhythms in the 
blind (Section 1.2.2.2), the first study to clearly describe circadian rhythm disorders was 
conducted by Miles et al. (1977). They showed conclusively that a blind man with no 
conscious light perception (NPL) had free-running physiological and behavioural 
rhythms with a period (tau) of 24.9 hours. The 28 year old man had a conventional 24-h 
lifestyle and complained of a cyclic sleep-wake disorder. Miles and colleagues reported 
that he had free-running rhythms in sleep-wake, temperature, alertness (Stanford 
Sleepiness Scale), performance, cortisol and urinary excretion rates, all with a period of 
24.9 h when the subject lived freely without restriction. This periodicity persisted 
despite a 10-day attempt to entrain his rhythms using a strict regime of bedtime, meals 
and activity. This study demonstrated for the first time that many parameters continued 
to free-run at an endogenous period despite the influence of living a conventional day.
This initial finding was supported by Orth et al. (1979) who investigated a 52 year old 
woman with no light perception for 50 days. She demonstrated a free-running cortisol 
rhythm with a major tau of 24.5 h. She was free to sleep at any time although she had 
knowledge of clock time and generally slept between 22.00 - 06.00 hr. However, her 
room was constantly illuminated and under such conditions, sighted individuals may 
also be expected to free-run. She did maintain regular mealtimes, social interaction and 
sleep-wake cycle and these had no apparent effect on the cortisol rhythm. Sleep did not 
appear to alter with the changing phase of the free-running cortisol rhythm although the 
researchers did report a minor 24 h component in cortisol production.
More recently. Sack et al. (1992) conducted a more extensive study of the plasma 
melatonin rhythms and subjective sleep of 20 NPL subjects. They revealed a
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heterogeneous distribution of melatonin rhythm types. Three were normally entrained 
(15%), three were abnormally entrained (15%) and 11 had free-running melatonin 
rhythms (55%) (tau range 23.86 - 25.08 h). The other three appeared to be arrhythmic 
(15%) and were classified as unstable. Most free-running subjects were described as 
having little variation in sleep as melatonin phase changed. Plasma cortisol was also 
measured in four individuals and was found to be phase-locked with the melatonin 
rhythm; the rise and fall in cortisol levels occurred at the same time as melatonin offset 
and onset, respectively.
In a case study of one of these subjects, subjective sleep and plasma melatonin were 
measured for two months prior to a detailed investigation of sleep propensity. Over this 
time, although melatonin free-ran at 24.65 h, sleep appeared fairly stable and entrained 
to 24 h. In a more intensive five-week study (Sack et al., 1989; Nakagawa et al., 1992), 
the researchers conducted polysomnography for one night, followed by a constant 
routine day and then a day when the subject was subjected to an ultra-short sleep-wake 
cycle (Lavie, 1986). The measurements included CBT, melatonin and cortisol. The 
unmasked measure of sleep propensity revealed by the ultra-short sleep-wake schedule 
free-ran in parallel at the same phase as CBT, melatonin and cortisol. The rhythms also 
appeared to be phase-locked i.e. the timing of the temperature maximum, cortisol 
minimum and melatonin onset coincided, and similarly the timing of the temperature 
minimum, cortisol maximum and melatonin offset coincided.
1.2.2.2 Short-term studies
The first study to demonstrate abnormal plasma melatonin levels in the blind was 
reported by Smith et al. (1981). These researchers took a day-time and night-time 
sample from four elderly men and showed higher daytime melatonin levels, a complete 
reversal of levels expected for sighted individuals. Following this small study, Lewy 
and Newsome (1983) investigated plasma melatonin profiles in ten blind subjects (9 
NPL, 1 LP) in more detail. Initially, a single 24-h plasma sample revealed that six 
subjects had an abnormally timed melatonin rhythm, three of these being phase- 
advanced and three being phase-delayed. Of the four subjects with normal melatonin
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profiles, three were bilaterally enucleated and one had anophthalmos. It was not possible 
to confirm whether these subjects were stably entrained with an abnormal peak time or 
whether any of the subjects were free-running, as follow-up melatonin profiles were not 
completed for most subjects (n = 8). Of two studied for a further four weeks, one subject 
demonstrated a stable but abnormally entrained melatonin rhythm (peak time 10.00 -
12.00 h, an approximate delay of eight hours) and the other subject had a free-running 
melatonin rhythm with a tau of 24.7 h.
Despite the limitations of this early work, the studies did confirm that blind people had 
abnormal rhythms or metabolism and that the abnormalities were a consequence of a 
loss of light perception. Orth and Island (1969), Kreiger and Rizzo (1971), Bodenheimer 
et al., (1973) and D’Allesandro et al. (1974) all found irregularities in the plasma 
profiles of corticosteroid production in a majority of blind subjects. Orth and Island 
(1969) studied three NPL subjects and demonstrated a normal, an abnormal and a free- 
running rhythm of 17-hydroxy corticosteroid (17-OHCS) production in these subjects. 
Kreiger and Rizzo (1971) showed that five out of seven blind subjects with light 
perception and nine from 12 subjects with no light perception had abnormal 11- 
hydroxycorticosteroid (11-OHCS) rhythms. Similarly, Bodenheimer et al. (1973) 
reported that grouped data of 24 h cortisol measurements from seven NPL subjects 
showed a phase-shifr compared to sighted controls. D’Allesandro et al. (1974) presented 
mean plasma cortisol data from 11 NPL patients that did not show a 24-h rhythmicity. 
All emphasised the importance of light in modulating the secretion of corticosteroids 
and noted a split of these rhythms from the sleep-wake cycle. Both rectal and oral 
temperature rhythms were also shown to have differing profiles in blind subjects with 
light perception (LP) when compared to sighted individuals (Tokura and Takagi, 1974; 
Tokura and Hirose, 1985). Similarly, irregularities of sleep and its timing were related to 
an abnormal phase of rectal temperature (Stavosky et al., 1980; Moog et al., 1987).The 
rhythm of excretion rates of electrolytes (N a\ Cf, K^) was also shown to be abnormally 
timed with a reduced amplitude in the blind (Lobban and Tedre, 1964; Simenhoff, 
1974).
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There have been several studies that did not find any irregularity in the rhythms of blind 
individuals. Migeon et al. (1956) failed to find any differences in the diurnal pattern of 
plasma and urinary excretion of 17-OHCS between sighted subjects, night-workers and 
blind subjects with no conscious light perception (NPL), although a reduction in the 
amplitude of plasma 17-OHCS was observed in the blind people. Weitzman et al. 
(1972) found cortisol and growth hormone rhythms in seven NPL subjects comparable 
to sighted individuals. Similarly, Scheving et al. (1987) found no phase difference in the 
epinephrine and norepinephrine rhythms of 14 blind subjects compared to sighted 
subjects although there was an increase in the mesor of norepinephrine levels in these 
subjects.
An exhaustive study of the ‘endocrine system’ of several hundred blind individuals was 
conducted by Hollwich and Dieckhues (1971). They found abnormalities in a wide 
variety of biochemical measurements in blind subjects (n = 220) compared to those with 
severely impaired vision (n = 140) and sighted subjects (n = 50). These included 
reduced serum levels of glucose, protein, cortisol, sodium and raised levels of creatinine 
and potassium which were mirrored in urinary analysis. However, sample collections 
were made only once and did not take into account any age or circadian differences 
between individuals. Ten blind subjects were studied from 6.00 - 20.00 h with plasma 
cortisol measurements every two hours. Although there was a reduction in cortisol 
production in the blind compared to sighted controls, the grouped mean results revealed 
no diurnal variation. Again, no attempt was made to account for the inter-individual 
variation in the diurnal pattern of cortisol production. However, Hollwich and 
Dieckhues (1971) did postulate the existence of an “excitatory effect” of light on the 
hypothalamus via an “energetic pathway of the optic system, ...independent of the visual 
pathway” that stimulated “releasing factors” from the hypothalamus that regulated 
hormone levels. This hypothesis was based on the finding that removing cataracts 
normalised “metabolic activity through increased corticotrophic activity as soon as light 
could once again gain entry into the eye”. These comments preceded findings 
confirming the existence of a physiologically distinct RHT (Section 1.1.3.2). Hollwich 
and Dieckhues also concluded that this reduction in metabolic activity in the blind 
accounted for the complaints of blind patients (including diminished physical capacity.
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insomnia, autonomic and emotional disturbances, hypoglycaemia). These complaints 
are very similar to those reported in the blind population at large (Section 1.2.3) which 
may be attributable to circadian disorders of physiology rather than altered metabolic 
rates per se.
Many studies have measured rhythms and metabolism in the blind over 24 hours but 
have not related the results to any behavioural rhythms. These short studies were 
obviously limited in their ability to phase type individuals accurately and probably 
underestimated the incidence of abnormal circadian rhythms. For example, free-running 
individuals would appear normally entrained for several days each cycle. Also, 
individuals were often grouped and therefore no account was taken of interindividual 
differences in overall levels of measurements or differences in phase-type.
1.2.2.3 Clinical studies
Further evidence of abnormal circadian rhythms in blind subjects stems from baseline 
and placebo data from clinical investigations. Several studies have defined rhythm 
abnormalities, especially in the sleep-wake cycle, in blind subjects prior to melatonin or 
light treatment (Sack et al., 1987; 1991; Arendt et al., 1988; Sarrafzadeh et al., 1990; 
Aldhous and Arendt, 1991; Palm et al., 1991; Tzischinsky et al., 1992; Jan et al., 1994; 
Czeisler et al., 1995a; Lapierre and Dumont, 1995) and these are discussed elsewhere 
(Section 1.2.5).
One particular clinical study deserves special consideration. A study was conducted by 
Czeisler and colleagues (1995a), which confirmed for the first time in humans that light 
signals could still reach the pineal gland and suppress melatonin production despite the 
fact that the subjects had no conscious light perception (NPL). The study was performed 
on 11 NPL subjects with varying causes of sight loss, eight of whom had a history of 
sleep disturbance. A light suppression test (Lewy et al., 1980) was perfomed on these 
subjects (90-100 minutes of 6,000-13,700 lux cool white light) and timed to coincide 
with expected peak of plasma melatonin production. The treatment failed to suppress 
melatonin in all eight of the subjects with sleep disturbance. However, the three
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remaining subjects, who did not complain of sleep problems, all had suppression of 
melatonin following light treatment, despite their complete blindness. Longitudinal 
reassessment of the phase position of their melatonin rhythm confirmed that they were 
normally entrained to 24 h. Of the eight that did not suppress, further assessment 
revealed that four of the eight were free-running and that the remaining four appeared to 
be normally entrained. These findings suggested that the RHT-mediated suppression of 
pineal melatonin was intact and functional in the three subjects that exhibited 
suppression (presumably mediated via the retina-RHT-SCN pathway) and the fact that 
they were entrained also implied that their endogenous clocks were photically entrained. 
However, the latter conclusion cannot not be proven from these results as there is 
evidence that light suppression of melatonin and photic entrainment have different 
sensitivities to light (i.e. a higher light intensity is required for entrainment than 
suppression) (Hashimoto et al., 1996). The findings also confirmed that some blind 
subjects appear to be normally entrained but do not exhibit light supression of melatonin 
which implies that time cues other than the LD cycle are able to entrain the endogenous 
oscillator.
1.2.2.4 Summary
In summary, previous research has demonstrated that the circadian rhythms of 
physiological parameters of blind subjects can be categorised as follows:-
a) normally entrained (by photic and non-photic zeitgebers) to 24 h
b) abnormally entrained to 24 h
c) free-running with a tau > 24 h (maximum delay reported 25.1 h)
d) free-running with a tau <24 h (maximum advance reported 23.83 h)
e) no distinct pattern (melatonin only)
However, there is no method of classifying individuals into these categories without 
long term studies of a number of physiological variables over several months.
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There does appear to be a consensus amongst these studies that all physiological 
parameters measured in normal or field conditions are phase-locked and have consistent 
relationships with each other (Sack et al., 1989; Sack et al., 1992; Nakagawa et al., 
1992; Folkard et al., 1990). The studies also suggest that there is no difference between 
individuals who are congenitally blind from birth and those becoming blind later in life 
(Weitzman et al., 1972; Simenhoff, 1974). There are also no apparent differences in 
circadian disorder according to the duration or age of onset of blindness (Kreiger and 
Rizzo, 1971; Sack et al., 1987). However, a difference has been described between blind 
subjects with and without conscious light perception (Simenhoff 1974; Hollwich and 
Dieckhues 1980).
1.2.3 Sleep studies in the blind
The effect of abnormal endogenous rhythms on sleep in field conditions appears to be 
inconsistent. Theoretically, as the sleep propensity rhythm is endogenous and has been 
shown to be phase-locked to strongly endogenous rhythms such as melatonin, cortisol 
and CBT (Nakagawa et al., 1992), then the sleep-wake cycle should also be expected to 
be phase-locked to these rhythms (Klein et al., 1993). However, sleep-wake patterns are 
also under considerable homeostatic control (Section 1.1.5) and are also subject to 
masking by, for example, social time cues and the desire to live a conventional 24 h day. 
Studies show that whilst remaining in normal social conditions (i.e. on a 24 h day) some 
individuals’ sleep patterns attempt to follow the phase of other endogenous rhythms, 
with night sleep consequently becoming more disrupted and daytime sleepiness 
increasing as the phase of the clock becomes more abnormal (Miles et al., 1977; Moog 
et al., 1987; Arendt et al., 1988; Aldhous and Arendt, 1991; Tzischinsky et al., 1991). 
However, the occurrence of disrupted sleep in free-running blind individuals is not 
universally observed as several studies did not measure any detrimental effect on sleep 
with changing circadian phase or phase abnormalities (Kreiger and Rizzo, 1971; Orth et 
al., 1979; Lewy and Newsome, 1983; Sack et al., 1992). Why this apparent 
inconsistency exists is not clear. It may be partly due to differences in methodology, 
poor sleep recording, differences in the individual relationship between homeostatic and
1-44
circadian sleep control or interindividuals’ susceptibilities to non-photic time cues or 
masking influences on sleep.
It is clear that sleep rhythms are affected by circadian disruption in a natural 
environment (e.g. in shiftwork or jet-lag) and experimentally by prolonged light 
deprivation (e.g. Middleton et al., 1996). Since lack of light perception can cause 
circadian rhythm disorders, sleep problems would be expected in the blind population. 
Several epidemiological studies have investigated the incidence of sleep disorders in the 
blind. However, there is some disparity in these reports of the extent of the problem. 
Miles and Wilson (1977) first reported that 76% of blind subjects with a range of visual 
loss complained of a sleep-wake disorder (n = 50). Additionally, 40% of subjects 
recognised that the symptoms were cyclic or episodic. Sasaki et al. (1992) demonstrated 
a lower incidence of sleep-wake complaints (40%) in 73 blind teenagers although they 
did postulate that an increase in sleep disorder (sleep phase delayed syndrome and non- 
24 h sleep rhythm) was associated with a decrease in light perception.
Recently, several studies on the incidence of sleep problems in the blind have been 
reported and again, the results are inconsistent. In our epidemiological study conducted 
with the Moorfields Eye Hospital (Tabandeh et al., 1995) (Chapter 2), 58% of blind 
registered individuals (n = 388) reported a sleep disorder as assessed by the Pittsburgh 
Sleep Quality Index (PSQI score > 5). The incidence and severity of sleep disorder was 
greatest in individuals with no conscious light perception (NPL).
Recently, Leger et al. (1996) reported on a postal study of 1073 blind individuals who 
were age, sex and location matched with sighted controls. Subjects completed the 
Nordic sleep questionnaire, the ‘Sleep questionnaire and assessment of wakefulness’ 
(SQAW) and sleep questions from the DSM-IV. A high proportion of the blind 
respondents (59%) reported no light perception. Sleep disorder was assessed in 794 of 
the 1073 ‘usable responses’ but no explanation was given for the selection of these 
subjects. Overall, significantly more of the blind individuals were said to have at least 
one sleep disorder (83%) (at least one of latency, night-time and early morning 
awakenings, reduced sleep duration or quality). Additionally, Leger and co-workers
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found that 17% of the subjects fulfilled the criteria for diagnosis of free-running sleep 
patterns (ICSD, 1990). Unfortunately, no information was provided about the severity 
of visual loss in individuals with ‘free-running’ sleep or on any relationship between 
sleep disorder and visual acuity. This is suprising in that the authors themselves stressed 
that the type of blindness and particularly loss of light perception is strongly associated 
with free-running rhythms (Leger et al., 1996).
Coincidentally, a similar-sized postal study of guide-dog owners (n = 1139) has also 
recently been conducted in the UK by Fouladi and co-workers (Fouladi et al., 1996; 
Moseley et al., 1996). The methodology for sleep assessment was not described but the 
study reported a low incidence of subjective disorder overall (18%) which reduced to 
14% in subjects who did not report being depressed (n = 981). They stated that sleep 
disorders were likely to be due to other factors than circadian rhythm disorders caused 
by loss of light perception.
It is important to remember when considering these studies that there are large 
methodological differences in the recruitment and assessment of the populations. There 
may be some bias in the type of individuals responding to such studies or postal 
surveys. There may also be profound differences in the definition of a sleep disorder 
between different questionnaires.
There are also a few clinical studies which only investigated sleep disorders in the blind. 
Martens et al. (1990) reported that 71% of NPL subjects (n = 16) complained of a 
chronic sleep disorder associated with increased sleep episodes and increased daytime 
sleep. In a detailed study of the sleep rhythms of four retarded blind children (ILP, 3 
NPL), Okawa et al. (1987) demonstrated that three had a free-running sleep cycle and 
that one was arrhythmic. Several methods have been employed to attempt to entrain 
these sleep-wake rhythm disorders with varied success (Section 1.2.5).
1.2.4 Other behavioural rhythm parameters
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There is very little documented evidence for disorders of mood or performance in blind 
people with circadian disorders. Miles et al. (1977) stated that alertness and performance 
free-ran with the same period as body temperature (24.9 h) although no further details 
were reported.
1.2.5 Treatment of circadian disorders in the blind
1.2.5.1 Melatonin
Ever since the phase-shifting properties of melatonin were first shown in humans 
(Arendt et al., 1984; Arendt et al., 1985a; Wright et al., 1986), it has been postulated 
that melatonin administration may reentrain free-running rhythms in the blind. This 
hypothesis was simultaneously tested by two groups of workers. Arendt and co-workers 
(Arendt et al., 1988) administered 5 mg melatonin or placebo daily for a month to a 59 
year-old man with free-running circadian rhythms (tau = 24.68 h). Treatment began 
when the endogenous melatonin rhythm was approaching a normal phase position. 
Melatonin treatment clearly consolidated the night-time sleep period and abolished day­
time naps. The subject also reported an improved sense of well-being. However, it was 
unclear whether exogenous melatonin had had any effect on the endogenous melatonin 
rhythm or any other marker of the circadian system. Further analysis of over 70 days of 
CBT and weekly urinary cortisol rhythms showed that these strongly endogenous 
rhythms remained free-running during the melatonin treatment despite the fact that the 
sleep-wake cycle appeared entrained (Folkard et al., 1990).
Conversely, several studies by Sack and colleagues (Sack et al., 1987; 1990; 1991) have 
reported apparent phase-shifts and entrainment in the endogenous melatonin rhythm 
following melatonin treatment. They first described phase advances in two blind 
subjects with free-running rhythms (Sack et al., 1987) of 7.6 h and 1.6 h following 5 mg 
melatonin at bedtime for 18 days. Treatment began when the endogenous melatonin 
rhythm was approaching its normal phase position (i.e. melatonin onset at 20.00 h). In 
the same experiment, 0.25 or 0.5 mg triazolam had a similar phase-shifting effect. These 
researchers later reported a case study of a man who had been self-medicating with 7.5
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mg melatonin daily at 21.30 h for several years (Sack et al., 1990; 1991). Following 
analysis of his endogenous melatonin rhythm, measured on three occasions at two­
weekly intervals, they concluded that it was normally entrained to a 24 h cycle. They 
suggested that the entrainment may have been due to the higher dose and longer 
treatment period compared to previous trials. However, visual inspection of the 
melatonin profiles prompts some questioning of whether the rhythm is entrained. The 
profiles are certainly not superimposable and the melatonin onset times vary by as much 
as 5-6 hours. A more detailed study of five free-running subjects (Sack et al., 1991) 
showed significant phase advances of both the endogenous melatonin rhythm (4/5 
subjects) and cortisol (2/3 subjects) following daily 5 mg melatonin treatment at 
bedtime. The mean cumulative advance for the group was 8.4 h. A similar effect was 
observed with 0.5 mg melatonin. One individual, however, was unaffected by the 
treatment. Sleep rhythms were unfortunately not measured but were reported to be 
conventional. There was no evidence for entrainment in any of these subjects and, 
following cessation of treatment, all of the subjects appeared to return to a free-running 
period similar to that seen before treatment.
These few experiments do not convincingly show that melatonin treatment is able to 
entrain the underlying circadian pacemaker, despite evidence for the contrary in animals 
(Redman et al., 1983). They do suggest, however, that melatonin treatment may 
temporarily shorten the period of the free-running rhythm which manifests as a phase- 
advance. If the underlying clock has continued to free-run in the blind subjects during 
melatonin treatment, then melatonin will have been administered at all circadian phases. 
Due to limitations in the frequency of plasma melatonin sampling, how these 
experiments correlate with the known melatonin phase response curve in sighted 
humans is not known. Daily sampling of a strongly endogenous marker of the circadian 
phase other than melatonin preferably under constant routine conditions is required in 
order to measure any phase-specific effects of melatonin treatment. As yet, this has not 
been performed.
The beneficial effects of melatonin treatment on alleviating sleep disturbance in the 
blind has been more extensively shown. Following the improvement of sleep observed
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in early studies (Arendt et al., 1988), Arendt and colleagues (Sarrafzadeh et al., 1990; 
Aldhous and Arendt, 1991) continued to show that melatonin improved sleep in blind 
people. Sarrafzadeh et al. (1990) demonstrated that 6 mg of melatonin given at 23.00 h 
and 5 mg given at 20.00 h advanced and stabilised sleep onset, reduced sleep latency 
and reduced the duration of night-time awakenings and day-time naps in a blind man 
with an abnormally entrained circadian system (advanced by ~ 5 h). There was, 
however, no evidence of phase-shifting effects on the endogenous cortisol rhythms. In 
the largest study of its kind to date, Aldhous and Arendt (1991) measured improved 
sleep in blind subjects with a variety of circadian disorders. In a placebo controlled trial, 
5 mg melatonin was administered at bedtime to eleven blind subjects with self-reported 
sleep disorders of which seven were reported to have a cyclical sleep-wake disorder. In 
those with free-running melatonin rhythms (tau > 24 h), melatonin stabilised the sleep 
period, reduced latency and increased sleep duration and subjective quality. However, 
one subject, with a period of 24.23 h, suffered worse sleep during the melatonin 
treatment. Overall, six of the eleven subjects showed statistically significant 
improvements in sleep without any corresponding evidence for entrainment of the 
endogenous urinary aMT6s rhythm.
Some research has been performed on the effects of melatonin administration on sleep 
in blind children. Tzischinsky et al. (1992) continuing their earlier study to measure the 
incidence of circadian sleep problems of the blind living in a boarding school 
(Tzischinsky et al., 1991), performed a sequence of experiments investigating the effects 
of dose and timing of melatonin administration. The first two attempts to alleviate the 
sleep disorder of a young blind man were unsuccessful. Placebo-controlled 
administration of 5 mg and 10 mg melatonin at 22.00 - 23.00 h for 2-3 weeks did not 
alleviate the subjects’ excessive day-time sleepiness and delayed sleep onset. However, 
once the treatment time was changed to 20.00 h, 2-3 h before bedtime, 5 mg melatonin 
caused an immediate and dramatic improvement in day-time alertness and a small 
advance in sleep onset and increase in sleep duration. There was also an associated 
advance in the acrophase of oral temperature.
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A study by Palm et al. (1991) investigated the effects of melatonin on the sleep of a 
severely mentally retarded 9 year old boy with bilateral microphthalmus. The boy had a 
clear free-running sleep-wake cycle (tau = 24.75 h) that was only marginally improved 
by a strict bedtime routine. Treatment with 0.5 mg melatonin at 18.00 h dramatically 
entrained the sleep-wake cycle producing a stable sleep period from 18.00/18.30 h - 
05.00/06.00 h. Discontinuing treatment for five weeks caused a return to the free- 
running sleep cycle within one week which was then reentrained with the réintroduction 
of treatment. Again, there was no evidence for entrainment of the endogenous rhythms 
of cortisol and temperature during treatment. A similar study recently described 
melatonin treatment of a five-year old severely retarded girl with microphthalmus with a 
free-running sleep-wake cycle (tau = 25.2 h) (Lapierre and Dumont, 1995). Behavioural 
impositions on sleep had no effect on entraining the cycle. Melatonin treatment was 
begun when the sleep-wake cycle approached a desired ‘normal’ phase (20.00 - 06.00 
h). Melatonin was administered in an oral suspension (0.5 mg in aqueous solution with 
2% ethanol) at 17.30 h for four days and then, because the treatment induced sleepiness 
within 30 minutes, it was altered to 19.30 h. The sleep period became stabilised 
(19.50/20.15 h - 6.00/7.00 h) and sleep duration was increased from around 9 h to 10.5 
h. There was no measurement of any other rhythm, so how the endogenous clock may 
have been affected is unknown.
In the most extensive study of melatonin administration to children to date, Jan et al. 
(1994) reported on 15 neurologically mutiply-disabled children (age range 0.5 - 14 
years), nine of whom had ocular or cortical blindness. Nine exhibited a free-running 
sleep-wake cycle, three had a delayed sleep onset and three had normally timed sleep. In 
a placebo-controlled study, 2.5 or 5 mg melatonin was given at the desired bedtime for 
ten days. All but one of the blind children showed some degree of improvement in their 
sleep with the main benefits being normalisation of the sleep period, increased night 
sleep duration and decreased day-time naps. The child whose sleep did not change 
following treatment, did experience improvement in mood and alertness. Several of the 
children showed a dramatic improvement in sleep. When the treatment was 
discontinued, ten of the 14 children experienced worsening sleep whereas in the 
remaining four, the melatonin-free sleep was acceptable. Unfortunately, as it was not the
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primary objective of the study to measure the effect of melatonin on circadian 
rhythmicity, no other rhythms were measured. Overall it was concluded that melatonin 
had a clear role to play in the treatment of certain types of sleep disorder.
1.2.5.2 Behavioural zeitgebers
The entraining effect of social zeitgebers has not been quantitatively examined in either
blind or sighted subjects. They are believed to have a significant effect in some blind
individuals following the report of a normally entrained blind subject who showed a
negative melatonin suppression test (i.e. the retina - RHT - SCN pathway is not intact).
(Czeisler et al., 1995a) (Section 1.2 .2 .3 ) . In the absence of photic entiainment, their first
was
conclusion was that non-photic zeitgebers were entraining the rhythm although there^no 
attempt to define the time cue. An alternative hypothesis, however, is that the individual 
had a free-running rhythm with a period very close to or at 24 h. Therefore, further 
experimentation is required to determine what the nature of the non-photic time cues 
may be before its role can be confirmed.
et al.,
Moog (Moog/, 1987) has investigated an alternative to photic zeitgebers in the blind. A 
‘potential complex zeitgeber’ has been designed in order to induce ‘activation’ in the 
morning in an attempt to entrain the clock. Moog developed a complex zeitgeber
which was administered for 3 weeks to 12 blind 
subjects. It consisted of a consistent bedtime and wake up time very day, a cold shower 
(14°C for 1 min), a heavy protein breakfast taken in a group setting and scheduled 
exercise (bicycle riding, 50 W over 15 mins). However, the results from these studies 
are confusing. Sleep and CBT were chosen as a phase-markers of the circadian system 
which is inappropriate given the heavy masking effects on temperature and sleep due to 
exercise, food intake and environmental temperature. In addition, the data could not 
distinguish between phase shifts and the timing of the endogenous period as no pre­
treatment measurements were made. The comparisons of grouped blind subject data to 
sighted individuals may also be very misleading as the blind subjects were grouped 
without considering their circadian rhythm types. There may have been a change in 
sleep and temperature rhythms throughout and following the treatment but this does not
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necessarily constitute a circadian phase shift. However, despite these shortcomings, it is 
essential to begin to try to elucidate what, if any, physical and social events have an 
entraining effect on the circadian system. If external non-photic stimuli are discovered 
then researchers can begin to investigate how these may affect the clock.
Any effects of non-photic zeitgebers in the blind are likely to be highly individual as 
many studies have reported that cyclic sleep disturbance persists despite conscious 
efforts on the part of the subjects (or carers) to maintain a strict social and sleep 
schedule or to exercise regularly (Okawa et al., 1987; Sack et al., 1990; Sack et al., 
1992; Jan et al., 1994). Similarly, living in such a highly scheduled environment as a 
boarding-school did not appear to prevent sleep disorder associated with delayed 
melatonin production (Tzischinsky et al., 1991).
1.3 Research aims of the thesis
The aim of the research described in this thesis was to conduct an extensive 
investigation into the circadian rhythms of blind subjects. Previous work had established 
that the blind community had a high incidence of sleep disorders that was thought to be 
due to circadian sleep disorders resulting from a lack of sufficient light perception. 
There had not been, however, an extensive study to investigate the relationship between 
sleep disorder and the severity of visual loss in the blind population. Chapter 2 describes 
an epidemiological study which measured the incidence of sleep disorders in blind 
subjects with varying degrees of visual loss in order to attempt to establish whether the 
severity of sight loss was associated with the severity of sleep disorders.
As the cause of sleep disorder is multifactoral, there was a need to establish whether the 
sleep disorders experienced by blind subjects were due to circadian rhythm disorders. 
Previous findings had provided details of the types of circadian rhythm disorders 
experienced by blind people. However, these reports were sparse, only a few individuals 
were studied and in general, behaviour was not investigated in a systematic manner. A 
further aim of this thesis, therefore, was to establish the circadian rhythm type of blind 
subjects with varying degrees of visual loss (Chapter 4) in order to determine to what
1-52
extent sleep disorders were due to circadian disorders. Chapter 5 describes the 
assessment of the circadian rhythm type of 49 registered blind subjects with varying 
degrees of visual loss using urinary aMT6s as a marker of circadian phase.
Although case studies had shovm some effects of circadian rhythm disorders on 
behaviour, there had been no extensive systematic investigation into the relationship 
between circadian phase (i.e. aMT6s) and behaviour (sleep, activity, mood, 
performance) in blind subjects with varying degrees of visual loss. In addition, there had 
been no detailed assessments of how circadian disorders affect behaviour in subjects 
attempting to live a normal lifestyle. Chapter 6, 7 and 8 investigate the sleep and activity 
rhythms of 49 blind subjects, monitored over at least four weeks in relation to the 
circadian phase of aMT6s. Chapter 6 assesses the rhythms of activity and subjective and 
actigraphically-derived sleep and naps and relates them to the rhythm of aMT6s. 
Chapter 7 specifically investigates the relationship between the timing of the aMT6s 
acrophase and the timing of day-time naps and Chapter 8 describes the effect of a free- 
running circadian system on sleep and activity. These Chapters are able to quantify for 
the first time the relationship between circadian phase, assessed using aMT6s, and sleep 
and activity in blind subjects living a 24 h lifestyle.
The circadian rhythms of mood and performance have not been previously studied in 
blind subjects in relation to circadian phase. Chapters 9 and 10 describe preliminary 
analysis to investigate the rhythms of mood and auditory performance and to measure 
any effects of changes in circadian phase.
Chapter 11 provides a comparison of subjective sleep diaries and actigraphically- 
derived automatic sleep scoring in order to determine their level of agreement in 
determining absolute sleep timings and measuring changes in sleep over time.
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CHAPTER 2
EPIDEMIOLOGY STUDY 
OF SLEEP DISORDERS 
IN THE BLIND
CHAPTER 2 - EPIDEMIOLOGY STUDY OF SLEEP DISORDERS IN THE 
BLIND 
2.1 Introduction
Blind individuals with a range of visual pathologies may lose the ability to be entrained 
by the light/dark cycle and consequently may have abnormally timed circadian rhythms, 
including sleep (Section 1.2.3). Sleep disorders have been widely reported in the blind 
community (Miles and Wilson, 1977; Martens et al., 1990; Sasaki et al., 1992; Fouladi 
et al., 1996; Leger et al., 1996; Moseley et al., 1996) with a range of incidence (18 - 
76%) generally higher than in sighted subjects (15 - 35%) (Karacan et al., 1976; Bixler 
et al., 1979; Mellinger, 1985). The primary reasons for these complaints are night-time 
disturbance and day-time sleepiness with associated detrimental effects on day-time 
alertness and performance. Case studies of blind individuals (Section 1.2.3) have 
confirmed that non - 24 h sleep - wake syndrome (ICSD, 1990) is present in some blind 
subjects presumably caused by an abnormally timed circadian system due to lack of 
adequate light perception required to entrain the clock.
The incidence of such sleep disorders in the blind community is not fully established, as 
previous studies have been limited in their sample population size and detail, 
particularly with regard to the type of sleep disorder and the individuals’ exact visual 
pathology. This chapter describes the assessment of subjective sleep disorder in relation 
to visual acuity, cause of sight loss, extent of visual field loss, duration and rapidity of 
blindness in blind individuals.
2.2 Methods
2.2.1 Subjects
388 registered blind subjects were recruited primarily from the Moorfields Eye Hospital 
outpatients clinics in addition to volunteers from colleges for the blind and the
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community. Interviews were conducted with every subject either by Dr. Homayoun 
Tabandeh or Dr. Rob Buttery of the Moorfields Eye Hospital. The study was approved 
by the Moorfields Eye Hospital Ethics Committee and all subjects gave informed 
consent prior to the interview. A further 15 subjects were interviewed and excluded 
from the study on grounds of evident affective disorder, as assessed by the Montgomery 
and Ashberg Depression Rating scale. A control group of sighted individuals (n = 44) 
was recruited from hospital staff, sighted patients or relatives of those attending the 
outpatients department.
2.2.2 Assessment of visual loss
Information was collected on the extent, rapidity, duration, cause of visual loss, 
presence of systemic disease and medications (Appendix A). Subjects had a range of 
severity of visual loss and were initially divided into two main categories; those with 
light perception (LP) and those with no conscious light perception (NPL). LP subjects 
were further categorised according to the extent of their visual loss as having 3/60 vision 
or better (Snellen scale), counting fingers (CF), hand movements only (HMO) or 
perception of light only (PL). The Snellen scale utilises the Snellen chart that has a 
series of letters that should be seen at a range of distances. The test is conducted at a 
distance of 6m and if only the top (largest) line of the chart can be seen, the vision is 
described at 6/60. If the bottom (smallest) line can be seen, the vision is 6/6 and is 
defined as ‘normal’ vision. If the top line cannot be seen from 6m, the subject is tested 
at 3m and if the top line can then be seen, the vision is 3/60. The subject is moved closer 
until if the top line cannot be seen at Im, then vision is classified into CF, HMO, PL or 
NPL.
Only subjects with ocular or anterior visual pathway lesions were included in the study. 
Their disease was classified into seven categories; age-related macular degeneration 
(ARMD), genetically determined disease, other retinal disorders, uveitis, glaucoma and 
optic nerve disease, bilateral enucleation for any cause and miscellaneous conditions, 
such as media opacities and amblyopia. The duration of visual loss was recorded in 
weeks, months or years and the rapidity of visual loss was categorised into days, weeks.
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months and years. Subjects were also divided into those with predominantly loss of 
peripheral field, central field or both. Gross measure of field is assessed by asking the 
subject whether one or two fingers are being held up in each quadrant of vision. Further 
investigation is performed by covering one of the subject’s eyes and a target (e.g. pen) is 
brought in from the periphery and the defects in field are assessed using the examiners 
eye as control.
2.2.3 Assessment of sleep disorder
Each subject was administered the Pittsburgh Sleep Quality Index (PSQI) (Buysse et al., 
1989; 1991) as part of a structured interview to collect details of any sleep problems 
experienced by the subjects. The PSQI is composed of seven components; subjective 
sleep quality, latency, duration, efficiency, disturbance, use of sleeping medication, and 
day-time dysfunction. These components contribute equally to a global PSQI score that 
has a possible range of 0 - 21 and a score of > 5 was taken as indicative of a sleep 
disorder.
2.2.4 Data analysis
Data analysis was primarily performed by Dr. Homayoun Tabandeh and colleagues. The 
relationship between sleep disturbance (PSQI score) and visual loss, age, ocular disease, 
duration and rapidity of visual loss was assessed by ANOVA and covariance, treating 
age as a continuous variable. The PSQI score was square-root transformed to give a 
more symmetrical distribution with a standard deviation unrelated to the mean. The data 
for subjects from the hospital population and volunteers from outside the hospital were 
analysed separately. There was no evidence of a difference between the two populations 
so the findings were combined for the remainder of the analyses.
2.3 Results
The total study population consisted of 44 sighted controls, 330 LP subjects and 58 
subjects with NPL. There was an overall significant difference in the PSQI scores of the
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three vision groups (sighted, LP, NPL) and between sighted, NPL and LP subgroups 
(Figure 2.1). There was a greater incidence of sleep disorders associated with increased 
visual loss (PSQI score > 5; sighted, 16%; LP, 54%; NPL, 78%) (Figure 2.2). The 
relationship between sleep abnormality and intensity of visual loss was significant 
(Pearson % = 37.51, p < 0.001) and persisted when adjusted for age. The most
frequently reported types of sleep problems were interrupted sleep (46.8%), increased 
sleep latency (40.3%), reduced sleep duration (36.0%), day-time sleepiness (17.3%) and 
irregular sleep (9.4%). There was no significant difference in the PSQI scores in relation 
to the duration, rapidity of visual loss or the type of field loss. Similarly, there was no 
difference in PSQI scores between subjects with congenital or acquired blindness. 
Figure 2.3 shows the mean ages and PSQI scores of the blind subjects categorised by 
disease type. Subjects with loss of vision due to uveitis and those with bilateral 
enucleations had significantly higher PSQI scores than the other diagnostic groups.
2.4 Discussion
This study found a high incidence (58%) of sleep disorders in a blind population with 
varying degrees of visual loss. There was an association between increased sleep 
disorder and increased severity of visual loss (sighted, 16%; LP, 54%, NPL, 78%).
The sleep-wake cycle is a circadian rhythm and, as such, is subject to the timing of the 
central oscillator, situated in the SCN (Section 1.1.5). The primary environmental 
zeitgeber is the LD cycle and therefore, any degree of visual loss may be expected to 
reduce the input of the entraining signal to the SCN (Section 1.2). This could result in 
desychrony between circadian rhythms, including sleep, and the environment (Section 
1.2.2). Therefore, sleep disorder may provide an indication of a disordered circadian 
system in the blind, as has been shown for similar circadian rhythm disorders such as 
jet-lag or shiftwork (Section 1.2.3). The finding that NPL subjects have the highest 
incidence of sleep disorder supports this view.
However, sleep control is complex and sleep disorders are multifactorial in origin, being 
influenced by emotional and physiological factors, daily routine and physical and social
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Figure 2.3 shows the mean (± sem) PSQI score (A) and age (B) for all blind subjects 
(n = 388), categorised into disease type. (ARMD - age-related macular degeneration, 
RD - retinal dystrophy, ON - optic nerve disorder, Enucl. - bilateral enucleation for 
any reason, Misc.- miscellaneous such as media opacities, ocular maldevelopment or 
amblyopia). There were significantly higher mean PSQI scores in subjects with 
uveitis or bliateral enucleation (*, p < 0.05, ANOVA). There was no significant 
difference in the mean ages of the subgroups. The numbers (n) within each subgroup 
are shown in italics.
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activity. The incidence of sleep disorder in sighted populations, (presumably not due to 
circadian disorders), is approximately 35% (Karacan et al., 1976; Bixler et al., 1979; 
Mellinger et al., 1985). We are therefore unable to state that all of the sleep problems 
observed in our study were due to circadian disorders. However, the findings that sleep 
disorder is higher in this blind population than in other studies of sighted subjects and 
that the incidence increases in those with no light perception compared to those with 
light perception, suggests that a significant number of blind people suffer sleep disorder 
as a result of their lack of vision and therefore circadian disorders. It could be argued 
that the stress of being blind may contribute to the higher incidence of sleep disorder. In 
our experience (Section 4.4), however, those with no light perception are generally 
better adapted to their disability than those with deteriorating sight and therefore any 
stress-mediated effects on sleep would not be expected to be greater in NPL subjects 
compared to LP subjects.
We did not find any relationship between sleep disorder (PSQI score) and the type of 
field loss, duration or rapidity of blindness. This may indicate either that these 
parameters do not affect photic input for circadian entrainment or that some degree of 
adaptation had occurred to diminish the effects of reduced photic input. It may also be 
the case that the global PSQI, which assesses only the previous months sleep, is not 
suitable to measure differences in the severity of sleep problems that may be related to 
long-term factors.
There was, however, an association between disease type and PSQI score. Individuals 
diagnosed as having uveitis or those with bilaterally enucleated eyes, had significantly 
higher PSQI scores. Uveitis is a general term for diseases of the uveal tract, which 
consists of the choroid, ciliary body and the iris of the eye. The retina and pineal share 
some metabolic pathways, for example, the pathway for melatonin production (Section 
1.1.4.1) and it has been demonstrated that pinealitis accompanies experimental 
autoimmune uveoretinitis (Al-Mahdawi et al., 1990) and that a syndrome involving 
pinealitis and uveitis exists in mammals (Kalsow et al., 1992; 1993). It has also been 
reported that reduced output of pineal melatonin production is observed in humans with 
uveitis (Touitou et al., 1986). It is therefore possible that the specific sites affected by
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uveitis interfere with the signalling required for photic entrainment. Bilateral 
enucleations, by definition, destroy the retina-RHT-SCN pathway and therefore prevent 
direct photic entrainment of the SCN. It would therefore be expected that individuals 
without eyes would exhibit circadian desychrony including sleep disorders. These 
findings uphold that hypothesis.
This study has confirmed and extended previous observations of a high incidence of 
sleep disorders in the blind compared to sighted controls. It is likely that a significant 
proportion of the sleep disorders is due to insufficient photic input to the oscillator 
controlling the timing of circadian rhythms, including sleep.
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CHAPTER 3
GENERAL METHODOLOGY
CHAPTER 3 - GENERAL METHODOLOGY 
3.1 Data collection
Subjects were provided with information about the trials in a format most convenient to 
them. The media employed were large print hard copy, audiotape, floppy disc or via e- 
mail. Subjects recorded data in a format of their choice and then provided the results to the 
researchers in printed hard copy, on audiotape, on floppy disc or via dictation or e-mail. 
Data were then transcribed from these formats onto spreadsheets for analysis. A cartoon of 
the study schedule is shown in Figure 3.1.
3.1.1 Physiological parameters
Subjects were asked to collect sequential four-hourly urine samples for 48 hours each 
week for four weeks. Subjects collected samples into plastic bottles and the urine volume 
or weight per collection period was measured and recorded. All subjects measured their 
own samples using either a measuring cylinder or speaking scales (Cobalt Systems Ltd., 
Reedham, Norfolk, UK), whichever was more appropriate. A 5 ml sample was transferred 
into plastic vials using Pasteur pipettes and frozen at - 20°C. On return to the laboratory, 
samples were thawed and divided into 1 ml aliquots and refrozen. Urinary aMT6s 
concentrations were measured and assayed using RIA (Section 3.2.1.1).
3.1.2 Behavioural parameters
3.1.2.1 Actigraphy
Subjects were asked to wear wrist-worn actigraphs (Motionlogger and Minimotionlogger, 
Ambulatory Monitoring, New York, USA) for the duration of the study. The monitors 
were pre-set to the ‘zero crossing mode’ so that the signal voltage from the motion 
transducer is compared to a reference voltage for a change of state, effectively measuring 
activity frequency (User Guide for the Motionlogger Actigraph, Ambulatory Monitoring).
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The subjects were only allowed to remove the monitor when it could get wet or if it 
interfered with any usual activity. They were asked to record the times of removal in an 
activity diary. The actigraphs were programmed to bin the data into one-minute epochs 
(the largest epoch that can be used for automatic sleep scoring). Raw data were 
downloaded directly onto computer disks at regular intervals and the actigraphs were reset. 
These data were edited and analysed using Action 3 software (Ambulatory Monitoring 
Inc., New York, USA).
3.1.2.2 Sleep diaries
Subjects were asked to keep a daily sleep diary for the duration of the study which took 
the following format:-
1. What is the date (please give the date on which you wake up)?
2. At what time did you go to bed?
3. At what time did you start trying to sleep at?
4. How long did it take for you to fall asleep?
5. How many times did you wake up in the night?
6. How many minutes sleep did you lose?
7. At what time did you wake up?
8. At what time did you get up?
9. Rate your sleep quality on a 9 - point analogue scale with these points defined; 1 = best 
sleep ever, 5 = neither the best nor the worst sleep, 9 = worst sleep ever.
3.1.2.3 Nap diaries
Subjects were asked to record spontaneously any naps outside their bedtime period in the 
following format:-
1. What is the time and date?
2. What time did the nap start?
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3. What time did the nap end?
4. How long was the nap?
3.1.2.4 Mood Scales
Subjects were asked to complete the following four 9 - point analogue scales once a day at 
the same time each day on the non-urine sampling days and every two hours whilst awake 
on urine sampling days. For each scale, five points were defined as follows:-
1. What is the time and date?
2. Rate your alertness on the following scale; 1 = very alert, 3 = alert, 5 = neither alert nor 
sleepy, 7 = sleepy, 9 = very sleepy.
3. Rate your cheerfulness on the following scale; 1 = very cheerful, 3 = cheerful, 5 = 
neither cheerful nor miserable, 7 = miserable, 9 = very miserable.
4. Rate your calmness on the following scale; 1 = very calm, 3 = calm, 5 = neither calm nor 
tense, 7 = tense, 9 = very tense.
5. Rate your depression on the following scale; 1 = very depressed, 3 = depressed, 5 = 
neither depressed nor elated, 7 = elated, 9 = very elated.
3.1.2.5 Performance
Subjects were asked to complete an auditory serial reaction time test every two hours 
whilst awake during the urine sampling days. The tests were specifically developed for 
this study by Professor Simon Folkard (University of Wales, Swansea, UK) and Dr. Peter 
Totterdell (University of Leicester, UK) and performed on a hand-held Psion organiser 
(Psion Organiser II, Model LZ, Psion pic, London, UK). Data were downloaded directly 
onto floppy disc.
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The auditory serial reaction time test (ASRT) consists of four sounds that are presented in 
a random order a total of 40 times each (160 stimuli in total). Each of the four sounds 
corresponds to a button on the Psion. The sounds are one octave apart and their 
frequencies are as follows:
ASRT (Hz) 33 131 5231 2093
The subject is asked to press the correct button in reply to each sound as quickly as 
possible. Once the subject has responded, the next stimulus begins immediately, 
regardless of whether the response is correct or incorrect. The parameters recorded for 
each half of the test for each hand are the reaction time (RT) of both correct and incorrect 
responses, the RT for all responses, the percent of incorrect responses and the percent 
‘gaps’ (defined as responses that are greater than 1 s). If the subject was disturbed during 
the test, they were asked to record when it was and repeat the test as soon as possible.
3.2 Data analysis
3.2.1 Physiological parameters
3.2.1.1 Assay of 6-sulphatoxymelatonin (aMT6s)
Urinary aMT6s concentration was measured by radioimmunoassay (RIA) using the 
method of Arendt et al. (1985b) adapted by Aldhous and Arendt (1988). The assay 
employs a specific antiserum to aMT6s raised in a sheep, which binds to urinary aMT6s in 
the samples. After an appropriate time to establish antibody-antigen binding, a fixed 
amount of I^^^-labelled aMT6s is added which competes with the unlabelled aMT6s for 
the antibody binding sites. Urine containing high concentrations of aMT6s Avill have 
relatively less I^^^-labelled aMT6s bound to the antibody. In contrast, urine containing low 
concentrations of aMT6s will have relatively more I^^^-labelled aMT6s bound to the 
antibody. The free and antibody-bound fractions are separated using a dextran-coated 
charcoal suspension. The free aMT6s fraction is adsorbed by the charcoal and separated
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by centrifugation. The gamma radiation from the charcoal pellets is measured using a 
gamma counter (Wallac 1470 Wizard automatic gamma counter, Wallac, Milton Keynes, 
UK) and concentrations are determined by interpolation against a standard curve, set up 
simultaneously using charcoal-stripped urine as a matrix. Urine with high aMT6s 
concentrations will have a high cpm as there vrill be relatively higher concentrations of 
free I^^^-labelled aMT6s stripped by the charcoal and measured in the pellet. Below is a 
brief description of the assay technique. All chemicals are obtained from Sigma Aldrich 
Co. Ltd. (Poole, Dorset, UK) and the charcoal-stripped urine, antiserum and radiolabel 
were provided by Stockgrand Ltd., University of Surrey, Guildford, UK).
1. Set up standard curve using charcoal stripped urine (Stockgrand Ltd.) (diluted 1:250 in
O.IM tricine buffer, pH 5.5; 17.9 g tricine (Sigma Ltd. product no. T-0377), 0.9 g NaCl,
1.0 g gelatin in 11 of double glass distilled water, heated for 50 °C for 30 minutes) and 
aMT6s standard (200 pg/ml) to 500 pi to give final concentrations of 0, 0.5, 1,2, 4, 7, 10, 
20 and 50 ng/ml. Both the standard curve and samples are set up in duplicate. The 0 
reference point (maximum binding) is measured in quadruplicate.
2. Dilute urine samples and quality control samples (low, medium, high) in tricine buffer 
to 500pl to give a final dilution of 1:250.
3. Dilute antiserum (Stockgrand Ltd. batch no ABS04 - G/S/0118-23884) in tricine buffer 
to give a final titre of 1:20,000 and add 200 pi to all tubes except the total and non-specific 
binding (NSB) tubes. Add 200 pi of tricine buffer to NSB tubes. Vortex tubes and 
incubate at room temperature for 30 minutes.
4. Dilute I^^^-labelled aMT6s (Stockgrand Ltd.) in tricine buffer to give 8,000 - 10,000 
cpm in 100 pi of dilute radiolabel. Add 100 pi of radiolabel to all tubes. Vortex and 
incubate overnight at 4° C.
5. Add 100 pi of dextran-coated charcoal (activated charcoal (Sigma Ltd. product no. C- 
5260) suspended at 2% weight/volume in tricine buffer, 0.2% dextran T-70
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weight/volume (Sigma Ltd. product no. D-1390), stirred for 1 h at 4 °C) to all tubes except 
the total tubes. Vortex and incubate for 15 minutes at 4° C.
6. Centrifuge at 3000 rpm for 10 minutes at 4° C. Decant supernatant and dab off excess 
on absorbent tissue. Count gamma radiation for 60 seconds in a gamma counter.
Samples with a high aMT6s concentration (over 40-50 ng/ml) were reassayed at a 1 ;2500 
dilution and those with a concentration below the limit of detection were reassayed at 
1:100 dilution. There is no significant loss of accuracy when using this range of urine 
sample concentrations in this assay (Bojkowski, 1988).
3.2.1.2 Analysis
Assay results were obtained in ng/ml and were converted to ng/hr for each collection 
period as follows:-
ng/hr = (ng/ml x urine volume (ml) or weight (g)) / hours of collection 
A 24-hour aMT6s output was calculated (pg/24 h) for each weekly sample period.
These values (ng/h) were subjected to 24 hour cosinor analysis (software provided by Dr. 
D.S. Minors, University of Manchester, U.K.) on both 24 h and 48 h vrindows. This 
revealed the aMT6s rhythm acrophase, amplitude, mesor, the probability of significance of 
the curve fit and % variance accounted for by the cosine curve (goodness of fit). Only 
results which showed a significant fit to a cosine curve (p < 0.05) were used in further 
analyses. Where collections were incomplete, the longest possible continuous sequence of 
collections was analysed. When a weight or volume was not recorded but the sample 
collected, it was estimated using the average weight or volume of similar time periods on 
other collection days. This occurred a total of 15 times from 1985 possible collections (0.8 
%).
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3.2.2 Behavioural parameters
3.2.2.1 Actigraphy
Raw data were converted to a format compatible with Action3 software (Ambulatory 
Monitoring, New York, USA). The times when the actigraph was removed were deleted 
using both the activity diaries kept by the subjects and visual assessment. All days with < 
67 % of data points present (i.e. <16 hours) were not used in further analysis. The raw data 
consist of a score for activity per minute (0 = no activity, increasing score indicates 
increasing activity).
The following analyses were performed on the data.
1. Mean daily activity was calculated (24.00 - 24.00 h).
2. A 24-hour cosine curve was fitted to the data (Action3 software) which yielded a daily 
acrophase time, amplitude, mesor and the probability of significance of the curve fit for 
activity.
3. Automatic sleep wake scoring was performed on the data (Action3 software). The 
software uses an algorithm which assesses the activity of the preceding four minutes and 
the subsequent 2 minutes before defining whether each minute is asleep, awake or ‘both’. 
Using the subjective sleep diary, the automatic sleep scoring was performed over a night­
time period (“going to bed time” to “get up time”). This revealed daily actigraphic 
measurements of sleep latency, sleep onset and offset, total night-sleep duration, number 
and duration of night awakenings and sleep efficiency. Similarly, automatic sleep scoring 
was performed over a day-time period (“get up time” to “going to bed time”) and revealed 
total day-time sleep duration and the number of separate sleep episodes.
3.2.2.2 Sleep and Nap Diaries
The sleep diaries revealed subjective measures of sleep latency, sleep onset (“time sleep 
was attempted” plus sleep latency), sleep offset (“wake up time”), total night-sleep 
duration (sleep onset time to sleep offset time minus “minutes sleep lost”), number and
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duration of night awakenings and subjective sleep quality. The nap diaries revealed the 
number and duration of day-time naps.
3.2.2.3 Mood Scales
The 9-point analogue scales from the urine sampling days revealed a mean daily score for 
alertness (alertnessf^sleepiness), cheerfulness (cheerflilomiserable), calmness 
(calmf^tense) and depression (depressedo-elated). Cosinor analysis was also performed 
on these data during the urine sampling days to reveal the acrophase, amplitude, mesor 
and the probability of significance of the curve fit.
3.2.2.4 Performance
Raw data files were converted to a format compatible with the spreadsheet software. From 
these raw data, the following were calculated for the whole test for both hands :-
1. Average reaction time of all responses (reaction time)
2. Percentage of correct responses (accuracy)
3. Percentage o f ‘gap’ responses (gaps)
A daily mean for reaction time, accuracy and gaps was calculated. A 24 h cosine curve 
was fitted to both sets of data in 24 h and 48 h windows for each week of the study. This 
revealed an acrophase, amplitude, mesor, probability of significance and % rhythm for 
both accuracy and reaction time.
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CHAPTER 4
SUBJECT DETAILS
CHAPTER 4 - SUBJECT DETAILS
This chapter describes the general characteristics of the whole study population together 
with individual details. Descriptions of specific subgroups within the whole population 
are contained in the relevant chapter.
4.1 General details
A total of 49 subjects were selected for detailed analysis of circadian rhythms (36 males, 
13 females). Of the 49 subjects, 36 were selected from the database compiled at the 
Moorfields Eye Hospital (Chapter 2) and the remaining 13 subjects were recruited by 
word-of-mouth within the blind community. The mean age (± SD) of the whole 
population (n = 49) was 46.1 ± 12.3 years (range 19 - 72). The majority of subjects 
(86%) complained of a sleep disorder as assessed by the PSQI (PSQI score > 5) (Section 
2.2.3). The mean PSQI score (± SD) was 8.4 ± 3 .5  (range 3-16). There was no 
statistically significant relationship between age and PSQI score in these subjects.
All of the subjects were in good health and were not taking any medication known to 
affect sleep and/or melatonin production (tricyclic antidepressants, monoaminoxidase 
inhibitors, serotonin reuptake inhibitors, benzodiazepines, neuroleptics, beta-blockers, 
sleeping medication) (Section 1.1.4.3.3).
4.2 Vision loss
Of these subjects, 19 had conscious light perception (LP) and 30 had no conscious light 
perception (NPL). LP subjects were further categorised according to the severity of 
visual loss as having visual acuity of at least 3/60 vision (n = 7), being able to count 
fingers (CF, n = 5), see hand movements only (HMO, n = 4) or perceive light only (PL, 
n = 3). NPL subjects were categorised into three groups according to the number of eyes 
present (two eyes present (2E, n = 12), one eye present (IE, n = 7), no eyes present (OE, 
n = 11). Individual details for visual loss, sex, age, PSQI score, diagnosis, onset.
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duration and rapidity of visual loss and field loss are shown in Table 4.1 for LP subjects 
and Table 4.2 for NPL subjects.
There were no significant differences with respect to age or PSQI score within the LP 
subgroups, within NPL subgroups or between LP and NPL subgroups (one-way 
ANOVA) (Figure 4.1). Overall, however, NPL subjects were significantly older than LP 
subjects (mean ages ± SD for LP and NPL subjects were 41.7 ± 11.7 yrs and 48.9 ± 12.0 
yrs, respectively; p < 0.05) (Figure 4.1 A) although there was no significant difference in 
the PSQI scores (Figure 4.IB).
Using one-way ANOVA, age and PSQI score were also analysed with respect to sex, 
duration of visual loss (birth, > 25 yrs, > 5 yrs, < 5 yrs) (Figure 4.2), rapidity of visual 
loss (days, weeks, months, years) (Figure 4.3) and field loss (central loss only, 
peripheral loss only, both central and peripheral loss) (Figure 4.4). There were no 
significant differences in PSQI or age with respect to any of these variables.
4.3 Disease
Only subjects with ocular or anterior visual pathway lesions were studied. The subjects 
suffered from a wide range of disease types (Tables 4.1 and 4.2). Definitions of the 
different diagnoses are shown in Table 4.3. The subjects were classified into the seven 
categories used to classify individuals in the epidemiological study (Chapter 2), namely 
age-related macular degeneration, genetically determined disease, other retinal 
disorders, uveitis, glaucoma and optic nerve disease, bilateral enucleation for any cause 
and miscellaneous conditions, such as media opacities and amblyopia. There were no 
significant differences between the ages or the PSQI score between the diagnostic 
groups (Figure 4.5).
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Figure 4.1 shows the mean (± SD) for age (A) and PSQI score (B) for all study subjects 
(n = 49) categorised according to the severity of visual loss (LP subjects, white 
columns) and the number of eyes present (NPL subjects, black columns). The number 
for each subgroup is shown in italics. There was no significant difference between the 
subgroups for age or PSQI score although overall, NPL subjects were older than LP 
subjects (*, p < 0.05, one-way ANOVA).
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Figure 4.2 shows the mean (± SD) age (A) and PSQI (B) score for ail study subjects 
(n = 49) categorised according to the duration of visual loss. The n for each subgroup 
is shown in italics. There were no significant differences between the subgroups (p > 
0.05, one-way ANOVA).
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Figure 4.3 shows the mean (± SD) age (A) and PSQI (B) score for all study subjects 
(n = 49) categorised according to the rapidity of visual loss. The n for each subgroup 
is shown in italics. There were no significant differences between the subgroups (p > 
0.05, one-way ANOVA).
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Figure 4.4 shows the mean (± SD) age (A) and PSQI (B) score for all study subjects 
(n = 49) categorised according to the field of visual loss. The n for each subgroup is 
shown in italics. There were no significant differences between the subgroups (p > 
0.05, one-way ANOVA).
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Figure 4.5 shows the mean (± SD) age (A) and PSQI score (B) for all subjects (n = 
49) categorised according to diagnostic criteria. The n for each subgroup is shown in 
italivs. There were no significant differences between the subgroups (p > 0.05, one­
way ANOVA).
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Table 4.3 Glossary of visual diseases 
Anophthalmos
Congenital disorder where the eye is underdeveloped. True anophthalmos is extremely rare as there is 
usually always a vestigial eye present although lost in the orbital tissues.
Behcet’s svndrome
Behcet’s syndrome is a disease with unknown aetiology but is presumed to be o f viral origin. The most 
common ocular complication is uveitis and can be associated with lesions o f the mouth and genitalia. It is 
seen particularly in young adults and recurs periodically and persistently in attacks o f extreme severity so 
that eventually vision is usually seriously impaired or lost.
Bruch’s membrane abnormality
Bruch’s membrane is a thin structureless lamella lying on the inner surface o f the choroid and adherent to 
the pigment epithelium o f the retina.
Buphthalmos
Also known as congenital glaucoma, buphthalmos is caused by a development abnormality o f the angle 
of the interior chamber o f the eye which prevents adequate drainage o f aqueous humor. The intraocular 
pressure in the eye increases as a result and the eye swells. The disease is usually bilateral and is more 
common in boys.
Cataracts
Any opacity o f the lens or its capsule, whether developmental or acquired is defined as a cataract. 
‘Complicated’ cataracts result from a disturbance o f the nutrition o f the lens due to inflammatory or 
degenerative disease o f other parts o f the eye.
Diabetic retinopathy
Diabetic retinopathy is a microvascular disease. Weakening o f the capillary walls causes small 
haemorrhages and micro-aneurysms. This leads to new vessel formation on the surface o f the retina and 
iris. When these changes involve the macular area, the central vision is profoundly affected. The causal 
factor o f diabetic retinopathy is unknown but appears to be dependent on the control o f the disease and 
the duration as it is common in patients after 10 years and found in the majority o f patients after 20 years.
Fundus flavimaculatus
This is a hereditary dystrophy o f the central pigment epithelium. It is a flecked retinal dystrophy affecting 
both eyes and appears usually in the third or fourth decade. The flecks never extend beyond the
4-10
equatorial retinal zone. Fifty percent o f individuals also have macular affections and the central vision 
fails when the macula is affected. It is now considered to be a part o f Stargardt’s disease.
Glaucoma
Glaucoma is a term used to describe intra-ocular pressure increases which may be due to increase in the 
formation o f aqueous humor or, more importantly, prevention o f its exit.
Leber’s congenital amaurosis
This is a pigmentary retinitis with congenital amaurosis in which blindness occurs in early infancy. It 
presents as bilateral blindness as soon as it can be registered, with nystagmus and some retention o f the 
pupillary reflexes and the eventual appearance o f a pigmentary degenerative change in the fundi. It is 
relatively common in infants and is an autosomal recessive trait.
Marfan’s syndrome
Marfan’s syndrome is a congenital dislocation o f the lens. The lens becomes drawn over the other side so 
that its free margin often spans the pupillary area.
Measles keratitis
Keratitis is inflammation o f the cornea that may arise from exogenous infections, from ocular infections 
and from endogenous infections.
Microphthalamus
This is a shrunken or vestigial eye.
Chorioretinitis
Rupture o f the choriod in association with retinal haemorrhage.
Myopia
Myopia is the condition where the retina is relatively too far back for the image to focus clearly on the 
retina i.e. the image focuses before the retina and the light rays have begun to diverge. This causes a 
blurred image on the retina.
Nystagmus
This is the term applied to rapid and involuntary oscillatory movements o f the eye, independent of 
normal movements. It is usually bilateral. It can be congenital or acquired. Congenital or early infantile 
nystagmus occurs at or within a few weeks of birth in congenital malformed eyes.
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Optic atrophy
This is the term usually applied to the condition of the disc when the optic nerve is degenerated. It is 
caused by damage to the nerve fibres at any point between and including the ganglion cells o f the retina 
and the lateral geniculate body. It is usually associated with loss o f either central or peripheral vision. It 
follows extensive disease o f the retina from destruction o f the ganglion cells, strangulation o f the nerve 
fibres or destruction o f the nerve in the orbit, for example following fracture o f the base o f the skull.
Retinal aplasia
This is a term used to describe maldevelopment o f the eye.
Retinal detachment fRDi
Retinal detachment is the separation o f the two embryonic layers o f the retina, the neuroretina from the 
pigment epithelium. There are two types - primary detachments where a hole develops in the retina and 
secondary, where the detachment is mechanical due to other events in the eye. Primary detachment is 
probably always due to the formation o f a hole on the retina which allows fluid from the vitreous to seep 
through and raise the retina from its bed. Secondary detachments may be due to the retina being pushed 
away from its bed by an accumulation o f fluid or a neoplasm.
Retinitis pigmentosa IRPl
R P i s a  group o f diseases causing a retinal dystrophy characterised by the deposition o f patches o f fine 
black pigment. It is hereditary, usually recessive and often sex-linked being most frequent in males. The 
disease becomes manifest between the ages o f 10 - 20 years and is slowly progressive with both eyes 
being equally affected. Visual loss expands both peripherally and centrally until a small island o f central 
vision alone remains (tunnel vision) which is gradually obliterated in middle age. Pathologically, the 
primary change is an atrophy o f the rods and to a lesser extent, the cones. There is also simultaneous 
gradual obliteration o f the retinal arteries and veins.
Retinoblastoma
Retinoblastoma is a malignant tumour in the retina due to proliferation o f neural cells which have failed 
to develop normally. It is a rare condition that is confined to infants and can be congenital. Treatment is 
usually the excision o f the eye.
Retinopathy o f prematurity fROPi
ROP occurs in premature infants who have been given high concentrations o f oxygen. New vessels form 
in the periphery on the retina and the vitreous which is usually followed by development o f fibrous tissue 
which proliferates to from a continuos mass behind the lens. The condition is usually bilateral and 
eventually causes retinal detachment and microphthalmia.
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Stargardt’s disease
Stargardt’s disease is a recessive, progressive dystrophy o f the central retina and develops between the 
ages o f 8-14 years. The final result is a complete disappearance o f the visual elements and the pigment 
epithelium in the centre o f the eye.
Subretinal neovascular membrane tSRNVlVfi
SRNVM is a cause o f macular degeneration. New vessel formation in the choroid results in haemorrhage 
and exudate which leads to scar formation.
4.4 Social factors
Tables 4.4 and 4.5 show the employment and domestic arrangements of LP and NPL 
subjects, respectively. Nine out of the 19 LP subjects (47%) and 21 out of the 30 NPL 
subjects (70%) were classified as workers. There was no difference in the age or PSQI 
scores between the two groups (mean age (± SD) = 47.4 ± 16.0 and 45.4 ± 9.8 years, 
mean PSQI score (± SD) = 9.1 ± 3.0 and 8.0 ±3.7 for non-workers (n = 19) and workers 
(n = 30), respectively).
4.5 PSQI score
Analysis was performed to investigate the relative contribution of the seven components 
to the global PSQI score within the study population (n = 49) to reveal the primary 
reasons for their subjective sleep disorder. Figure 4.6A shows the percent contribution 
of each of the seven components and Figure 4.6B shows the mean score (± sem) for 
each of the seven components (possible range 0 - 3). The primary complaint was short 
sleep duration which contributed on average to 18.4 % of the global PSQI score (Figure 
4.6A), followed by poor sleep quality (18.2%), long sleep latency (17.9%), daytime 
dysfunction (17.9%), poor sleep efficiency (14.4%), sleep disturbance (12.2%) and the 
use of sleeping medication (0.1%).
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Table 4.4. Social details for 19 LP subjects, categorised according to their severity of 
visual loss ( > 3/60 vision; CF (counting fingers), HMO (hand movements only), PL 
(perception of light only).
Visual loss
Subject No.
Sex Age PSQI Employment Lives with
3 / 6 0
4 M 36 9 Bank worker Family
5 M 52 8 Retired civil servant Alone
8 M 23 8 Full time University student Shared
9 F 46 12 Unemployed Family
10 M 24 13 Unemployed Family
12 M 33 6 Computer engineer Alone
47 M 61 7 Social worker Family
CF
1 F 47 10 Part-time school secretary Family
2 F 47 10 Civil servant Family
11 M 35 7 Building society clerk Family
15 M 36 7 Bank clerk Family
19 M 26 6 Unemployed Family
HMO
3 F 61 9 Unemployed Family
7 M 59 9 Retired underground worker Family
21 F 35 6 Unemployed Family
37 F 48 5 Unemployed Family
PL
6 M 41 8 Physiotherapist Family
40 F 47 3 Remedial therapist Family
41 M 35 6 Computing Alone
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Table 4.5. Social details of 30 NPL subjects, categorised according to the number of 
eyes present.
V isual loss
Subject N o.
Sex A ge PSQI Em ploym ent L ives with
2 eyes
13 M 48 12 Full-time Open University student Alone
16 F 61 6 Retired teacher Family
17 M 44 14 Quality Management facilitator Family
22 F 50 12 Telesales operator Family
25 M 62 11 Retired Alone
35 M 49 9 Disability capability consultant Family
38 M 57 7 Retired Family
39 M 46 5 Computer systems analyst Family
42 F 47 9 Remedial therapist Family
46 M 36 3 Computer programmer Alone
49 M 46 11 Solicitor Family
50 F 39 14 Unemployed Family
1 eye
14 M 32 11 Computer security consultant Alone
20 M 66 13 Retired physiotherapist Family
26 M 44 5 Self-employed Family
27 M 72 4 Physiotherapist Family
29 M 47 3 Civil servant Family
44 M 59 8 Retired computer operator Family
51 M 60 14 Word processor operator Family
no eyes
18 M 44 16 Probation Officer Family
23 M 41 8 Computer operator Alone
24 M 68 12 Retired Family
28 M 65 7 Charity Executive Alone
31 M 35 3 Bank worker Alone
33 M 55 4 Administrator Family
34 F 19 5 Full-time student Family
36 M 44 3 Home tuition organiser Family
43 M 35 12 Project Manager Family
45 M 42 8 Computer programmer / Analyst Family
48 F 54 14 Computer programmer Family
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Figure 4.6 shows the distribution of the seven components that contribute to the 
global PSQI score. Figure 4.6A shows the percentage contribution of the components 
to the PSQI for all subjects (n = 49). Figure 4.6B shows the overall mean (± sem) 
score for each of the seven components (range 0 - 3) for all subjects (n = 49). Two 
components made significantly less contributon to the global score (*, p < 0.05, one­
way ANOVA).
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CHAPTER 5
MELATONIN RHYTHMS IN 
RELATION TO VISUAL LOSS
CHAPTER 5 - MELATONIN RHYTHMS IN RELATION TO VISUAL LOSS
5.1 Introduction
The pineal hormone melatonin is considered to be one of the most reliable markers of 
the periodicity of the endogenous body clock and it is minimally masked by sleep, 
activity or stress (Section 1.1.4.3.5). The major metabolite of melatonin is 6- 
sulphatoxymelatonin (aMT6s), and its pattern of production in both plasma and urine 
faithfully reflects that of melatonin in both normal and phase-shifted conditions. 
Abnormally timed aMT6s production can be used as an indicator of circadian rhythm 
disorders as observed in shift work, jet lag and age-related sleep disorders (Section 
1.1.4.3.5).
Blind individuals may have abnormal retinal processing and/or a defective RHT, and 
therefore may not be capable of photic entrainment. In this case, their circadian rhythms, 
including the rhythm of melatonin production, would be expected to exhibit a non-24 h 
pattern (Section 1.2.2). Studies have concluded that blind individuals can be classified 
into four categories; (i) normally entrained to 24 h, (ii) abnormally entrained to 24 h, 
(iii) free-running with a period either greater or less than 24 h, (iv) unstable, with no 
discernible pattern (Section 1.2.2.4). In previous studies, the majority of blind 
individuals have had no conscious light perception. As the effects of light are intensity- 
dependent both with regard to light-induced melatonin suppression and light-induced 
phase shifts in sighted humans, the severity of visual loss may determine whether photic 
entrainment can occur. There has been no previous attempt to assess the relationship 
between endogenous circadian rhythms and visual loss or type of disease. Additionally, 
there have been few longitudinal field studies of blind individuals living in normal 
conditions measuring the effect of a “conventional” 24 h lifestyle on endogenous 
rhythms.
This chapter describes the aMT6s rhythms of 49 registered blind individuals many of 
whom had sleep disorders, and relates the pattern of melatonin production to the 
severity of their visual loss and eye disease.
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5.2 Methods
5.2.1 Subjects
Forty-nine registered blind subjects were recruited for the study. Full details of the study 
population are described in Chapter 4. Briefly, of these 49 individuals, 19 had conscious 
light perception or better (LP subjects) and 30 had no conscious perception of light 
(NPL subjects). LP subjects were classified according to the severity of their visual loss 
as having visual acuity of at least 3/60 vision (n = 7), being able to count fingers (CF, n 
= 5), see hand movements only (HMO, n = 4) or perceive light only (PL, n = 3). NPL 
subjects were classified into three groups according to the number of eyes present on the 
basis that there may be a quantitative difference in the number of photoreceptors present 
in each group (two eyes present (2E, n = 12), one eye present (IE, n = 7), no eyes 
present (OE, n = 11)).
5.2.2 Study Schedule
Full details of the study schedule are described in Chapter 3. All subjects collected urine 
samples for at least three consecutive weeks. All subjects produced at least three 
sequential 48 h urine collections (3 collections, n=l; 4 collections, n=46; 5 collections, 
n=2) over at least three weeks.
5.2.3 Assay
Urinary aMT6s concentrations were measured by radioimmunoassay (RIA) using the 
method of Arendt et al. (1985b) adapted by Aldhous and Arendt (1988) (Section 
3.2.1.1). The inter-assay coefficients of variation (CV) were 17.7%, 21.8%, 12.8% and 
10.0% at 3.4 ng/ml (n = 59), 23.5 ng/ml (n = 59), 39.6 ng/ml (n = 32) and 43.9 ng/ml (n 
= 19), respectively. All the samples fi*om an individual were measured in a single assay 
and the intra-assay coefficients of variation were 10.8% and 10.5% at 3.7 ng/ml (n = 10) 
and 26.4 ng/ml (n = 10), respectively.
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5.2.4 Data analysis
5.2.4.1 24 h aMT6s production
The mean 24  h aMT6s output was calculated for each week (|Lig/24 h) for each subject 
with the associated CV. The data were grouped according to sex, age (19 - 29, 30 - 39, 
40 - 49, 50 - 59, > 60 yrs), severity of visual loss (LP subjects - > 3/60 vision, CF, 
HMO, PL; NPL subjects - two, one or no eyes present), light perception (LP, NPL) and 
circadian rhythmicity (normally entrained (NE), abnormally entrained (AE), free- 
running (FR), unclassified (UN)) and were assessed by one-way ANOVA.
5.2.4.2 Assessment of circadian rhythmicity
aMT6s output for each sequential collection period (ng/ml) was converted to ng/h and 
subjected to cosinor analysis (software provided by Dr D.S. Minors, University of 
Manchester, U.K.) to provide the acrophase time (phi (cp)), amplitude and mesor of the 
aMT6s rhythm. Only results which showed a significant fit to a cosine curve (p < 0.05) 
were used in further analyses. To assess any change in the timing of aMT6s production 
and to determine the periodicity of the rhythm for each subject, regression lines were 
fitted through the significant acrophases (tau (t) = 24 h + slope). A rhythm was 
considered to be significantly free-running (FR) when the 95% confidence limits of the 
line did not cross 0 {i.e. 24.00 h). Subjects were considered to be entrained if the 
regression analysis was not significantly different from 24 h. Subjects were classified as 
abnormally entrained (AE) if  the mean acrophase time fell outside the normal range for 
sighted individuals (range; mean ± 2SD = 4.2 ± 2.9 h, n = 80; unpublished results, J. 
English and J. Arendt, University of Surrey, U.K.) and normally entrained (NE) if the 
mean acrophase fell inside the normal range. For free-running subjects, any correlations 
of tau with age and PSQI score were determined. Amplitudes derived from cosinor 
analysis were analysed by one-way ANOVA to investigate any difference between 
subjects and a CV for amplitude was calculated to measure within subject variability. 
The data were grouped according to sex, age (19 - 29, 30 - 39, 40 - 49, 50 - 59, > 60
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yrs), severity of visual loss (LP subjects - > 3/60 vision, CF, HMO, PL; NPL subjects - 
two, one or no eyes present), light perception (LP, NPL) and circadian rhythmicity 
(normally entrained (NE), abnormally entrained (AE), free-running (FR), unclassified 
(UN)) and were assessed by one-way ANOVA.
5.3 Results
5.3.1 24 h aMT6s production
All subjects produced measurable amounts of urinary aMT6s as assessed by RIA. There 
was a high degree of consistency in the 24 h aMT6s output within an individual. The 
mean CV (± SD) for 24 h aMT6s output for LP and NPL subjects was 21.3 ± 10.9% and
17.1 ± 12.3%, respectively. There was no significant difference in the mean 24 h output 
within LP or NPL subgroups, between all LP and NPL subgroups or overall between LP 
and NPL subjects (p > 0.05). The mean (± SD) 24 h aMT6s output was 12.7 ± 7.5 pg/24 
h and 9.4 ± 6.4 pg/24 h for LP and NPL subjects, respectively (Figure 5.1).
Figure 5.2A shows the correlation between age and mean 24 h aMT6s output for all 
subjects. There was no significant effect of age on aMT6s output (p > 0.05) but there 
was a trend for output to decrease with increasing age (r = -0.19). There was also no 
significant difference between the 24 h aMT6s output with respect to sex (p > 0.05).
5.3.2 Assessment of circadian rhythmicity
5.3.2.1 Subjects with light perception
Overall, 18 of the 19 LP subjects showed a significant rhythm in aMT6s production as 
assessed by cosinor analysis. Table 5.1 shows the mean acrophase times (± SD) and the 
period of the aMT6s rhythm for all LP subjects. Figure 5.3 shows the plot of the mean 
acrophase times (± SD) for all subjects, categorised according to circadian type and light
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Figure 5.1 shows the mean (± SD) for 24 h aMT6s output for all subjects according to 
the severity of visual loss (LP subjects) and the number of eyes present (NPL 
subjects). The white columns represent LP subgroups and the black columns represent 
NPL subgroups. The number of each subgroup is shown in italics. There were no 
significant differences between the subgroups.
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Figure 5.2 shows the correlation between age and mean 24 h aMT6s output (n = 49, pg 
aMT6s/24 h) (A) and aMT6s rhythm amplitude (n = 47, pg aMT6s/h) (B). LP and NPL 
subjects are represented by open and closed circles, respectively. There is a non­
significant trend for a decrease in both 24 h aMT6s output and amplitude with 
increasing age.
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Subject
Visual
loss
phi
mean (± SD)
Tau 
(±95% limits)
Circadian
status
>3/60
4 4.30 (1.10) 24.00 NE
5 6.23 (0.64) 24.00 NE
10 4.33 (0.85) 24.00 NE
12 4.20 (0.64) 24.00 NE
9 1.03 (0.81) 24.00 AE
47 9.00 AE
8 ns UN
CF
1 4.48 (1.08) 24.00 NE
2 3.07 (1.21) 24.00 NE
19 5.03 (0.74) 24.00 NE
11 2.43 (1.46) 24.00 NE
15 8.90 (0.90) 24.00 AE
HMO
3 4.70 NE
7 4.90(1.92) 24.00 NE
21 4.28 (0.21) 24.00 NE
37 4.10 NE
PL
6 4.80 (0.99) 24.00 NE
41 4.30 (0.70) 24.00 NE
40 21.20 AE
Table 5.1 shows the mean acrophase times (± SD) and tau for ail LP subjects, 
categorised by the severity of their visual loss, ‘ns’ depicts no significant acrophase 
times. Where tau is not shown, there were too few significant acrophase times (< 3) to 
fit a regression line. Circadian status is also shown (NE, normally entrained; AE, 
abnormally entrained; FR, free-running, UN, unclassified).
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Figure 5.3 shows the mean ± (8D) aMT6s acrophase time for ail subjects (n = 49) for 
the whole study, grouped according to circadian rhythm type. They are categorised 
according to light perception (white, LP; black, NPL) and their circadian rhythm type 
(□ ■ , NE; 0 # ,A E ; A, FR; <>♦, UN). The shaded area represents 2 8D from the 
mean aMT6s acrophase for sighted subjects (n = 80, unpublished results, English and 
Arendt) which is shown by the white line.
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perception. One subject (S8) did not show any significant rhythm and was defined as 
unclassified.
The type of circadian rhythm with respect to the subjects’ visual loss was then assessed. 
Six out of 7 subjects with > 3/60 vision had a circadian rhythm in aMT6s. Four of these 
were normally entrained to 24 h and two subjects had abnormal acrophases (S9 and 
S47) (Figure 5.4A). Subject 9 had an advanced acrophase time (mean ± SD = 1.0 ± 0.8 
h) and S47 had a delayed acrophase time (only one significant acrophase = 9.0 h). Of 
the five subjects with CF vision, four were normally entrained to 24 h and one subject 
appeared to have an abnormally entrained delayed aMT6s rhythm (SI5, mean ± SD = 
8.9 ± 0.9 h). All four individuals with HMO vision had aMT6s rhythms normally 
entrained to 24 h. Three subjects had light perception only (PL) and of these two were 
normally entrained to 24 h and one subject appeared to be abnormally entrained with an 
advanced acrophase time (S40, only one significant acrophase = 21.2 h).
Four LP individuals had less than three significant acrophases and were classified 
according to their significant acrophase results albeit with some reservation as to the 
confidence of the classification. S3 and S37 had single acrophase times within the 
normal range whereas S40 and S47 had single acrophases outside the normal range. In 
cases like these it is not possible to determine if a single acrophase, whether normal or 
abnormal, is part of a free-running rhythm or an entrained rhythm. Observation of the 
raw data plots suggested they had relatively stable, and therefore entrained rhythms 
(normally (S3, S37) or abnormally (S40, S47) entrained) rather than free-running 
rhythms.
In summary, of 19 LP subjects, 14 individuals had normally entrained aMT6s rhythms 
(74%), four subjects appeared to be abnormally entrained (21%) and one was 
unclassified (5%) (Table 5.3). Figure 5.5A shows a representative example of a subject 
with a normally entrained aMT6s rhythm. The aMT6s rhythm profiles for all other 
subjects are in Appendix B.
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Figure 5.4 shows the individual weekly aMT6s acrophase with the associated 
regression lines for each subject. Subjects are categorised into LP (A) and NPL 
subgroups according to the number of eyes present (two eyes, (B), one eye (C), no eyes 
present (D)). The shaded area represents the range of aMT6s acrophases for normally 
entrained individuals (n = 80, unpublished results). The key shows the subject number 
(S) and the associated tau (h) of the aMT6s rhythm.
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Figure 5.4 shows the individual weekly aMT6s acrophase with the associated 
regression lines for each subject. Subjects are categorised into LP (A) and NPL 
subgroups according to the number of eyes present (two eyes, (B), one eye (C), no eyes 
present (D)). The shaded area represents the range of aMT6s acrophases for normally 
entrained individuals (n = 80, unpublished results). The key shows the subject number 
(S) and the associated tau (h) of the aMT6s rhythm.
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Figure 5.5 shows representative plots of weekly 48 h aMT6s profiles (mg/h) for a 
normally entrained (SI) (A), an abnormally entrained (S I6) (B) and a free-running 
(S I8) (C) subject. The shaded area represents the range over which aMT6s acrophase is 
considered normal (n = 80, unpublished results).
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5.S.2.2 Subjects with no perception of light
Overall, 29 out of 30 NPL subjects showed a significant rhythm in aMT6s production. 
Table 5.2 shows the mean acrophase times and the period of the aMT6s rhythm for all 
NPL subjects. Figure 5.3 shows the plot of the mean acrophase times (± SD) for all 
subjects, categorised according to circadian type and light perception. One subject (S35) 
did not show any significant rhythm and was defined as unclassified.
The type of circadian rhythm with respect to the subjects’ visual disorder was then 
assessed. Eleven out of 12 subjects with two eyes present (2E) had significant 
acrophases (Figure 5.4B). Four had normally entrained rhythms and five appeared to be 
abnormally entrained. Of the two subjects with free-running rhythms, one had a 
significant rhythm (S17, t = 24.34 ± 0.10 h) whereas one (S46) was clearly jfree-running 
but due to a short collection period (3 weeks) the 95% confidence limits of the line 
crossed 24.00 h (t = 24.54 ±1.38 h). Of the seven subjects with one eye present (IE), 
two subjects had normally entrained rhythms and five had significant free-running 
rhythms (t range 24.35 - 24.79 h) (Figure 5.4C). There were eleven subjects with no 
eyes present (OE) and one individual appeared to be normally entrained to 24 h (S34, 
mean acrophase ± SD = 6.7 ± 1.2 h) (Figure 5.4D). Seven subjects had significant free- 
running rhythms (t range 24.39 - 24.68 h) and three individuals (S28, S43, S45) clearly 
had free-running rhythms although they did not achieve significance according to our 
criteria. Of these, S28 and S43 had free-running rhythms observed in the raw data plots 
(Appendix B) but the 95% confidence limits of the line just crossed 24.00 h (t = 24.41 ± 
0.58, 24.13 ± 0.18 h, respectively). S45, due to technical problems, had fewer samples 
and the cosinor fits were non-significant. Observation of the raw data plots revealed a 
tau of approximately 24.9 h.
With respect to the number of eyes present, the incidence of rhythm abnormalities was 
greater in unilaterally and bilaterally enucleated individuals (two eyes present, 42% 
abnormally entrained, 17% free-running; one eye present, 71% free-running; no eyes 
present, 91% free-running) (Table 5.3). In summary, of the 30 NPL subjects, seven 
individuals were normally entrained (23%), five subjects were abnormally entrained
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Subject
Visual
loss
phi 
mean (± SD)
Tau 
(±95% limits)
Circadian
status
2 EYES
25 2.80 (0.62) 24.00 NE
39 5.73 (1.38) 24.00 NE
42 3.10(0.32) 24.00 NE
49 2.7 (0.28) NE
13 14.25 (1.08) 24.00 AE
16 20.30 (0.62) 24.00 AE
22 20.57 (0.06) 24.00 AE
38 7.88 (0.59) 24.00 AE
50 7.20 AE
46 23.73 (3.59) 24.54(23.16-25.92) FR
17 17.18(3.13) 24.34 (24.24 - 24.44) FR
35 ns UN
lE Y E
27 3.25 (0.53) 24.00 NE
29 2.13 (0.15) 24.00 NE
14 21.78 (7.17) 24.79 (24.70 - 24.88) FR
20 3.74 (7.57) 24.68 (24.48 - 24.87) FR
26 13.95 (3.65) 24.39 (24.05 - 24.73) FR
44 13.18 (3.30) 24.35 (24.04 - 24.66) FR
51 18.2 (3.40) 24.37 (24.25 - 24.49) FR
GEYES
34 6.65 (1.17) 24.00 NE
18 17.05 (8.15) 24.68 (24.47 - 24.89) FR
23 17.83 (4.98) 24.39 (24.29 - 24.49) FR
24 11.53 (5.57) 24.59(24.05-25.10) FR
28 11.86(4.07) 24.41 (23.83 - 24.99) FR
31 5.98 (6.23) 24.68 (24.43 - 24.93) FR
33 2.40 (6.45) 24.60 (24.32 - 24.88) FR
36 10.25 (5.37) 24.60 (24.32 - 24.88) FR
43 10.33 (1.40) 24.13(23.95-24.31) FR
45 2.10 > 24.00 FR
48 11.75 (5.41) 24.41 (24.15-24.68) FR
Table 5.2 shows the mean acrophase times (± SD) and tau (±95% confidence limits) for 
ail NPL subjects, categorised by the number of eyes present, ‘ns’ depicts no significant 
acrophase times. Where tau is not shown, there were too few significant acrophase times 
(< 3) to fit a regression line. Circadian status is also shown (NE, normally entrained; 
AE, abnormally entrained; FR, free-running, UN, unclassified).
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Severity 
visual loss
Circadian Status Total
NE AE FR UN
LP >3/60 2 (2 ^ 0 7
CF 4(gQ) 1(2Q) 0 0 5
HMO 4 (100) 0 0 0 4
PL 2(^:9 1(35; 0 0 3
Subtotal 14 (74) 4(21) 0 1(5) 19
NFL 2E 4(33; 5(4^ 2^7:^ l(i^ 12
IE 2 (2 ^ 0 5(^ 77; 0 7
OE 1 W 0 10 (91) 0 11
Subtotal 7(23) 5(17) 17 (57) 1(3) 30
Total 21 9 17 2 49
For definitions o f subgroups, see text.
Table 5.3 provides a summary of the circadian classification for all subjects according to 
severity of visual loss (LP subjects) and the number of eyes present (NPL subjects). The 
circadian status is defined as normally entrained (NE), abnormally entrained (AE), free- 
running (FR) and unclassified (UN) aMT6s rhythm. Figures in italic parenthesis show 
the percentage incidence of each circadian type within each subgroup and the figures in 
bold parenthesis show the percentage incidence in LP and NPL subjects overall.
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(17%), 17 subjects appeared to be free-running (57%) and one was unclassified (3%) 
(Table 5.3). Figures 5.5B and 5.5C show representative plots of individuals with 
abnormally entrained and free-running aMT6s rhythms, respectively.
In free-running NPL subjects there was no significant correlation between tau and the 
age or PSQI score of the subjects (r = -0.05 and -0.14, respectively) (Figure 5.6). There 
was no significant difference in age, PSQI or mean 24 h aMT6s output within all 
subjects (n = 49) when classified according to the four circadian types (normally 
entrained (NE), abnormally entrained (AE), free-running (FR), unclassified (UN)) or 
between subjects with normal and abnormal (AB) aMT6s rhythms (p > 0.05) (Figure 
5.7). There was also no effect of rapidity or duration of blindness on circadian status.
There was a significant difference (p < 0.05) in the mean amplitude between individuals 
although this was not associated with any particular variable (mean amplitude range = 
0.05 - 1.43 pg/h). However, aMT6s rhythm amplitudes were consistent within an 
individual; the mean CVs (± SD) for amplitude for LP and NPL subjects were 23.6 ± 
9.7% and 27.9 ± 22.9%, respectively. There was no significant difference in the mean 
amplitude within LP or NPL subgroups, between all LP and NPL subgroups or overall 
between LP and NPL subjects (p > 0.05). Similarly, there was no significant difference 
in the mean amplitude within different circadian rhythm types (NE, AE, FR) or between 
subjects with normal and abnormal (AB) aMT6s rhythms (p > 0.05). As observed for 24 
h aMT6s output and age, there was a non-significant trend for a decrease in aMT6s 
amplitude with increasing age in all subjects (r = -0.28) (Figure 5.2B).
5.3.2.3 Disease
Several diseases were prevalent in the study population (Tables 4.1 and 4.2). Only 
individuals with eyes were included in this assessment as the loss of eyes clearly 
prevents analysis of light perception in relation to disease.
Ten of the 19 LP subjects and four of the 19 NPL subjects with eyes suffered from a 
form of retinitis pigmentosa (RP). Of these 14 RP subjects, eleven had normally
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Figure 5.6 shows the relationship between aMT6s tau with age (A) and PSQI (B) in 
free-running subjects (n = 16).There was no significant correlation between tau and 
either parameter.
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Figure 5.7 shows the mean (±SD) for age (A), PSQI score (B) and 24 h aMT6s output 
(C) for all subjects categorised according to their circadian rhythm type (NE, normally 
entrained; AE, abnormally entrained; FR, free-running; UN, unclassified; AB, abnormal 
rhythms). The number of each subgroup is shown in italics. There were no significant 
differences between the subgroups with respect to age, PSQI score or 24 h aMT6s 
output.
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entrained aMT6s rhythms (8 LP, 3 NPL) and three appeared to have abnormally 
entrained rhythms (2 LP, 1 NPL) (Figure 5.8A). Retinal detachment was present in one 
LP subject and six of the 19 NPL subjects with intact eyes. Of the seven individuals 
with retinal detachment, two were normally entrained (1 LP, 1 NPL), four were 
abnormally entrained (4 NPL) and one subject had a free-running aMT6s rhythm (1 
NPL) (Figure 5.8B). No other diseases were common to more than three subjects.
5.4 Discussion
The present findings show that a high proportion (77%) of registered blind people with 
no perception of light (NPL) had abnormal circadian rhythms as assessed by the pattern 
of melatonin production. Within the NPL group the incidence of circadian aMT6s 
abnormalities is greater in unilaterally and bilaterally enucleated individuals. 
Conversely, a much lower proportion of subjects with light perception or better (LP) 
have abnormal aMT6s rhythms (26%), and it appears that within the LP groups, 
decreasing vision does not influence the incidence of abnormal rhythms.
As the phase-shifting effects of light are intensity-dependent (Section 1.1.1.2.1), it is 
possible that the rhythm abnormalities found were due to insufficient light intensities in 
the subjects’ normal environment. The light intensities these individuals were exposed 
to were not measured in this study but they were all living in a normal environment and 
were exposed to light intensities comparable to those experienced by sighted individuals 
who exhibit normally entrained rhythms in these conditions. It is therefore unlikely that 
the abnormal aMT6s rhythms observed are due to insufficient light exposure.
In animals it has been established that an intact RHT is essential for the entrainment of 
circadian rhythms by light (Section 1.1.3.2.1) and an intact SCN is required for the 
rhythmic production of circadian outputs (Section 1.1.3.1). The RHT is a monosynaptic 
tract that arises from a distinct set of ganglion cells in the retina and projects to the 
SCN. Studies have attempted to isolate the retinal photoreceptors required for circadian 
entrainment but it is still unclear whether rods, cones, a novel photoreceptor or a 
combination or subset of photoreceptor types are involved (Section 1.2.1).
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A - Retinitis pigmentosa (n = 14)
2 1 %
79%
B - Retinal detachment (n = 7)
14%
57%
I I Normally entrained
29%
Abnormally entrained Free-running
Figure 5.8 shows the distribution of circadian rhythm types in two common disease 
types; retinitis pigmentosa (A) and retinal detachment (B).
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The measurement of circadian outputs or ‘downstream’ rhythms can be employed as an 
indirect assessment of retina - RHT - SCN function. Subjects with normally entrained 
rhythms are likely to have an intact and functional RHT, whilst in subjects with free- 
running rhythms, the RHT is likely to be dysfunctional. The type and anatomical 
position of the disease, and/or the number of eyes present may quantitatively alter the 
number of ‘circadian’ photoreceptors of the retina. Of the NPL subjects, those with one 
or two eyes present have the highest proportion of individuals who are normally 
entrained, and this may be due to light entraining the SCN via an intact retina - RHT - 
SCN (Sack et al., 1992; Czeisler et al., 1995a). The finding that some individuals with 
one eye present have normally entrained rhythms supports the idea that bilateral photic 
innervation is not required for subconscious circadian entrainment.
Subjects with no eyes, by definition, do not have an intact retina - RHT - SCN pathway 
and therefore would not be expected to have photically entrained rhythms. This 
hypothesis is upheld in the present results. Only one subject (S34) did not appear to 
have a free-running rhythm. Although this subject has been diagnosed as anophthalmic 
{i.e. the eyes are not present), there is the possibility that this subject may have vestigial 
eyes remaining (cryptophthalmos), and that subconscious light perception is entraining 
the rhythm. There are two other possible hypotheses to explain this finding. A likely 
explanation is that our four week study was not long enough to detect individuals with a 
slow free-running rhythm, and that we have studied S34 whilst in a ‘normal’ phase of a 
very slow free-running cycle. Alternatively, non-photic zeitgebers may be entraining the 
rhythm: the existence of such individuals has been previously reported (Czeisler et al., 
1995a).
In those NPL subjects with entrained aMT6s rhythms, this study cannot determine 
whether the entrainment is via subconscious hypothalamic light perception or by non- 
photic zeitgebers. An evaluation of melatonin suppression by light (Lewy et al., 1980) 
would indirectly test the integrity of retina - RHT - SCN function in NPL subjects. 
Melatonin suppression would suggest that subconscious light perception was entraining 
the rhythm. A negative result would suggest entrainment by non-photic zeitgebers, and 
both outcomes have been recently demonstrated in NPL subjects by Czeisler and
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colleagues (1995a). The identification and role of non-photic time cues in human 
circadian rhythms still requires thorough investigation. Most of the free-running blind 
subjects (14 out of 17) were fully employed with conventional working hours. As their 
aMT6s rhythms were not entrained by the very strong temporal and social signals 
associated with keeping working hours, our results imply that the influence of non- 
photic zeitgebers on aMT6s rhythms in blind individuals is likely to be highly 
individual.
There are both LP and NPL subjects who appear to be abnormally entrained to a 24 h 
day, a result also described in previous studies (Lewy and Newsome, 1983; Sack et al, 
1992). These results may be artifactual due to the restricted length of the study period. A 
rhythm appearing abnormally entrained may be free-running but with a period very 
close to 24 h and would therefore take many weeks to exhibit a clear free-running 
rhythm. Similarly, repeated measurements at regular intervals may coincidentally 
measure the rhythm at the same circadian period. To control for this, longitudinal 
studies are required that measure rhythms at irregular intervals over at least several 
months and these are currently being completed.
The abnormal timing of strongly endogenous circadian rhythms (e.g. melatonin, core 
body temperature, cortisol) is known to be associated with some sleep disorders 
(Section 1.2.2). In the present study, the PSQI was used to select patients having 
disordered sleep and therefore possibly disordered circadian rhythms. Our results show 
that individuals with free-running rhythms had a higher PSQI score than normally 
entrained individuals. This difference did not reach statistical significance because there 
was a small proportion of individuals with free-running rhythms who do not report a 
subjective sleep disorder (n = 4), according to the PSQI (PSQI score < 5).
The effects of specific visual diseases on light processing for circadian function in 
humans is unknown. Studies of mice with retinal degeneration suggest neither rods nor 
cones are required to mediate photic manipulation of circadian rhythms (Section 1.2.1). 
Although the association between human ocular disease type and circadian rhythms has 
not been investigated fully, preliminary studies of colour blind individuals suggest that
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deficient cone function has no effect on the ability of melatonin to be suppressed by
light (Ruberg et al., 1996). Due to the large diversity of visual disorders in the study
population, this report can only draw preliminary conclusions about the relationship
between disease type and circadian rhythms in the blind. Several diseases were
relatively common, and could be associated with circadian rhythm status. Fourteen
subjects were diagnosed as having retinitis pigmentosa (RP), a group of disorders some
of which affect rods primarily and others which affect mid-peripheral rods and cones.
The majority of these (n = 11, 79%) had normally entrained rhythms, three were
abnormally entrained and none appeared to be free-running. This finding suggests that
RP does not significantly interfere with photic information processing for circadian
entrainment. The possibility exists, however, that a mutation different from those in the
subjects tested might affect circadian entrainment. Of the seven individuals with retinal
detachments, a condition in which the retina becomes separated from the pigment
epithelium, two were normally entrained, four appeared to have abnormally entrained
NPL
aMT6s rhythms, and one was free-running. Interestingly, of only five^^individuals in 
total with abnormally entrained rhythms, four of these (80%) had retinal detachments. 
This finding suggests that the detached retina may interfere with light effects that are 
mediated via the retina - RHT - SCN pathway and affects the type of circadian rhythm 
disorder. These preliminary observations should prompt a closer inspection of visual 
disease, in addition to levels of light perception of individuals, when investigating 
circadian rhythms in blind subjects.
The amount of melatonin produced over 24 h does not appear to differ in blind subjects 
compared to sighted individuals (Bojkowski and Arendt, 1990). Our results confirm the 
well - documented decrease in overall melatonin production and amplitude associated 
with increasing age (Section 1.1.4.3.2). No other variables (degree of light perception, 
severity of visual loss, circadian status, sex) were associated with changes in total 
aMT6s production. These results also reiterate the high degree of consistency in 
production rates and amplitude of aMT6s in the majority of individuals, regardless of 
circadian rhythm status.
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As abnormal circadian rhythms are known to be associated with sleep disorders, it is 
likely that a significant proportion of blind individuals reported to have sleep problems 
(Section 1.2.3) also have underlying circadian disorders. However, this association 
between blindness and sleep disorder is often not recognised clinically, and may lead to 
inappropriate treatment of sleep problems which do not address the underlying circadian 
cause. Longitudinal assessment of blind individuals with sleep complaints can assist in 
identifying those individuals who are likely to suffer from non-24 h sleep disorder 
(ICSD, 1990). The disorder can often become highly debilitating and distressing, in 
addition to the stress of being blind. As demonstrated in this study, assessment can 
easily be achieved by non-invasive and inexpensive urine collections over a suitable 
period. It is recommended that aMT6s assays be performed in blind individuals, 
particularly following loss of light perception or enucleation, in order both to educate 
sufferers and to prompt chronobiotic treatment where appropriate.
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CHAPTER 6
SLEEP AND ACTIVITY 
AND THEIR RELATION TO 
CIRCADIAN STATUS
CHAPTER 6 - SLEEP AND ACTIVITY AND THEIR RELATION TO 
CIRCADIAN STATUS 
6.1 Introduction
It has been widely reported that the sleep-wake patterns of blind people may become 
disrupted (Section 1.2.3). This is thought to be due primarily to a lack of photic 
entrainment of the circadian pacemaker, resulting in an abnormally entrained or free- 
running circadian system (Section 1.2.2.4). Evidence from isolation studies of sighted 
individuals living in constant dim light show that both sleep-wake and activity patterns 
in humans demonstrate distinct circadian rhythmicity that may or may not run at the 
same period as strongly endogenous variables, for example, melatonin or CBT (Section
1.1.2.2). Some degree of sleep disorder in the blind has been previously reported 
(Section 1.2.3), the quantification of sleep and activity of blind people living in a normal 
environment has not previously been performed. The rhythm of melatonin production 
has been described for each individual in the study population (Chapter 5). Chapter 6 
addresses sleep and activity in these blind subjects with respect to the overall sleep 
patterns, whether or not the sleep-wake (SW) and activity patterns demonstrate a free- 
running pattern and the relationship between sleep and activity patterns and the 
melatonin rhythm.
6.2 Methods
6.2.1 Subjects
The sleep and activity rhythms of all 49 subjects are reported. Full subject details are 
described in Chapter 4.
6.2.2 Data collection and analysis
Sleep and activity data were collected as described in Section 3.1.2.
6.2.2.1 Daily mean sleep and activity
6 -1
An overall individual mean 'was calculated for each subject for all subjective and 
actigraphic sleep parameters (sleep latency, onset, offset, number and duration of night 
awakenings, night sleep duration, subjective sleep quality, actigraphic sleep efficiency, 
number and duration of day-time naps). Overall mean activity scores and activity 
acrophase times were also calculated. Subjects were grouped according to their 
circadian rhythm type (NE, normally entrained; AE, abnormally entrained; FR, free- 
running; UN, unclassified; Tables 5.1 and 5.2) and a one-way ANOVA was performed 
to investigate whether there were any differences in the mean sleep and activity 
parameters between groups.
Ô.2.2.2 Measurement of changes in sleep and activity
In order to measure any changes in the pattern of sleep timing, daily sleep onset and 
offset times, derived from both subjective and actigraphic methods, were subjected to 
regression analysis to reveal the tau of any free-running sleep rhythm (subjective 
sequence range, 24 - 55 days; actigraphic sequence range, 7 - 3 6  days). On four 
occasions, an abrupt jump was seen in the raw sleep data and in these cases, the longest 
consecutive sequence of days was used in the regression analysis (sequence range, 15 - 
25 days). Nap rhythms were analysed by fitting a regression line to the midpoint times 
of all naps derived from the sleep logs. Actigraph-derived nap data grossly 
overestimated the incidence and duration of naps (Chapter 11) and therefore were not 
subjected to regression analysis. Activity data were subjected to cosinor analysis to 
reveal a daily acrophase for activity (sequence range, 5 -3 4  days). Regression lines 
were fitted to significant acrophase times to reveal the tau of any free-running activity 
rhythm. Similar to the regression analysis of aMT6s acrophases (Section 5.2.4.2), the 
sleep, nap and activity rhythms were considered to be free-running if the 95% 
confidence limits of the regression line did not cross 0 (i.e. 24 h; tau (h) = 24 + slope).
6.2.2.3 Relationship between sleep and activity with aMT6s rhythms and effect of age 
or PSQI score
6 - 2
In order to investigate any circadian effects of the position of the aMT6s acrophase on 
sleep and activity in entrained individuals (normally and abnormally entrained), 
correlation analysis was performed between mean sleep or activity parameters and the 
mean aMT6s acrophase time. The significance of the correlation was derived from the 
ANOVA of a best-fit regression line. Mean sleep and activity parameters and aMT6s 
acrophase were also correlated with age and PSQI score. In free-running subjects, the 
same analysis was performed between the period of the aMT6s rhythm with the periods 
of sleep and activity rhythms and age and PSQI score. Subject 45 was excluded from 
these analyses as an accurate estimation of aMT6s rhythm tau was not possible (Section
5.3.2.2).
6.3 Results
6.3.1 Mean sleep and activity measurements
6.3.1.1 Daily mean sleep
Figures 6.1 and 6.2 show the mean (± sem) for all subjective and actigraphic sleep 
parameters for all subjects respectively, grouped according to their circadian rhythm 
types. Comparison of sleep parameters between circadian subgroups (Figure 6.3), 
revealed that mean subjective sleep offset, night sleep duration and number of naps 
(Figure 7.2) showed significant differences between the circadian subgroups (p < 0.05, 
one-way ANOVA). Post-hoc analysis (Duncan’s new multiple range test) revealed that 
sleep offset was significantly delayed (Figure 6.3F) and night sleep duration was 
significantly longer (Figure 6.3E) in UN subjects. Similar results were observed for 
actigraphically-derived mean sleep onset and offset times (p < 0.05, one-way ANOVA) 
in that post-hoc analysis confirmed that both sleep onset and offset times were 
significantly delayed in UN subjects (Figures 6.3D and 6.3F, respectively). As the UN 
subgroup only had two subjects and appeared to be weighting the ANOVA, the UN data 
were removed and the analyses were repeated. The only significant differences between 
NE, AE and FR subgroups were in subjective and actigraphic night sleep duration
6-3
&.sI
I
-w
%
m m 11
O(N
oc .5
o
o  o  o  o  o  o  o I  ( N m' d "  o -—I ' d " o  (N r~4 (N r<i m ' d " —-I c4  m  v^ I—I.—(,—( fs) (N (N (N (N r o  m  m 'd "  'd"'d" COC/7C/7C/!lC/9C/^ C/7CZ)C^C/7C/2(y2C/5C/DC/DC/7C/9C/7V5C/OC/DC/!)C/2C/!lC/5C/7C^C/7C/7!y!)C/!)C/2C/2C/5C/^ (/3C/5C/7C/5C/7C/5C/!)C/3C/bC/7C/7(/5C/!)C/)(/l
W).sI
I
O
%
W
I
3aÆ
f
*i#
— r -
— VO
— lO
k
O
— Tf- B
— m g
; g
— CN
c/7t/:c/:)c/2c/2c/2GOc/5ooc/7t/5c/2c/3t/7coùOc>Qc/îc/0(Ziî>oc/oc/3c/7criGOcric/5Grior)c/:ic/:icria)cricric>riiy)c/5c/3c/7c>ri(>7(y7c/7(yDc/oc/Dcri
S'
I
. j
I
P
m i
m
I
oas
oVO
om
O  O  O  O  O  O  O - H .—< ^ .—( fs | r< T ^  O — O  (N r 4  <N| m  (N r o  « n -H ,-H ^  r 4  (S  <N (N (N m  r o  r o  ■ri r oC/5C/3C/2C/7C/7C/7ùOC>OV7C/7(/2(y3(y7C/5C/7C/7C/3C>riV5C/7C/7C/3C/7Cr)C/7ùOC/OC/2C/7C/3C/3C/Oa)C/7(>OC/2C/)or)tZ)C/7C/7C/DC/DC/)C/7C/)C/3GO(Z)
□
<
is
i ;
t l
i f  
1
.G I
I
I
t l
1?i
G
B i
I , '
l>
Q ^  
:>
§-&
<uL
l î lÜ t)û 00
I Io <u 
T3 Oh 
&  % 2^
l! l
c/3 rTi
6-4
(U<DC/3
OS
O
oo
im
m
O  O  O  O  O  O  O ' f S  r o  ■^ O O  f N ( N CN m  r <T^ Tt  1—I.—I (N  r<^  i n .—I ^  ^  (N  CN cN (N  fN  r<^  m  r<T ^ T j - > r >  r<^^  c/2c/3c/:)c/:ic/5c/5a3c/:)c/3c/3c/:ic/:ic/2c/Oc^ty:)c/2c/3c/D(yDonc/3c/ot/D(/3c/2c/2cyoc/3c>ooric/:iüOc/Dooc>oc/Dc/:iooc/)c>oc/Qc/Dc/:ic/Dor!(y5c/Doo
o<u
■ f
C/D
Cj
;-H
c2
CT
Io
&(U
I
W
a«4Ho
a0
1 a 
Q
W
U 11
i
S i
1
— ON 
OO
r-
NO g  aoin M
T)-
m
(N
—' (N m  Tt v~i VO o '—I (N On ^  C" ^  c^ >/D o  00 </n o\ ■^  <?> cN iO\ r<^  ^  (N 00 o r ~ - 00 o  m  ^  00 >—' ro'O r<D >o 00'—I >/^O O O O O O O I  >—I (N r<T^ O’—< ■^ Tj-o CN (N (N ro m Tt"I  ^  CN lO <—1 >—I >—ICN fS <N CN (N m m m r j - i n  roC/D C/D C/D C/D C/D C/D C/D C/D C/D C/D C/D C/5 00 C/D C/D C/D C/0 C/D C/D C/D C/D C/D C/D t/D C/D C/D C/D C/D C/D C/D C/D C/D OO CO C/D C/D OO C/D C/D C/D C/D C/D C/D C/D C/D C/D C/D C/D C/3
I
(Ü
§
e -d)
<§
(N
(N
(N(N
' (N  O v '—' 0 \ >/  ^O  r ' 00 >/  ^ On On <N lOv fO  VO CN o o  O  00 O  T)-VO 00 '
- — ,^ Q^^jv4fS)rrjr<DTt-'Nt' '    __ rovOr*TTt->/^ vooo'(NCNr^ CNCNrOfOm-^ rJ-Tj-—'—"I (N r<-i Tl->o VO O '  0000000>—<r-(^ >—(fsirOT}-O’—I T(-'^004 fS(Nmr<NTj-'Nj-1—1—1 rvlfTNVD'CNCN cS fSrO com ■■^ Tl-Tt «/"iroQ C/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DC/DGOC/DC/DO O O O O O O r
kaoM
I
I
f
(UC/D
-H
li
g
"O
v2
NO NO 
<U (U
a a
.2P iSPLZ iZ
6-5
I
8-<U
I— 00
— m
— (N
r /5  'C ^ 'o o f ^ o o ' / ^ r ~ < j \ '^ O N f N O N r < i ^ ( N o o o '^ r ~ o o o f O '^ ^ o O '—i r o 'O c o '^ 'n v o o o '—'« oOOOOOOO^"—"—I-^ (Nr<T^ O^  ■ '^ 0^(N(N CM ror^ '^ '^ '—"—'(Nr'TO’— T^ r'ICNrv|(Nr<^ ror<T^ '^ '^ '^ '^ >/^ mI c/Dc/3c/3c/3(/)GO&ri(y3c/:)coootz)c/:ic/5a5c/5c/3c/Dcoco(>oc/2iy2cococo(yDa)ooc/:5c/Da3GOc>OGr)i>oc/Dt>oc/Dc/D!/Dooa5coc/oc/:)GOc/oc>o
(wO
— CN
«4H0 
G
1G
Q
o
■■f o
ICN r<T ^ u i  VC o ’—' cN CTs ^  t ~ - ^  o v  »n  o  0 0  >o  o \  cN Os m  VO cN 0 0  o  T f r - 0 0  o  m  ^  o o  ^  r o  "O m  >o VO o o  >—I >n1 CM cn Tt-o  ^  •'5l" o  cN CM CM m  c<s ■'^  ■rt-'M  O O O O O O O ^ 'K V!3C/:iGOC/5C/DC/:iGOC/2COC/3C/5C>OC/:)(/3COC/2GClCOC/3(Z)C/2C/Diy2COajC/OCOC/DC/2COt/DC/3COC/3t/DOOC/D!/3a)COV3COCOC/3C/3(>OC/DC/DC/D
cn
g-
G«4Ho
d
%
I
i
n
III
I
Ü
iI i 1 i
— (N
o CM m  ■'  ^>ri VO o  ^  CM Ov ^  ^  0 \ m  o  00 <o O s 0 \ CM Ov CO VO CM 00 o  ■ ' + o o  o  m  ■T(-VO 0 0 m  VO CO r f - V C  0 0  ^  >c^O  O  O  O  O  O  O I  CM r < ^ O  *—I 'd" O  CM CM CM r n  m 'd"  Tl"'—"—I CM r n  I—I ^ I  CM CM CM CM CM CO r n  ^  ^ ' d "  mC/OMC/2C^C/2C/3C/3(/3V:iC/3ùOC/5C/5CZ)a)C/2C/3C/:C/2C/DC/DùOt/3C/DC/DC/DC/2(/3C/2C>OC/)(>OGClC/2ùO(Z]C/DC>OC/Dt/3C>:)00!>Oa3C/DC/3a)(ZlGO
u
Go
VI
bs3
%
a0
1
!o
Î
a
I :
K
C VO 
00 W
di &
g ^
II
00 ^
î fVO <u
K
6 -6
o(D
¥
%
&
.5
ICQ
-w
WD
fl
IS
Q
H tu I
M
■i
I
II
i
i
i *
oo
(N
( N r o > o ' O  r - o  ' cN o  ^  ^  O M o o  r ~  0 0  «n  Os e s  ON m  v o  (N  o o  o  0 0  o  v o  0 0  ^  'O  r< T ^  >n v o  o o  ^  «r>
o  o  o  o  o  o  o  ^  ^  ' ( S  r<T ^ o r f  o  (N  CN fN  r<^  m ■ ^ ’—I’—I (N  m  >n I rN (N  (N  CN CN r o  r*s m  >n m
C/3 c/5 GO c/3 c /:  c/3 C/:i c/3 C/3 CO 00 C/3 c/2 c/:) C/D (Z) 00 c/3 CÆ t/2 C/D C/:i C/D c/2 c/3 C/D c/:) c/2 c/3 C/:i C/:i C/2 c/2 GO C/D CZ) C/D (Z) ùO c/5 c/5 c/2 c/2 c/:) c/5 v:i c/2 c/2 c/o
om
&.s
I
I _  o
Ifi
d
% o
(S
^  <N m < o  s o  o  ^  cN o s  ^  Os l o  o  r ~  00 <o  Os Os fN cr \ r o  s o  fN  00 o 00 o  m s o  0 0  *-< m  s û  m  <r> s o  0 0  >—I <r>
o  o  o  o  o  o  o  >—I <—I »—> •—( (N  r*S o ’—I o  (N  tN  t S  r o  r o  ^ ' ( S  m  >0 ^  ^  I (N  (N  fsj (N  CM m  r*S m  "«t ^  ^  r<^C/DCOC/^aîCOC/DCOCOCOaîCOC/î&OaiCOC/îaîC/DC/îùOCOC/DCOliOC/DC/DC/JC/OCOùOCOCOCOCOOOCOCZlCOCOCOC/tlCO&OCOC/iC/DC/JC/OOO
r §
ù-
g
o
>—I ( S  r<S m  s o  o  >—' (N  Os ^  Os lO  o  r~-00 >0 o s o s  (N  Os r o  s o  fN  00 o  00 o  r<T ^ SD 00 ^  r o  s o  r<TrJ->/^ s o  00 ^  >o
o  o  o  o  o  o  o  ^  ^  ^  ^  (N  r*S o o  (N  (N  ( S  m  r<T ^ >—I >—ICN r*s >o ^  ^  ^  (N  CN 04 fN  CN m  r o  e n ■ r t - > o  m
t/3173 (/3 CO CO c/:) (>0 00 c/2 c/3 c/3 C/!) t/:j c/:) C>0 C/3 CO CO CO CO CO CO CO CO c/3 GO CO c/3 o o  CO tZ) CO CO CO CO 0000 CO ùO CO CO o o  V 3 00 GO c o  c o  c o  c o
u □ 
l g
Cîû Rh
l l l
i
l l i
i î i
+ fS  gw f—I
ifs
rfi o
L=
3 ! % ^ '
a
<
6-7
mo\
_  o
— oo
^  (N >o o  ^  (N ON ^  ^  ON >o o  oo >o t''ON ON (N Os VO (N 00 o  T i - 00 o  m  Tj-'Æ> 00 ^  m '<0 m  >o ^  00 •-< >o
O  O  O  O  O  O  O  ^  ^  ^  ^  (N  m  O — O  CN CN (N  r<N m I  ^  (N  m  > n ^ ( N  CN ( N ( N CN r o  r o  r o  r<^CO CO C/D C/2 C/D C/:i C/:i C>0 C/5 C/D C/5 C/:! CO CO CO CO C/:) 03 00 CO 00 C/5 CO C/D C/D C/3 C/:) C/5 C/3 C/!) t/3 C/5 !/D C/5 C/D C/3 C/0 C/0 C/0 GO OO CO C/3 CO 00 GO C/0 CO
G«Mo
fio‘■Cfiufi
Q
w
i
m
m
I
î i
i
«
A
o\
00
r--
kvo s  o
>n®
—H (N r o « n  NO o ’—' (N ONr ~- H o\ «n o  00 «o r~ ON Tt On (N Os r*N NO (N 00 o  00 o  m-Tf'O 00 ^  ro NO m >0 NO 00 >-^  >n o  o  o  o  o  o  o '—"—I ^ ' (N m'd" o -—l'd" o  <N rs) (N m  ro rj-■^.—I.—c (SI m  >o ^  ^ ' (N (N (N cN (N m  m  m  Tf r t  >n mc/3 cri c/3 C/î CO CO C/D c/3 C/D c/5 c/5 c/5 (>0 c/2 C/!! GO c/3 c/3 c/:) c/5 V3 C/D t/D t/3 CO VD C/D c/5 C/D C/5 V5 C/D C/D CO O) c/3 CO (>0 GO c/5 CO CO 00 C/D GO ùO GO 00
U50fiOs-ü
i i
$
f I
—  T f
—  m
(N
^  Ë(N f i
M  K
(NCN
(N
O
(N
o \
^  tN ro-Tf in  vo  O  ^  (N ON ^  ^  ON > 0  o  0 0  u~i ON Tf ON (N Os ro  *0  (N 0 0  o  Tl- 0 0  o  f<N Tj-NO 0 0  ^  m  NO r<N ■si->n NO 0 0  ^  «o
o  o  o  o  o  o  o  ^ — -T ^  (S| ro  ■sf o ' •sf •sj -o  <N fN| (N ro  ro  ■st ■st ■—"—I (-si ro  ^  ^  ' rsICsI r-l r-J Cs) r o  ro  <T) Tt Tt ■st r<-) C/2C/2C/2C/5y3C/Da3a3C/DC/DC/3C/3C/5C/DC/5C/DC/2tZlùOC/OC/Da5C/DV5C/)C/5tZlC/300üOC/ÏOOC/5i>OC/DCZlC/5(/3C/5C/OGOa)C/DGOC/)OOC/)COOO
O
<Df
fi
.g
Ph
I
O
s ’
I
a
fi
0
1
Q
( U
§
s
a
I
tI
(Ut/3
&
i
M
M
I
sg
u
<  
(N (N 
^  NO
I I
.3P
6 -8
aom 4#
o
o \
ooo
o
o
‘O O O O O O ’—1^ ' —I'—' ( N r O ' ^ O ’—'■ ^ • ^ O t N f N C N r o r O '^ '^ '  ------------- ----------------------------------- — '"—'—  --------------
r'oooro'+'ooo' I r o  VO m ';)■ iri  vd  oo  '
I fN (N (N fS  CN CO m  r o - r j - i n  r oC/2 CO C/2 CO 00 GO CO GO 00 00 GO c/3 t/)OQ CO CO CO CO GO CO GO c/3 C/3 00 CO CO CO CO CO C/3 O) c/5 GO CO c/3 COCO CO CO CO CO (Z! CO c/2 CO GO c/5 CO CO
O
O
(N
O</}
aCQ
a(Mo
Go
oo
ovnI3
Q o
^  cs r<T^ in VO o  ^  (N ov ^  "  ovm o  r^ 00 in r^ ov CTv CN c?i tn VO (N 00 o  ■Tf r~ 00 o  ro 'it VO 00 ^  m  VO r*T^ in VO 00 ^  in OOOOOOO^' — "—'CNmin^^ o^jcNfNmmmmm'd-' '^ '^rj-'d-incn c/2 C/!lùO CO c/5 C/Î 00 C/!l 00 CO 00 00 0000 CO c/2 CO c/5 C/3 CO 03 CO cn CO c/3 coco 0)0) CO CO CO CO CO 00 CO CO CO 00 00 CO 00 00 CO 03 COC/3 CO C/D
om
o
(N
!»a3
G4-1o
d
;z:
o
III
o
k
3
o
ffi
3
;z:
I
1
s-
(U
§
c/3
I
s
t<4Ho
3
0
1
Ï
01
I
,o
I ,
a <
n
I
o o  o  o  o  o  o  o '—I'—I ^  ^  (N m  Tt o  >—' Tf o  (N (N (N (n ro •^ •^ ^  •—I fN ro i n ^  (N (N (N (N nj fn <n (n-Tf Tt r j - i n  mC» C/:i C/D C/D CO C» CO CO C» C» C» C» C» C» CO C» CO CO CO CO GO 00 !/3 GO CO GO CO CO C» GO C» C» C» C» CO C» C/D C» !/) C» CO CO CO CO oo GO (/) GO 00
3
u(U (D -Fl GC
> o\
IT
(N v,^  
^  C»
6-9
 ^ A
Latency
(mins)
No. night 
awakenings
Duration of 
night 
awakenings 80 
(mins)
40 -
Figure 6.3 shows the mean (± sem) for subjective (■) and actigraphic (L=) 
measurements of sleep latency (A), number of night awakenings (B) and duration of 
night awakenings (C) categorised according to aMT6s circadian rhythm type (NE, 
normally entrained; AE, abnormally entrained; FR, free-running; UN, unclassified). 
There were no significant differences between the circadian rhythm types using either 
method (p > 0.05, one-way ANOVA). The ‘n ’ for each subgroup is shown in italics.
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onset (h)
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23
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Sleep 
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Figure 6.3 shows the mean (± sem) for subjective (■) and actigraphic ( - ’) 
measurement of sleep onset (D), night sleep duration (E) and sleep offset (F). See 
Figue 6.3 A-C for details. There were no significant differences between the circadian 
rhythm types using either method for sleep onset (p > 0.05, one-way ANOVA). 
However, there was a significant difference in night sleep duration and sleep offset 
between the groups (*, p < 0.05, one-way ANOVA).
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2
Figure 6.3 shows the mean (± sem) for subjective sleep quality (H) (■) and 
actigraphic sleep efficiency (G) { ) See Figure 6.3 A-C for details. There were no 
significant differences between the circadian rhythm types using either method (p > 
0.05, one-way ANOVA).
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(Figure 6.3E) with both parameters showing significantly longer night sleep duration in 
normally entrained subjects.
Several individuals demonstrated extreme deviations (> 2SD) in mean sleep parameters 
from the mean of all study subjects consistently with both methods (Figures 6.1 and
6.2). S50 showed a large sleep latency (Figures 6.1 A, 6.2A), S13 had extremely short 
night sleep duration (Figures 6 .IE, 6.2E) and two subjects (SI3 and S23) had long nap 
durations (Figures 6.1H, 6.2H). Two subjects had outstanding mean sleep timings, 
namely S25 who had an advanced sleep onset (Figures 6 .ID, 6.2D) and S8  who had 
extremely delayed sleep onset and offset time (Figures 6.1D, 6.2D and 6.1F and 6.2F, 
respectively).
6 .3.1.2 Daily mean activity and activity acrophase
Figure 6.4 shows the mean (± sem) for daily mean activity and activity acrophase for all 
subjects (n = 49). There were three individuals with outlying mean activity acrophases 
(> 2 SD from the group mean) (Figure 6.4B). Subjects 16 and 25 had an advanced 
activity acrophase whereas S8  had a delayed mean acrophase. There were no signiirant 
differences between either of these parameters with respect to circadian rhythm type 
(Figure 6.5). The individual subjective daily sleep onset and offset data for all subjects 
i  can be found in Appendix B.
6.3.2 Incidence of free-running sleep and activity rhythms
Regression analysis revealed free-running sleep and activity rhythms in some 
individuals both with and without free-running aMT6 s rhythms. Of the 32 subjects 
without free-running aMT6 s rhythms (Tables 5.1 and 5.2), four subjects (S10, SI 1, S37, 
S50; 13%) showed a free-running rhythm in subjective sleep onset, two subjects (S4, 
S50; 6 %) had free-running subjective sleep offset and two subjects (S42, S49; 6 %) had 
free-running naps (Figure 6 .6 ). Similarly, free-running rhythms were found for two 
(S ll, S37) (6 %) and three subjects (S2, S7, S I9) (9%) for actigraphically-derived sleep 
onset and offset, respectively. Two individuals without a free-running aMT6 s rhythm 
showed a free-running activity rhythm (S ll, S29) (6 %) (Figure 6 .6 ).
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Figure 6.5 shows the mean (± sem) for daily mean activity (A) and activity acrophase 
(B). See Figure 6.3 A-C for details. There were no significant differences between the 
circadian rhythm types (p > 0.05, one-way ANOVA). The ‘n ’ for each subgroup is 
shown in italics.
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Figure 6.6 shows the periodicity of aMT6s, activity, nap and sleep (subjective and 
actigraphic) rhythms in all NPL (■) and LP (□ ) subjects without a free-running aMT6s 
rhythm (n = 32). The period (tau) is shown on the left vertical axis and subject numbers 
are shown on the horizontal axis. The right vertical axis represents the overall mean (± 
sem) difference of rhythms from 24.GG h (group, n = 32). All parameters are plotted on 
the same scale and the scales are the same as Figure 6.7 for comparison.
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Figure 6.7 shows the periodicity of aMT6 s, activity, nap and sleep (subjective and 
actigraphic) rhythms in 16 free-running NPL subjects (■) (S45 is not shown - see text). 
The period (tau) is shown on the left vertical axis and subject numbers are shown on the 
horizontal axis. The right vertical axis shows the overall mean (± sem) difference in the 
rhythms from 24 .00 h (group, n = 16). All parameters are plotted on the same scale and 
the scales are the same as Figure 6 . 6  for comparison. ^
Of the 17 individuals with free-running aMT6 s rhythms, free-running rhythms were 
found in 5 subjects (S20, S23, S31, S46, S48) (29%) and 4 subjects (S14, S20, S26, 
S31) (24%) for subjective sleep onset and offset, respectively (Figure 6.7). Similarly, 
free-running rhythms were found in 4 subjects (SI4, S I 8 , S20, S31) (24%) and 2 
subjects (SI4, S20) (12%) for actigraphic sleep onset and offset, respectively (Figure 
6.5). There were 5 subjects (S14, S26, S I 8 , S23, S48) (29%) with a free-running nap 
rhythm and 7 subjects (S14, S18, S20, S31, S33, S36,S 46) (41%) with free-running 
activity (Figure 6.7).
In individuals with free-running aMT6 s rhythms, with one exception (subjective sleep 
onset, S48), sleep, nap and activity rhythms free-ran at taus > 24.00 h and in all cases, 
the period of these rhythms was shorter than the period of the corresponding aMT6 s 
rhythm (aMT6 s rhythm range, 24.13 - 24.79 h; sleep and activity rhythm range, 23.95 - 
24.26) (Figure 6.7). The majority of free-running subjects (10/17, 59%) had a free- 
running rhythm in at least one behavioural parameter, the incidence of which was 
greater in those with aMT6 s periods > 24.5 h compared to those with aMT6 s rhythms < 
24.5 h (S45 not included; 7/8, 8 8 % and 3/8, 38%, respectively) (Figure 6.7). This 
incidence was also higher than in subjects without free-running aMT6 s rhythms (11/32, 
34%) (Figure 6 .6 ). There was no overall significant difference in the mean taus of 
behavioural rhythms between FR and non-FR subjects, although the mean difference of 
the significant taus from 24 h was consistently longer in FR subjects (Figures 6 . 6  and
6.7).
6.3.3 Relationships between sleep and activity rhythms and melatonin rhythms
6.3.3.1 Entrained subj ects
There were some significant relationships between the timing of mean sleep and activity 
data and the timing of aMT6 s acrophase. There were significant positive correlations 
between mean aMT6 s acrophase and mean subjective latency (r = 0.45, p < 0.05) and 
sleep onset (r = 0.47, p < 0.05) (Figure 6 .8 ). There was also a strong but non-significant
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Figure 6 . 8  shows the relationship between mean subjective sleep parameters and 
activity acrophase and mean aMT6 s acrophase time in normally and abnormally 
entrained subjects (n = 30). There is a significant correlation between sleep latency, 
onset and activity acrophase with aMT6 s acrophase time (*, p < 0.05). Sleep offset 
shows a non-significant positive trend and the number o f night awakenings and sleep 
quality show a non-significant negative trend with aMT6 s acrophase.
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trend with negative correlations between mean aMT6 s acrophase and mean subjective 
number of night awakenings (r = -0.32, p = 0.08). Actigraphically-derived sleep data did 
not generally support these findings except for sleep onset which showed a positive 
correlation just outside the level of significance (r = 0.34, p = 0.06). Activity acrophase 
and aMT6 s acrophase were significantly positively correlated (r = 0.41, p < 0.05) 
(Figure 6 .8 ). Daily mean activity did not show any significant relationship.
6.3.3.2 Free-running subjects
Figure 6.9 shows the relationship between the period of the aMT6 s rhythm and the 
period of sleep and activity rhythms in all free-running subjects. There were significant 
positive correlations between the aMT6 s tau and the taus for activity, subjective sleep 
offset and both actigraphic sleep onset and offset (r = 0.67, 0.52, 0.63 and 0.55, 
respectively, p < 0.05) (Figure 6.9).
6.3.4 Relationships between sleep and activity and age or PSQI score
6.3.4.1 Entrained subjects
With respect to age, there was no significant relationship between the timing of the 
mean aMT6 s acrophase and age in NE and AE subjects (r = - 0.15, p > 0.05) (Figure 
6.10A). However, there was a significant negative effect of age on the timing of the 
mean activity acrophase (r = - 0.57, p < 0.05) which showed that an advanced activity 
acrophase was associated with older subjects (Figure 6.1 OB). Subjective mean sleep 
onset and offset times showed significant negative correlations with age (r = - 0.47, r = - 
0.67, p < 0.05, respectively) (Figure 6.11 A, B) and a similar relationship was observed 
in actigraphically-derived mean sleep offset (r = - 0.65, p < 0.05) and sleep onset 
although analysis for sleep onset fell just outside the level of significance (r = - 0.35, p = 
0.06). Subjective sleep quality showed a significant positive correlation with age, with 
worse sleep quality associated with older subjects (Figure 6.11C).
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Figure 6.9 shows the relationship between aMT6 s rhythm tau and the tau of sleep and 
activity rhythms for subjects with free-running aMT6 s rhythms (n = 16). There was a 
significant correlation between all o f the sleep and activity taus and aMT6 s taus except 
subjective sleep onset (*, p < 0.05). In all cases, a longer aMT6 s tau was associated 
with a longer tau for the behavioural rhythms.
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Figure 6.10 shows the relationship between mean aMT6 s acrophase (A) and mean 
activity acrophase (B) with age in entrained subjects (NE/AE, n = 30). There was a 
significant effect of age on activity acrophase (*, p < 0.05) with an advanced 
acrophase associated with older subjects. There is no corresponding similar effect of 
age on aMT6 s acrophase.
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Figure 6.11 shows the relationship between mean subjective sleep onset (A) and 
mean subjective sleep offset (B) and mean subjective sleep quality (C) with age in 
entrained subjects (NE/AE, n = 30). There was a significant effect of age on onset 
and offset with advanced sleep timing associated with older subjects. There was a 
similar significant effect in actigraphically derived sleep offset. Sleep quality was 
also significantly correlated with age, with older subjects having a worse overall 
sleep quality (*, p < 0.05).  ^ 2 3
When similar analyses were performed with PSQI score, only subjective sleep data 
showed any significant relationship. Mean sleep latency and duration of night 
awakenings showed a significant positive relationship with PSQI score (r = 0.48 and r = 
0.43, respectively, p < 0.05) (Figures 6.12A and B) whereas night-sleep duration was 
negatively correlated with PSQI score (r = - 0.59, p < 0.05) (Figure 6.12C).
6.3.4.2 Free-running subjects
There were no significant relationships between any mean sleep parameter and age or 
PSQI score. There was, however, a significant relationship between activity acrophase 
and age (Figure 6.13) but not with PSQI score. A shorter activity tau was associated 
with older age (r = - 0.59, p < 0.05) (Figure 6.13). There was no similar effect of age on 
aMT6 s tau (Figure 5.5A).
6.4 Discussion
This chapter demonstrates the large diversity of sleep and activity patterns in a group of 
blind subjects, the majority of whom complain of a sleep disorder. This diversity, as 
illustrated by the absolute measurement of sleep parameters, is highly individual and 
does not tend to depend on the circadian rhythm type of the individual as assessed using 
aMT6 s rhythms. However, there is a strong overall relationship between endogenous 
circadian rhythms and the timing of sleep and activity in entrained subjects and in 
changes in timing of sleep and activity in free-running subjects.
The lack of a clear relationship between the mean sleep parameters and circadian 
rhythm type suggests that more detailed and individual analysis of sleep is required 
when investigating the effects of circadian rhythm type on sleep and activity (Chapters 7 
and 8 ). The mean night sleep duration was significantly longer in normally entrained 
subjects compared to abnormally entrained and free-running subjects following removal 
of the unclassified subgroup. This suggests that night sleep duration may be the best 
indicator of gross effects of circadian rhythm type on night-time sleep. There were 
several individuals whose mean sleep and activity acrophase measurements deviated
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Figure 6.12 shows the correlation between subjective sleep latency (A), duration of 
night awakenings (B) and night sleep duration with PSQI score for all entrained 
(NE/AE) subjects (n = 30). There was a significant positive correlation between sleep 
latency and duration of night awakenings with PSQI score and a significant negative 
correlation between night duration and PSQI score (*, p , 0.05, one-way ANOVA).
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Figure 6.13 shows the relationship between aMT6 s rhythm tau (A) and activity tau (B) 
with age in subjects with free-running aMT6 s rhythms (n = 16). There was a significant 
effect of age on activity tau (*, p < 0.05) with a shorter tau associated with older 
subjects. There was no similar effect of age on aMT6 s tau.
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substantially (> 2SD) from the study population mean. Subject 13, whose aMT6 s 
rhythm was abnormally entrained (mean aMT6 s acrophase = 14.3 h) had extremely 
short night sleep duration and long day-time nap duration. This is more readily observed 
in Raster plots of the SW cycle (Appendix B) and reveals a highly arrhythmic SW cycle 
with a large proportion of total sleep occurring during the day-time (Chapter 7). Subject 
23 also had long day-time nap duration which was associated with a free-running 
aMT6 s rhythm (Chapters 7 and 8 ). There were two subjects with unusual sleep timings. 
Subject 25 (NPL, normally entrained) had an advanced sleep onset and activity 
acrophase that may be age-related (S25 is 62 years old), as observed in the group 
findings assessing the effect of age (Figures 6.9B and 6.10A). Subject 8  (LP, 
unclassified) showed extreme delays in sleep onset and offset times and activity 
acrophase which may also be age-related (S8  is 23 years old) and is also likely to be due 
to lifestyle as S8  was a full-time student during the study with no requirement to keep 
normal hours. The long mean sleep latency observed in S50 (NPL, abnormaly entrained) 
may be due to the phase-delay in the aMT6 s rhythm (aMT6 s acrophase, (n = 1) = 7.2 h) 
as observed in the group findings assessing the relationship between sleep and aMT6 s 
timing (Figure 6 .8 A).
The finding that significant correlations exist between aMT6 s acrophase and sleep 
timing, sleep quality and activity acrophase in entrained subjects underlines the view 
that there is a circadian influence on sleep and activity (Section 1.1.5.1) despite the fact 
that the aMT6 s rhythms were stably entrained. As all of the subjects lived normally 
throughout the study, sleep will have been attempted at a conventional time in the 
majority of subjects and it appears that their ability to sleep may be determined by the 
position of the aMT6 s acrophase. There were significant positive correlations between 
aMT6 s acrophase and subjective sleep latency and sleep onset (Figure 6 .8 ) which 
suggests that sleep was easier to initiate in subjects whose aMT6 s acrophase is advanced 
and therefore closer to conventional bedtime i.e. individuals with a relatively advanced 
aMT6 s acrophase will find it easier to sleep conventionally than those with relatively 
delayed aMT6 s acrophases. Similarly, the timing of the peak of activity was positively 
correlated with aMT6 s acrophase (Figure 6 .8 ) which underlines the strong circadian 
influence on activity rhythms, even in entrained individuals. Using the International
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Classification of Sleep Disorders (ICSD, 1990), abnormally entrained individuals fulfill 
the criteria for either delayed sleep phase syndrome (DSPS) in individuals with delayed 
aMT6 s acrophases (S47, S15, S13, S50, S38) or advanced sleep phase syndrome 
(ASPS) in individuals with advanced aMT6 s acrophases (S9, S40, S I6 , S22). This 
corresponds to the convention that individuals can be categorised into Tarks’ and ‘owls’ 
or ‘morning’ and ‘evening’ types depending on the position of their own clock, despite 
the fact that they are stably entrained. The negative trends between aMT6 s acrophase 
and mean number of night awakenings and sleep quality may suggest that sleep is less 
disturbed and of a better quality in those with delayed clocks.
Further work is required to confirm these findings but there may be several reasons for 
this relationship. Conventionally, people believe that they need a certain amount of 
sleep and because individuals with relatively advanced clocks are waking earlier than 
they expect, they may feel that they have not slept long enough. They may interpret this 
spontaneous wakening as ‘night awakenings’ and continue to attempt sleep until their 
‘expected’ wake up time. This would then lead to poor sleep quality and disturbed sleep 
following their spontaneous waking as sleep would be attempted at an inappropriate 
circadian time (i.e. when CBT is rising; Czeisler et al., 1980a). Secondly, in recording 
sleep quality, the delayed subjects subconsciously may not include their inability to get 
to sleep in their assessment. The major influence may be that when they finally sleep, it 
is less disturbed and therefore perceived as ‘better quality’.
It would be expected, particularly under the single hypothesis of rhythm control 
(Section 1.1.2.2), that sleep and activity rhythms would free-run in individuals with 
free-running aMT6 s rhythms. This hypothesis is upheld in these findings. The incidence 
of subjects with free-running behavioural rhythms is greater in subjects with free- 
running aMT6 s rhythms (10/17, 59%) compared to those who are entrained (11/32, 
34%) (Figures 6 . 6  and 6.7). There is also a strong positive relationship between the taus 
of the different rhythms in free-running subjects (Figures 6.12). However, not all 
subjects with free-running aMT6 s demonstrate free-running behavioural rhythms and 
their periods are consistently shorter than the aMT6 s tau, albeit strongly correlated. 
There are two likely explanations. Firstly, social zeitgebers, known to have effects on
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rhythms in animals (Section 1.1.1.2.2), may be partially entraining behavioural rhythms 
and therefore shortening the tau without a corresponding effect on melatonin rhythms. 
Secondly, the behavioural requirements of a 24 h lifestyle, may be having a ‘masking’ 
effect on the behavioural rhythm itself therefore masking the true pattern that would be 
observed in a time-free environment. Behavioural rhythms certainly free-run at periods 
closer to that of melatonin and CBT in sighted individuals living in constant dim light 
with no social impositions (Middleton et al., 1996).
The behavioural parameter that appears least influenced by masking is activity. 
Compared to sleep rhythms, the incidence of free-running activity rhythms is highest in 
subjects with free-running aMT6 s rhythms and lowest in subjects without free-running 
aMT6 s rhythms. This appears to suggest that activity most accurately reflects the 
circadian type (classified according to the aMT6 s rhythm). However, both the timing of 
activity acrophase and the period of the activity rhythm were strongly correlated with 
age, with advanced acrophase times and reduced taus in older individuals (Figures 6.9 
and 6.13, respectively). Similarly, the timing of mean sleep onset, offset and quality 
were also significantly related to age with relatively advanced sleep of a worse quality 
in older subjects (Figure 6.10). These results suggest that age affects sleep and activity 
to a greater extent than aMT6 s although whether it is masking or a true effect on the 
underlying endogenous control is unknown. It is evident, therefore, that some caution is 
needed when interpreting behavioural rhythms as they may be more susceptible to age- 
related effects than the melatonin rhythm. These findings also highlight the difficulties 
in excluding other factors when analysing the relationship between rhythms. A larger 
sample size or age-matched populations may help resolve this problem.
There was an association between some subjective mean sleep measurements and PSQI 
score in non-free-running subjects. Sleep latency and duration of night awakenings both 
increased and night sleep duration decreased with increased PSQI score. It is possible 
that these sleep parameters are the ones to which the PSQI is most sensitive and they 
may therefore provide a further indication of the degree of sleep disorder.
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The occurrence of free-running sleep and activity rhythms in entrained subjects cannot 
be due to the influence of a free-running circadian system, unless the aMT6 s rhythms 
assessment was providing an inaccurate reflection of the underlying oscillator. There is 
no evidence to suggest that this is possible. It may be the case (for example in SI 1), that 
the aMT6 s period is close to 24 h and therefore any change in the timing of aMT6 s is 
difficult to detect in the four-week protocol employed. The limit of detection for a free- 
running aMT6 s rhythm is higher than that for the behavioural rhythms due to a much- 
reduced number of data points for the regression analysis of aMT6 s. It may therefore be 
the case that in a subject with a aMT6 s period close to 24 h, the free-running period in 
the aMT6 s rhythm is not detectable over four weeks whereas free-running behavioural 
rhythms are. The way to confirm any short behavioural or aMT6 s periodicities would be 
to undertake a longer study. There may also be problems with the sensitivity of the 
analysis techniques used. Although some of the very short periods (i.e. < 24.1) revealed 
by the regression analysis are statistically significant, this may not reflect a true free- 
running rhythm. In order to confirm this possibility, the analysis methods could be 
tested on behavioural rhythms that are known to be slowly free-running and establish 
the best level of accuracy of tau estimation achievable over a known number of days’ 
data.
In conclusion, mean sleep parameters are not a good indication of circadian rhythm 
type. There is a strong relationship between the timing of mean sleep and activity in 
non-free-running subjects with mean aMT6 s acrophase, meaning the occurrence of 
‘morning’ and ‘evening types’. Free-running sleep and activity rhythms occur 
predominantly in subjects with free-running aMT6 s rhythms albeit at a reduced tau. The 
activity rhythm appears to provide the most consistent reflection of free-running aMT6 s 
rhythms, although there may be a confounding age-related effect on activity, and to a 
lesser extent, sleep timing.
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CHAPTER 7
NAP INCIDENCE 
AND TIMING
CHAPTER 7 - NAP INCIDENCE AND TIMING 
7.1 Introduction
The first extensive study of the sleep rhythms in a blind man living in normal society 
(Miles et ah, 1977) clearly indicated that the incidence and timing of day-time naps was 
not random. However, subsequent investigations either did not confirm this finding in 
all subjects studied (e.g. Sack et ah, 1992) or reported day-time sleepiness but provided 
no data as to its incidence and timing (e.g. Lewy and Newsome, 1983). As opposed to 
isolation studies of sighted individuals, fiee-running blind subjects continuing to live in 
a conventional 24 h society cannot always sleep at their desired times due to, for 
example work commitments. There has been no previous attempt to quantify the 
incidence of napping in blind subjects or to attempt to relate nap incidence and timing to 
endogenous circadian rhythmicity. This chapter describes the incidence of naps in 
relation to aMT6 s rhythms and specifically investigates the relationship between the 
timing of naps and the timing of aMT6 s production. Chapter 8  presents more detail 
about naps in relation to a free-running circadian system.
7.2 Methods
7.2.1 Subjects
Of the 49 subjects studied, 21 had normally entrained (NE) aMT6 s rhythms, 9 appeared 
to be abnormally entrained (AE), 17 had free-running rhythms (FR) and two were 
unclassified (UN) (Chapter 5). Of the abnormally entrained subjects, 5 had no light 
perception (NPL) and 4 had light perception (LP) (Chapter 4 for subject information and 
Tables 5.1 and 5.2 for details of circadian classification). 46 out of the 49 subjects had at 
least one self-defined nap during the study. The three that failed to nap all made a 
conscious effort not to do so. There were thirteen subjects who napped infrequently and 
had fewer than 5 naps throughout the whole study.
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7.2.2 Data analysis
Subjects were asked to record any sleep outside their bedtime period in a nap diary 
(Section 3.1.2.3). The mean number and duration of naps per day was calculated for all 
subjects. Unpaired Student’s t-test was used to compare napping between LP and NPL 
individuals. To establish whether there was a significant effect of circadian status on 
napping, one-way ANOVA was applied to the data with circadian status as the factor 
(NE, AE, FR, UN) followed by post-hoc analysis (Duncan’s multiple range test).
To investigate the relationship between aMT6s phase and nap timing, using the 
midpoint time of all naps, naps were assigned to groups depending on whether the naps 
occurred within or outside a 5-h range before and after the daily aMT6s acrophase. For 
normally and abnormally entrained subjects, the mean aMT6s acrophase time was 
considered to be the daily acrophase (Table 5.1 and 5.2). In free-running subjects, the 
daily aMT6s acrophase was estimated from the aMT6s regression analysis (Section
5.2.4.2). Within subjects the number of naps occurring within and outside the 5-h range 
was compared using paired Student’s t-test.
7.3 Results
7.3.1 Nap incidence and duration
Figure 7.1 shows the mean data for the number and duration of naps per day, grouped 
according to severity of visual loss (> 3/60, CF, HMO, PL, 2E, IE, OE). There was no 
overall significant difference in the number or duration of naps between the seven 
groups. When analysed as a group (LP versus NPL), there were significantly more naps 
of a longer duration in NPL subjects (mean ± sem = 0.6 ± 0.1 naps/day, 0.4 ±0.1 h/day) 
compared to LP subjects (0.3 ±0.1 naps/day, 0.2 ± 0 h/day, p < 0.05) (Figure 7.1). 
These differences were upheld when analysed with respect to the circadian status of the 
individuals. One-way ANOVA, revealed that normally entrained subjects had 
significantly fewer naps per day than all other circadian groups (p < 0.05) (Figure 7.2).
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Figure 7.1 shows the number (A) and duration (B) of naps per day in all individuals, 
grouped according to the severity of visual loss (>3/60 , counting fingers (CF), hand 
movements only (HMO), light perception only (PL), two eyes present (2E), one eye 
present (IE), no eyes present (OE)). Subjects with and without light perception are 
represented by white and black bars, respectively. There were significantly more naps 
of a longer duration in NPL subjects compared to LP subjects (p < 0.05, *).
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Figure 7.2 shows the relationship between the number (black bars) and duration (h, grey 
bars) of naps per day and circadian rhythm types. Values are means ±sem. Normally 
entrained subjects (NE) have significantly fewer naps per day compared to subjects with 
abnormally entrained (AE), free-running (FR) or unclassified (UN) aMT6s rhythms (p < 
0.05, *). NE subjects also have a shorter duration of naps per day but this did not reach 
significance. Numbers in italics show the ‘n ’ value for each subgroup.
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7.3.2 Relationship between the timing of aMT6s phase and the timing of naps
Figure 7.3 shows the number of naps inside and outside a 5-h range before and after the 
estimated daily aMT6s acrophase for all subjects with free-running (FR) and abnormally 
entrained (AE) aMT6s rhythms. Of the LP and NPL subjects with abnormally entrained 
or free-running aMT6s rhythms (n = 25), there were significantly more naps within the 
5-h range (65 %) (paired Student’s t-test, p < 0.05) (Figure 7.3). Similarly, there were 
significantly more naps within the 5-h range in NPL subjects with abnormally entrained 
or free-running rhythms (n = 21, 67%, p < 0.01) and in NPL subjects with free-running 
rhythms (n = 16, 65%, p < 0.01).
7.4 Discussion
These results show that the incidence and duration of napping is greater in individuals 
with abnormal circadian rhythms (abnormally entrained or free-running). They also 
indicate that the timing of these naps does not appear to be random - they are associated 
with the time of peak aMT6s production.
It is clear, even from Miles’ study (Miles et al., 1977), that the timing of naps in free- 
running individuals is not random but is associated with a specific phase of the free- 
running endogenous clock. In our study in free-running subjects, this association 
occasionally manifests as a free-running nap rhythm (Section 6.3.2). Commonly, 
however, the timing of naps is clustered around the aMT6s peak. This is particularly 
evident when comparing subjects with abnormally entrained rhythms at different times 
of the day (Figure 7.4B). Sleep is controlled by both homeostatic and circadian
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mechanisms which usually work in synchrony to consolidate periods of sleep during the 
night and wake through the day (Section 1.1.5). However, in individuals with 
abnormally timed aMT6s rhythms, these two components appear to separate. The 
relationship between day-time naps and aMT6s acrophase suggest that the timing of 
these naps is under circadian control and reflects the body’s endogenous circadian sleep 
propensity rhythm. Therefore, these naps may reveal the circadian component of sleep 
without the masking effects of any homeostatic influence.
It is not possible to prove any causative link between melatonin production and day­
time sleep induction in this study. Certainly, however, there is a strong association 
between melatonin onset and sleep induction in sighted men (Tzischinsky et al., 1993) 
and between melatonin and sleep propensity in both sighted (Akerstedt et al., 1979) and 
blind subjects (Nakagawa et al., 1992). Exogenous melatonin has also been shown to 
have sleepiness-inducing effects (e.g. Arendt et al., 1984; Deacon and Arendt, 1995) 
(Section 1.1.4.5.2). Alternatively, the association may not be causative; melatonin 
could be a phase-marker of another sleep-inducing factor. For example, the melatonin 
rhythm has been shown to be very closely phase-locked to both CBT and cortisol (e.g. 
Nakagawa et al., 1992).
Our findings do not specifically support either hypothesis. There is an inconsistency in 
the relationship between the aMT6s acrophase and the exact time of day sleep induction. 
Sometimes the naps occur before the aMT6s acrophase, sometimes after the acrophase 
and sometimes on either side of the acrophase. If, for example, melatonin onset induced 
sleep, then the naps would be expected to occur before the peak of the metabolite of 
melatonin, aMT6s. These results are confounded by the fact that subjects are unable to 
sleep at the desired time, for example due to work committments. The findings may also 
reflect problems of resolution in the analysis of aMT6s in that the four-hourly urine 
collection periods and differing metabolic rates in individuals may artifactually affect 
the time between melatonin production and aMT6s expression. Further work with more 
frequent sampling of urinary aMT6s and plasma melatonin may allow a closer 
assessment of the relationship between sleep induction and endogenous melatonin 
production. The development of a specific melatonin-antagonist which does not affect
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sleep would also help to determine whether the presence of endogenous melatonin was 
essential for ‘circadian’ naps. However, no such antagonist exists at present.
There are several counter arguments to these conclusions. Firstly, the incidence of 
napping is wide-spread in the general population and may have nothing to do with an 
abnormal circadian system. Habitual napping can occur in certain situations (e.g. after 
work or when the opportunity exists, for example at weekends) and in certain subgroups 
of the population (e.g. young children and elderly people). We have observed habitual 
napping in some of our subjects with normally entrained rhythms (Figure 7.4A). 
These naps are most probably due to a mixture of opportunity and complex homeostatic 
influences on sleep (Section 1.1.5). However, even when such naps are observed in 
normally entrained subjects, they still have consistently fewer naps of a shorter duration 
than individuals with abnormally entrained rhythms. It is also possible that napping may 
be influenced by alterations in circadian rhythmicity independent of those caused by 
sight loss, for example in shiftworkers or the elderly.
It could also be said that the higher incidence of naps in those with abnormal rhythms 
was due to opportunity. In fact, it is surprising that any naps were observed at all in this 
subgroup, as more subjects with abnormal rhythms work (18/28, 64%) than those with 
normal rhythms (11/21, 52%) (Section 4.4)
A further criticism of these results could be that as self-defined naps occur in the day­
time they are inevitably associated with an abnormally timed aMT6s acrophase. 
However, as previously discussed, the number of naps is significantly higher in the 
abnormally entrained group overall and the timing of these naps changes with the 
changing aMT6s acrophase (in free-running subjects) (Chapter 8).
There are individual exceptions to these overall findings which may explain why 
previous studies did not find such a high incidence of napping in their subjects. Some 
subjects with abnormally entrained or firee-running rhythms either did not nap or napped 
infi-equently (< 0.2 naps/day, n = 4). In general, these subjects either made a conscious 
effort not to nap or were ‘too busy’. Conversely, some subjects found the desire to nap
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overwhelming and could not fight that desire even though they tried. Exceptionally few 
subjects with free-running rhythms stated no desire to nap (n = 2) and did not report a 
sleep disorder. To account for those who are too busy to nap, future studies will attempt 
to record times when the desire to nap is very strong in subjects but they are unable or 
unwilling to take a nap. Obviously, both the circadian and homeostatic influences on 
naps are highly individual.
Overall, there are more naps of a longer duration in NPL compared with LP subjects. 
Similarly, those with fi-ee-running and abnormal aMT6s rhythms also had a greater 
incidence of naps compared to those with normal rhythms. The relationship between the 
timing of naps and aMT6s production is strong although it is unproven whether or not 
the association is causative. The results demonstrate that the measurement of naps is 
essential in circadian studies. A high incidence of naps or a strong desire to nap may 
provide a sensitive behavioural indicator of a disordered circadian system.
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THE EEFECT OF CHANGES 
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CHAPTER 8 - THE EFFECT OF CHANGES IN CIRCADIAN PHASE ON 
SLEEP AND ACTIVITY 
8.1 Introduction
The circadian rhythms of SW and activity may become desynchronised from the 
rhythms of strongly endogenous variables (SEV) (e.g. melatonin, cortisol, core body 
temperature) (Section 1.1.1.2). Sleep also has an important homeostatic element, 
dependent on the waking time between sleep periods, that interacts with the circadian 
aspect of the SW cycle (Section 1.1.5). Despite the fact that the periods of SW and 
activity rhythms can differ greatly from SEYs, there is still a degree of interaction 
between the rhythms or ‘relative co-ordination’. For example, sleep periods are longer if 
begun on the rising limb of the temperature rhythm rather than the falling limb (e.g. 
Czeisler et al., 1980a).
As sleep is under a circadian influence, free-running blind subjects living a conventional 
24 h lifestyle should in theory show sleep disturbance as their SE Vs become 
desychronised from the normal 24 h day. This manifests primarily as day-time naps, the 
timing of which ‘attempts’ to free-run with a SEV such as melatonin (Chapter 7). How 
this affects night-time sleep is not fully known. It has been reported anecdotally that 
sleep changes with circadian phase in free-running blind individuals (Section 1.2.3) but 
no attempt has been made to quantify any change.
This chapter addresses the interactions between circadian phase assessed by aMT6s and 
sleep and activity and investigates whether these interactions follow any pattern in free- 
running blind subjects living in field conditions.
8.2 Methods - Section A
8.2.1 Subjects
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Sixteen subjects with free-running melatonin rhythms, as measured by urinary 6- 
sulphatoxymelatonin (aMT6s) (15 males, 1 female; mean age ± SD = 48.9 ± 12.1 years, 
range 32 - 68 years) are described (Chapter 4 for subject details and Section 5.3.2.2 for 
aMT6s results). One further subject had a free-running aMT6s rhythm but, due to 
technical problems with the collections, no daily aMT6s acrophase could be calculated. 
All of these subjects had no conscious light perception (NPL). Twelve of the 16 subjects 
(75%) complained of a sleep disorder as assessed by the Pittsburgh Sleep Quality Index 
(PSQI > 5) (Section 4.1).The mean score (±SD) of those subjects with and without sleep 
complaints were 11.2 ± 3.4 (n = 12) and 3.3 ± 0.5 (n = 4), respectively. All subjects 
lived a conventional lifestyle and no restrictions were placed on their behaviour during 
the study. Twelve of the 16 subjects were employed with conventional working hours at 
places of work away from home. One individual was self-employed and worked from 
home but kept approximately conventional working hours. The three remaining subjects 
were all retired and were able to keep any hours they wished.
8.2.2 Study schedule
Full details of the study schedule are described in Chapter 3. Briefly, all subjects were 
studied for at least 4 weeks and were required to keep daily sleep and nap diaries, wear 
activity monitors and collect sequential four-hourly urine samples for 48 hours of each 
week for analysis of aMT6s.
8.2.3 Data analysis
Using the estimated daily aMT6s acrophase times (Section 5.2.4.2), subjective and 
actigraphic sleep and nap data were divided into one-hourly bins. The estimated daily 
aMT6s acrophase was coupled with the previous nights sleep and that days naps. 
Similarly, the daily mean activity and the activity acrophase were also divided into 
hourly bins. For those free-running subjects whose aMT6s rhythm passed through a 
normal phase (24.00 - 06.00 h) during the study, one-way ANOVA was performed to 
compare sleep and activity when aMT6s was ‘in phase’ (24.00 - 06.00 h) and ‘out of 
phase’ (06.00 - 24.00 h) on each subject. Group analysis was performed on these data 
using a paired Student’s t-test.
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A more detailed analysis was performed on those subjects who passed, at least partially, 
through four circadian phases (24.00 - 06.00 h, 06.00 - 12.00 h, 12.00 - 18.00 h, 18.00 -
24.00 h) using one-way ANOVA (phase as factor). In order to allow group comparisons, 
all sleep, nap and activity data were expressed with respect to each individuals’ own 
overall mean. Data were then grouped and analysed by one-way ANOVA according to 
the four circadian phases. Post-hoc analysis (Duncan’s multiple range test) was used to 
reveal where significant changes occurred. Similarly, hourly-grouped data were also 
analysed by one-way ANOVA to assess any overall change in sleep or activity.
8.3 Results - Section A
8.3.1 Changes in sleep and activity over two circadian phases
8.3.1.1 Subjective sleep
Eleven of the 16 subjects with free-running aMT6s rhythms passed, at least partially, 
through a normal (acrophase range 24.00 - 06.00 h) and abnormal phase (acrophase 
range 06.00 - 24.00 h). Analysis of the subjective sleep data showed that the parameters 
that appeared to be most sensitive to changes in phase were the number and duration of 
day-time naps. Six out of 11 subjects (55%) had a significant difference in the duration 
of naps per day between phases, with all having a shorter duration of day time naps in 
the normal phase. Similarly, the number of naps per day changed significantly between 
phases in 5 out of 11 subjects (45%), all having fewer naps per day in the normal phase. 
This reduction in the number and duration of day-time naps was apparent in all 11 
subjects, regardless of statistical significance. Figures 8.1 A and 8.IB show the number 
and duration of naps recorded whilst the subjects’ aMT6s rhythm was ‘in phase’ (24.00 
h - 06.00 h) and ‘out of phase’ (06.00 - 24.00 h), respectively.
Group analysis of subjective sleep data in all 11 subjects (paired Student’s t-test) 
confirmed the finding that there were significantly fewer naps of a shorter duration 
when aMT6s was in a normal phase position (24.00 - 06.00 h; mean (± sem) = 0.2 ±0.1 
naps/day, 0.1 ± 0.0 h/day) compared to an abnormal phase position (06.00 - 24.00 h; 
mean (± sem) = 0.8 ± 0.2 naps/day, 0.5 ±0.1 h/day).
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Figure 8.1 shows the mean number (A) and duration (B) of subjectively recorded 
naps per day in 11 individuals with free-running aMT6s rhythms that passed, at least 
partially, through a normal (aMT6s acrophase 24.00 - 06.00 h) and an abnormal 
(aMT6s acrophase 06.00 - 24.00 h) phase. Most individuals had significantly more 
naps of a longer duration during the abnormal phase (06.00 - 24.00 h) (*, p < 0.05, 
Student’s t-test). The group mean (± sem) shown by the grey bars, also showed a 
significant increase in the number and duration of naps during the abnormal phase 
(**, p < 0.05, paired Student’s t-test.
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8.3.1.2 Actigraphic sleep
Analysis of actigraphic sleep in individuals who passed through the two phases was 
only possible on nine subjects due to insufficient data. Group analysis of actigraphic 
sleep data in all 9 subjects (paired Student’s t-test) revealed no significant group 
differences between the phases.
8.3.1.3 Daily mean activity
Analysis was performed on 10 individuals who had daily mean activity during normal 
(24.00 - 06.00 h) and abnormal (06.00 - 24.00 h) phases. There was no significant 
difference in activity between the phases when analysed as a group with each 
individuals’ daily mean activity expressed with respect to their own overall activity 
mean (n=  10).
8.3.1.4 Activity acrophase
There were 10 subjects with sufficient activity acrophase data to assess changes in the 
time of peak activity both in and out of a normal aMT6s phase (24.00 - 06.00 and 06.00 
- 24.00 h, respectively). Group analysis, with activity acrophases expressed with respect 
to each individuals’ own mean, did not show any significant difference in the timing of 
activity acrophase with aMT6s phase (paired Student’s t-test, ns; n = 10).
8.3.2 Changes in sleep and activity over four circadian phases
When analysed in more detail, six subjects with a aMT6s period > 24.5h (S14, S I8, 
S20, S31, S33, S36) were found to have aMT6s rhythms passing, at least partially, 
through all four of the following circadian phases; 24.00 - 06.00 h, 06.00 - 12.00 h,
12.00 - 18.00 h, 18.00 - 24.00 h. Table 8.1 shows a summary of details for these 
subjects.
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Table 8.1 Details of six NPL subjects analysed for changes in sleep with respect to 
circadian phase
Visual loss
Subject No.
Sex Age PSQI aMT6s Tau (h) Employed
1 eye
14 M 32 11 24.79 Yes
20 M 66 13 24.68 No
no eyes
18 M 44 16 24.68 Yes
31 M 35 3 24.68 Yes
33 M 55 4 24.60 Yes
36 M 44 3 24.60 Yes
8.3.2.1 Subjective sleep
Group analysis of the subjective sleep data of these six individuals expressed with 
respect to their own means, revealed significant changes in sleep latency and the number 
of naps (p < 0.05) (Figures 8.2A and 8.2G, respectively) over the four circadian phases. 
The significantly longer sleep latency occurred when the aMT6s rhythm was delayed 
(06.00 - 12.00 h) compared to the 12.00 - 18.00 h and 18.00 - 24.00 h phases. There 
were significantly fewer naps during the normal aMT6s phase (24.00 - 06.00 h) 
compared to all other phases. No other sleep parameters showed a statistically 
significant change.
8.3.2.2 Actigraphic sleep
Inspection of the individual data for actigraphically-derived data showed that two 
individuals (SI8, S36) did not have complete data sets for all four circadian phases. For 
actigraphically-derived grouped sleep data expressed with respect to each individuals’ 
own mean (n = 4), there were significant differences in night sleep duration, sleep offset 
and the number of night awakenings with respect to the four circadian phases (Figures 
8.3C, 8.3D and 8.3E, respectively). Post-hoc analysis revealed that sleep offset was 
significantly phase advanced in both the 12.00 - 18.00 h and 18.00 - 24.00 h phase 
compared to the other two phases. Night sleep duration was significantly shorter when 
aMT6s peaked between 12.00 - 18.00 h compared to all other phase. The number of
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night awakenings was significantly greater during the 06.00 - 12.00 h phase than during 
the 18.00 - 24.00 h phase
Even though statistical significance was not achieved in most subjective or actigraphic 
analyses, there were some consistent and strong trends in the sleep data with respect to 
circadian phase (Figures 8.2 and 8.3). For example, night sleep duration was greatest 
between 24.00 - 06.00 h and shortest between 12.00 - 18.00 h in both the subjective and 
actigraphic results (Figures 8.2C and 8.3C, respectively). The duration of night 
awakenings was highest between 12.00 - 18.00 h and shortest between 18.00 - 24.00 h 
phases in both methods (Figures 8.2E and 8.3E). The change in nap duration with phase 
was very similar in both methods, namely that nap duration was longest in the 12.00 -
18.00 h phase and shortest in the 24.00 - 06.00 h phase.
There were some similarities in the changes in sleep timing measured by both methods. 
Sleep offset was advanced during the 12.00 - 18.00 h and 18.00 - 24.00 h phases 
compared to the normal phase (24.00 - 06.00 h) measured both subjectively (Figure 
8.2D) and actigraphically (Figure 8.3D). Sleep onset times were relatively delayed 
during the 06.00 - 12.00 h phase and relatively advanced during the 18.00 - 24.00 h 
phase compared to the normal phase (24.00 - 06.00 h) (Figures 8.2B and 8.3 B).
8.3.2.3 Daily mean activity
Four individuals (SI4, S20, S31, S33) had daily mean activity data for all four circadian 
phases. Group analysis of these four subjects, with daily mean activity expressed with 
respect to their own means, showed no significant difference between the phases 
although daily mean activity was lowest when the aMT6s acrophase was maximally out 
of phase (12.00 - 18.00 h) (Figure 8.4A).
8.3.2.4 Activity acrophase
Four individuals (S14, S20, S31, S33) had sufficient activity data to analyse the 
relationship of four aMT6s phases on the timing of the activity acrophase. Group 
analysis, with activity acrophase expressed with respect to each individuals’ own mean, 
showed a non-significant trend for a delay in activity acrophase when the aMT6s phase
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Figure 8.4 shows the group (n = 4) relationship between mean (± sem) activity (A) 
and activity acrophase (B) and four aMT6s phases, expressed with respect to each 
subjects’ own mean. The shaded area represents the period over which aMT6s is 
condsidered normal. There are non-significant trends for decreased activity when 
the aMT6s is maximally out of phase (12.00 - 18.00 h). There is also a non­
significant trend for a delay and advance in activity acrophase as the aMT6s is 
relatively delayed (06.00 - 12.00 h) and relatively advanced (18.00 - 24.00 h) 
compared to the normal phase. 8-10
was delayed (06.00 - 12.00 h) and an advance when the aMT6s phase was advanced 
(12.00 - 18.00 h and 18.00 - 24.00 h) (Figure 8.4B).
8.3.3 Changes in sleep and activity analysed by hour
8.3.3.1 Subjective sleep
Figure 8.5A-I shows grouped data (hourly) for subjective sleep latency, onset, night 
sleep duration, offset, number and duration of night awakenings, sleep quality and the 
number and duration of day-time naps plotted against estimated daily aMT6s acrophase 
(n = 6, Section 8.3.2). One-way ANOVA of mean hourly data for all 6 subjects 
(expressed with respect to their own mean) revealed overall significant differences in 
night sleep duration (Figure 8.5C), sleep offset (Figure 8.5D) and the number and 
duration of naps (Figures 8.50 and H, respectively) (p < 0.05). Sleep onset just failed to 
reach significance (p = 0.07).
8.3.3.2 Actigraphic sleep
Figure 8.6A-I shows grouped data (hourly) for actigraphically derived sleep latency, 
onset, night sleep duration, offset, number and duration of night awakenings, sleep 
efficiency and the number and duration of day-time naps plotted against estimated daily 
aMT6s acrophase (n = 4; Section 8.3.2.4). One-way ANOVA of mean hourly data for 
all 4 subjects (expressed with respect to their own mean) revealed overall significant 
differences in night sleep duration (Figure 8.6C), sleep offset (Figure 8.6D), duration of 
night awakenings (Figure 8.6F), nap duration (Figure 8.6H) and sleep efficiency (Figure 
8.61) (p < 0.05).
8.3.3.3 Activity mean and acrophase
Figures 8.7A and 8.7B show grouped hourly data for daily mean activity (A) and 
activity acrophase (B) plotted against estimated daily aMT6s acrophase (n = 4). One­
way ANOVA showed that both parameters change significantly with changes in the 
daily aMT6s acrophase (p < 0.05).
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Figure 8.7 shows the relationship between daily mean activity (A) and activity 
acrophase (B) and circadian phase (n = 4). The mean (±sem) activity parameters 
(with respect to each subjects’ own mean) are plotted against hourly aMT6s 
acrophase times. Grey areas represent the mean (± ISD) acrophase times for 
normally entrained subjects (n = 80, unpublished results). Both parameters show an 
overall significant effect of circadian phase (*, p <0.05, one-way ANOVA).
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8.4 Methods - Section B
8.4.1 General methods
Following the observation of unparallel changes in sleep onset and offset with aMT6s 
phase (n = 6, Section 8.3.3.land Figure 8.5), the phase angle between subjective sleep 
onset and offset was calculated with repect to daily aMT6s acrophase in two free- 
running subjects that passed completely through a whole circadian cycle during the 
study (SI4, S20).
8.4.2 Determination of a circadian effect on the phase angle between sleep onset and 
offset and its relationship to circadian phase
The phase angle was determined by calculating the difference between the onset and 
offset times throughout the study for each subject and expressed in degrees relative to 
their own circadian cycle. For example, the tau of the individual (e.g. 24.68 h) = 360° 
therefore the phase angle between onset and offset is calculated as follows:-
(time between onset and offset (h) / 24.68) x 360
In order to group the two subjects, the phase angle values were indexed between 0 and 1 
and the circadian phase was grouped every 15°. In order to smooth the data for ease of 
presentation, a four point moving average was calculated and plotted.
8.4.3 The relationship between phase angle and sleep timing
In order to determine the theoretical pattern of sleep onset and offset required to achieve 
the observed phase angle, sleep onset was plotted as a function of a constant sleep offset 
and sleep offset was plotted as a function of constant sleep onset. Assuming that sleep 
onset and offset contributed equally to the variation in phase angle, a figure was plotted 
to show what the profile of the resultant sleep period would look like in theory. In order 
to test whether this was a true assumption in the study population, the extent of any
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difference in variation between sleep onset and offset times was investigated. The 
standard deviation (SD) of the sleep onset and offset times were calculated for all free- 
running subjects (n = 17) and analysed using paired Student’s t-test.
8.5 Results - Section B
8.5.1 Determination of a circadian effect on the phase angle between sleep onset and 
offset and its relationship to circadian phase
Figure 8.8 clearly shows that there is a non-symmetrical relationship between the phase 
angle between sleep onset and offset and circadian phase with the maximum angle 
occurring at approximately 0° and the minimum angle occurring between 60 - 90°.
8.5.2 The relationship between phase angle and sleep timing
Assuming that sleep onset and offset contribute equally to the variation observed in 
phase angle (Figures 8.9A and B), Figure 8.9C shows what the resulting sleep period 
would be. However, analysis of the mean SD of sleep onset and offset for 17 free- 
running subjects results showed that the mean SD of sleep offset was significantly 
greater than the mean SD for sleep onset and that the sleep onset (mean SD (± sem) = 
0.99 ± 0.11 h and 1.31 ±0.14 for onset and offset, respectively, p < 0.05). Figure 8.9D 
shows what Figure 8.9C looks like when the difference in SD is applied (i.e. the 
variation in sleep onset is only 75% (0.99/1.31) of the variation in the the sleep offset 
curve). If Figure 8.9D is plotted sequentially over several circadian cycles, a sleep 
pattern appears that resembles the pattern of sleep undergoing relative co-ordination 
with the melatonin rhythm (Figure 8.10).
8.6 Discussion
This chapter quantifies for the first time the changes in sleep of free-running blind 
individuals living a conventional 24 h lifestyle in field conditions. It confirms the fact
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Figure 8.8 shows the relationship between the phase angle between sleep onset and 
offset with circadian phase. The vertical axis shows the phase angle between sleep 
onset and sleep offset, expressed in degrees according to each individuals’ own tau 
(n = 2) and then indexed from 0 - 1 to allow group comparisons. The horizontal 
axis shows the phase of the aMT6s rhythm calculated in degrees (0® = aMT6s 
acrophase at 04.00 h). The bars represent the mean (± sem) phase angle between 
sleep onset and offset grouped every 15®. A four-point moving average of these data 
is also shown (i.e. 60®, ■). There is a clear non-symmetrical relationship between 
the phase angle between sleep onset and offset and circadian phase with the largest 
angle occurring at approximatey 0® and the minimum angle occurring between 
approximately 60 - 90 ®.
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sleep onset 
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C
onset =  offset
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onset =  75% offset
Figure 8.9 shows how the observed phase angle between sleep onset and offset is 
achieved if either sleep offset (A ) or sleep onset (B) is kept constant. Figures 8.9C 
and 8.9D show how the relationship between sleep onset and offset changes if the 
two parameters have equal amplitudes (C) or unequal amplitudes (D) (see text) in 
order to achieve the observed phase angle.
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Figure 8.10 shows a theoretical model of sleep undergoing relative co-ordination, 
derived from sleep onset and offset curves with identical shapes but inverted and 
with unequal amplitudes. The shape and relative amplitude of the curves are based 
on experimental data as described in the text. The black bars represent the resulting 
sleep period and the white squares represent the theoretical course of the aMT6s 
acrophase as an indicator of circadian phase.
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that sleep and activity rhythms are sensitive to endogenous circadian timing and remain 
so despite attempts to entrain the sleep-wake and activity cycle by social routine.
Sleep disorders in the blind community have been well documented (Section 1.2.3) and 
a large proportion of these are thought to be due to circadian desychrony because of 
insufficent photic entrainment. Chapter 7 has established that day-time napping is a 
primary symptom of this complaint in the blind and has a stong circadian aspect. In 
normally entrained individuals, homeostatic mechanisms interact with circadian 
influences to ensure sleep occurs at an optimal time. How this interaction changes in a 
free-running individual is not known. Blind individuals living in a conventional 
environment are unique in that they effectively ‘split’ these two controlling influences 
on sleep. In most of these free-running subjects, sleep is attempted and occurs at an 
approximately normal and consistent time and the night-time sleep period is usually the 
longest sleep period in a day (Section 6.2.2.1). In order for this to occur, the homeostatic 
mechanism of sleep control, which determines the type and length of sleep depending 
on the length of time an individual has been awake (Section 1.1.5), must be relatively 
stable. However, in attempting to keep a relatively normal bedtime, subjects 
inadvertently are attempting to sleep at all stages of their circadian cycle. Therefore, the 
homeostatic mechanisms are relatively stable whilst the circadian component of sleep 
free runs. Observation of changes in sleep allows the assessment of the interaction 
between these processes and the relative contribution that each process makes.
The length of the study did not allow complete assessments of sleep over a full circadian 
cycle for most subjects. In practice, depending upon the individual tau, this may take up 
to several months and would be impractical. We therefore assessed the relationship 
between the phase of the endogenous pacemaker, using aMT6s as a marker (Section 
1.1.4.3.5), and sleep in several ways.
An initial analysis was performed to compare the difference in sleep when the aMT6s 
rhythm was in either of two circadian phases (normal, 24.00 - 06.00 h and abnormal,
06.00 - 24.00 h). This analysis confirmed that the number and duration of naps were the 
most sensitive parameters to gross changes in circadian phase. The number and duration 
of day-time naps increased when the aMT6s was in an abnormal phase position (Section 
8.3.1). These findings were most prominent in the subjective data and were confirmed to
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a lesser extent in the actigraphically-determined sleep. The sensitivity of naps to 
changes in aMT6s phase was also reflected in the analysis of the data according to four 
circadian phases (Figure 8.5). Additionally, the duration of night-time sleep and number 
and duration of day-time naps demonstrated an inverse relationship. Night-time sleep 
was longest and day-time sleep was shortest when the aMT6s phase was normal and 
vice versa when the aMT6s rhythm was abnormal. Group analysis of both subjective 
and actigraphic sleep data confirmed this relationship.
There were also some significant relationships between the four circadian phases and 
the timing of sleep. Two subjects had significant changes in sleep onset and offset with 
circadian phase. There was a tendency for sleep timings to be delayed when the aMT6s 
acrophase was delayed relative to its normal phase position and for sleep timings to 
advance when the aMT6s acrophase was advanced. However, observation of both the 
individual and the group analysis revealed that sleep onset and offset were affected 
differently by circadian phase; the pattern of change of the two parameters was not 
parallel (Figure 8.8).
The comparison of the phase angle between sleep onset and offset shows a distinct 
relationship with aMT6s phase. This relationship may form the basis of a model to 
predict relative co-ordination observed in free-running blind subjects living in field 
conditions (Folkard et al., 1990; Sack et al., 1992) and sighted subjects in temporal 
isolation (Wever, 1979). Relative co-ordination arises from the interaction of two 
rhythms with different périodicités and/or amplitudes running in and out of synchrony 
with each other and therefore altering the phase angle between them. Currently, it is 
unclear whether this arises from variation in rhythms within a single oscillator system 
(Daan et al., 1984; Daan and Beersma, 1992) or from a multioscillator system (e.g. 
morning and evening oscillators; Illnerova, 1991 and Section 1.1.2.2). Using the 
difference in the phase angle between onset and offset times, it may be possible to 
predict the sleep period once the phase of an individuals’ endogenous rhythms are 
known. Currently, the model rests on the assumption that the change in sleep offset in 
relation to aMT6s phase has a larger amplitude than sleep onset. Further investigation 
using more subjects is required to establish confidence in this assumption and in order 
to quantify the relative amplitudes of variation in sleep onset and offset.
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The hourly analysis also confirms and extends the relationship previously described 
between night- and day-time sleep duration. Both subjective and actigraphic assessment 
of sleep showed significant overall differences in both parameters. The nap duration 
tended to be maximal and night sleep duration tended to be minimal when the aMT6s 
acrophase was -180° out of phase. It could be argued that this relationship is due solely 
to homeostatic influences on sleep, i.e. the increase in day-time naps is proportionally 
reducing the propensity for night-time sleep (Klein et al., 1993). This is likely to be a 
contributing factor as naps are thought to effect night-time sleep duration and structure 
(Section 1.1.5.2). However, this relationship would also occur if it was a secondary 
effect of the influence of the circadian phase on sleep. As the aMT6s acrophase free- 
runs, it becomes gradually more abnormal and desychronised from the night-time sleep 
period. This decreases the propensity for night-time sleep as it is being attempted at 
inappropriate circadian phases. Simultaneously, the endogenous propensity to sleep 
(marked by aMT6s acrophase) occurs in the day-time and causes naps at times that 
reflect this endogenous influence. Therefore the inverse relationship between the 
duration of night- and day-time sleep may be driven by the endogenous circadian 
propensity to sleep. Further evidence comes from the fact that night sleep duration is 
determined by sleep onset and offset times and these are clearly under circadian control 
and have a distinct relationship with aMT6s phase (Figure 8.8).
Other sleep parameters (e.g. latency, number of night awakenings, quality, efficiency) 
do not show any consistent changes with changing aMT6s phase. This is because these 
other parameters remained consistent within the sleep period whilst the timing of the 
sleep period changed as already described. For example, sleep latency would not be 
expected to change if individuals were going to bed earlier or later in response to their 
endogenous sleep propensity. Surprisingly, subjective sleep quality did not show 
consistent changes in individual or group results. This may be due to several reasons. 
There are likely to be large inter-individual differences in how sleep quality is perceived 
and some individuals did not record any change in sleep quality at all throughout the 
study, despite obvious changes in their sleep patterns. It may also be that the 9-point 
analogue scale used to assess sleep quality is not appropriate in these circumstances.
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There did not appear to be any consistent change in daily mean activity with circadian 
phase although the timing of the activity acrophase did vary consistently. Group 
analysis of activity acrophase with respect to the four circadian phases showed a similar 
non-signficant trend to sleep timing in that the activity acrophase was delayed when the 
aMT6s acrophase was relatively delayed and advanced when the aMT6s acrophase was 
relatively advanced (Figure 8.4D). This relationship was confirmed by the one-hourly 
analysis (Figure 8.7B) which showed gradual advances and delays in activity acrophase 
as the aMT6s acrophase was relatively advanced and delayed compared to the normal 
phase.
These findings confirm that sleep and activity are subject to circadian control in addition 
to homeostatic mechanisms. In free-running subjects living in a normal environment, 
whose main sleep period consistently occurs during the night, the circadian influence 
alters the timing of sleep and activity in a predictable manner in response to changes in 
circadian phase. In addition, the endogenous circadian propensity to sleep is revealed by 
the occurrence of day-time naps, the timing and duration of which change predictably in 
relation to circadian phase.
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CHAPTER 9
MOOD RHYTHMS AND 
THEIR RELATIONSHIP TO 
CIRCADIAN PHASE
CHAPTER 9 - MOOD RHYTHMS AND THEIR RELATIONSHIP TO 
CIRCADIAN PHASE 
9.1 Introduction
There are well established circadian rhythms in subjective assessments of well-being, 
especially subjective alertness or sleepiness (e.g. Akerstedt et al., 1979; Folkard et al., 
1983; Section 1.1.5). For the purposes of these studies, these parameters are described 
as mood although they are not strict assessments of mood in a psychiatric sense. In a 
single case study, subjective sleepiness has been shown to be phase-locked with the 
timing of melatonin production in a free-running blind man under laboratory conditions 
(Nakagawa et al., 1992). It would therefore be expected that the timing of mood 
rhythms would exhibit shifts in relation to changes in strongly endogenous variables, 
such as melatonin in free-running subjects living in normal conditions. It is not 
established that mood changes associated with circadian rhythm disorder are a result of 
direct phase shifts in endogenous mood rhythms. They may be an indirect consequence, 
for example of sleep loss. Such effects on mood may well be more important to the 
quality of life in subjects with abnormal circadian systems when attempting to live a 
conventional 24 h lifestyle.
This chapter describes an attempt to establish whether strong circadian rhythms in mood 
are observed in blind subjects living in field conditions and whether there is a 
relationship between circadian rhythms in mood and aMT6s. This chapter also describes 
whether mean daily mood, as a measure of overall well-being, changes with respect to 
aMT6s rhythms in subjects with free-running aMT6s rhythms.
9.2 Methods
All subjects were asked to complete four mood scales (alert <=> sleepy, cheerful <=> 
miserable, calm tense, depressed o  elated) every two hours whilst awake during the 
48 h urine sampling periods (Section 3.1.2.4). A daily and overall mean was calculated
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for each scale for all subjects. The overall mean was used to investigate any differences 
in mean mood between circadian types (NE, AE, FR, UN) by one-way ANOVA. 
Correlations were performed between mean mood scores and age and PSQI scores and 
the significance of the correlation was derived from the ANOVA of the best-fit 
regression lines.
In order to investigate the effect of circadian phase on daily mean mood, mood scales of 
subjects with free-running aMT6s rhythms were expressed with respect to each 
individuals’ overall mean for each scale and then divided according to the 
corresponding daily aMT6s acrophase time (Section 5.2.4.2). The data were grouped 
according to four circadian phases (24.00 - 06.00, 06.00 - 12.00, 12.00 - 18.00, 18.00 -
24.00 h) and into hourly bins and analysed by one-way ANOVA (phase or hour as 
factor). Significant differences between groups were assessed by post-hoc analysis using 
Duncan’s multiple range test. These analyses were only performed on grouped data as 
there were insufficient days to perform the analysis on individual data.
The mood scales for all subjects were subjected to cosinor analysis for 24 h and 48 h 
windows to reveal the acrophase, mesor and amplitude of any rhythm. As the incidence 
of significant cosine fits was too low for further analysis (Section 9.3), the time of day 
of minimum alertness (or maximal sleepiness) recorded by each subject on each 
sampling day was analysed. In a similar manner to the analysis of day-time naps 
(Section 7.2.2), the time of minimum alertness, cheerfulness, calmness and maximum 
depression was grouped according to whether it occurred within or outside a specified 
(3, 4 or 5 h) range before and after the daily aMT6s acrophase in all subjects with 
abnormal aMT6s rhythms (AE and FR, n = 24). Days with no variation in mood were 
excluded from the analysis. The number of times occurring within and outside this 
range was analysed using paired Student’s t-test.
9.3 Results
All but three subjects (n = 46) successfully completed all four mood scales on all urine 
sampling days. Two of these three subjects (S25, S28) completed the scales but failed to
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record the time of each recording. These two subjects were removed from subsequent 
analysis. One subject (S26) did not complete the ‘depressed o  elated’ scale. Figure 9.1 
shows the overall daily mean (± sem) for all four mood scales. There were no significant 
differences between the overall mean mood (all four scales) with respect to circadian 
type. Neither was there a significant relationship between age and mean mood score. 
There was, however a strong relationship between PSQI score and mean mood. The 
scales for ‘alert o  sleepy’ and ‘cheerful <=> miserable’ were significantly positively 
correlated with PSQI (r = 0.31 and 0.37, respectively) i.e. increased sleepiness and 
misery was correlated with a more severe sleep disorder (Figures 9.2 A and B). The 
scale for ‘depressed o  elated’ was significantly negatively correlated with PSQI score 
(r = -0.38) i.e. increased depressed mood was correlated with more severe sleep disorder 
(Figure 9.2D). There was no significant relationship between the scales for ‘calm <=> 
tense’ and PSQI score (Figure 9.2C).
Analysis of mood data from free-running subjects (n = 15) with respect to four circadian 
phases revealed that there was a significant relationship between phase and ‘calm <=> 
tense’ (Figure 9.3 C) with the greatest mean ‘tenseness’ occurring when the aMT6s 
rhythm was maximally out of phase (12.00 - 18.00 h) (one-way ANOVA, p < 0.05). 
Similarly, although the effect was not statistically significant (p = 0.12), mean 
‘alertness’ was at a maximum during the normal aMT6s phase (24.00 - 06.00 h) and 
mean ‘sleepiness’ was at a maximum when the aMT6s was maximally out of phase 
(12.00 - 18.00 h) (Figure 9.3A). Analysis of hourly data did not show any significant 
overall effect of circadian phase on mood (Figure 9.4).
Cosinor analysis of mood revealed very few significant acrophase times. Analysis of 24 
h data of all the subjects (n = 46) revealed that overall, only 28%, 23%, 19% and 13% of 
days (n = 372) had significant acrophase fits for alert <=> sleepy, cheerful <=> miserable, 
calm tense and depressed <=> elated scales, respectively. The corresponding 
percentages for analysis of 48 h windows (n = 183) were 44%, 21%, 17% and 8%, 
respectively.
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alert
cheerful
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Figure 9.3 shows the group mean (± sem) mood of all free-running subjects (n = 15) 
with respect to four circadian phases, expressed in relation to each individuals’ own 
mean. The grey bar represents the phase over which aMT6s acrophase is considered 
normal (24.00 - 06.00 h). Only ‘calm - tense’ showed a significant relationship with 
phase (*, p < 0.05, one-way ANOVA).  ^^
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Figure 9.4 shows the group mean (± sem) mood for all free-running subjects (n = 15) 
with respect to hourly aMT6s acrophase time, expressed in relation to each individuals’ 
own mean. The grey bar shows the times over which aMT6s acrophase is considered 
normal (n = 80, unpublished results. University of Surrey). There was no overall 
significant relationship between aMT6s acrophase and mood. 9-7
Analysis of the relationship between the time of minimum mood and aMT6s acrophase 
revealed that the number of minimum mood points did not significantly differ within or 
outside a 5-h range before and after the daily aMT6s acrophase for all abnormally 
entrained and free-running subjects. However, observation of the raw data suggested 
that there was a reduction in alertness, cheerfulness and calmness associated with the 
start and end of the day (just after waking and just before going to bed) and also some 
lowered mood not associated with bedtimes. The times of minimum mood that occurred 
just after waking and immediately prior to sleeping were excluded and the analysis 
repeated. The incidence of minimum alertness was greater within the 5-h range before 
and after the aMT6s acrophase in subjects with abnormal aMT6s rhythms (AE and FR, 
59%, n = 24) (Figure 9.5) but the analysis was just outside the level of statistical 
significance (p = 0.05, paired Student’s t-test). The incidence in abnormally entrained 
subjects only (n = 9) and free-running subjects only (n = 15) was 69% and 54%, 
respectively although the analysis was not significant (p = 0.09 and 0.35, respectively). 
Similar analysis for cheerful miserable, calm o  tense and depressed <=> elated did 
not show any significant difference.
9.4 Discussion
Subjective mood, and especially alertness, has been shown to have a strong endogenous 
circadian component (e.g. Folkard et al., 1983) which persists during prolonged sleep 
deprivation (Akerstedt et al., 1979). Alertness is also thought to be controlled by 
homeostatic mechanisms comparable to those controlling the SW cycle (Monk et al., 
1989). The diurnal variation in alertness is therefore controlled by a two-process model 
comprised of an underlying circadian influence that interacts with mechanisms 
dependent on the time an individual has been awake (Section 1.1.5).
The results described in this chapter represent the first attempt to characterise the mood 
profiles of blind individuals and quantify any variation in mood due to an underlying 
circadian rhythm disorder. Analysis of overall mood in subjects grouped by circadian 
rhythm type did not show any statistical significance. The majority of these subjects 
reported a subjective sleep disorder (86%, PSQI > 5) and sleep disturbance for any
9-8
fS
0\
c^
o
00 
_  m
oin
VO
m
o
_  CO
CO
CO
CO
00
CO
VOTj-
VOCN
5
VO
CO
00
?5
m
I
A
g
O
u
a
.s
I
8uo
a
T3 'O <D
I  § ^
i;t I
cS OP3
(U
IÎ!
I l l
<D w
I
<L)
a
W )
. 8
g
ag
II
OJ oW) II
"g a
o
( N
00 VO (N
(4^o
:§
0 0  VO
III
(N <u
c/3
II
9-9
reason will be likely to have an effect on mood. The overall mood scores in subjects 
with a sleep disorder may not be different in those with and without a circadian sleep- 
wake disorder and would therefore not be expected to differ between circadian rhythm 
types. This relationship between mood and sleep disorder is reinforced when analysed 
regardless of circadian rhythm type. An increased PSQI score, indicative of increased 
sleep disorder, is associated with increased sleepiness, misery and depressed mood, 
although the latter analysis appeared to be skewed by several individuals. These results 
suggest that the severity of sleep disorder per se may be the determining factor 
influencing mood.
The fact that there were very few significant cosine fits may also suggest a reduced 
effect of circadian mechanisms on mood in these subjects. Cosine curves would be 
expected to fit data with the robust circadian rhythms previously demonstrated in mood, 
especially alertness (e.g. Akerstedt et al., 1979; Monk et al., 1989). There may be 
several explanations for why this is not the case in the present study. It is likely that 
circadian and homeostatic components governing sleepiness are split or phase-shifted in 
subjects with abnormal circadian rhythms therefore the combined effects of the two 
mechanisms are not observed, practically ‘dampening’ the rhythm. However, this 
explanation cannot account for the lack of cosine fits in subjects with normally 
entrained rhythms. There may be strong masking effects on mood, for example stress or 
light exposure, which are amplified in individuals living in field conditions and which 
may alter the subjective mood profile without altering the underlying circadian pattern. 
However, alertness, for example, has been shown to have a robust diurnal rhythm in 
field conditions in sighted subjects (e.g. Deacon and Arendt, 1994a). It may be that this 
blind population, the majority of whom have a sleep disorder, have a truly different 
diurnal variation in mood to sighted subjects without sleep disorders. The presence of a 
sleep disorder may disrupt the extent of recovery in mood (especially alertness) so that 
the marked decrease in alertness usually observed just prior to sleep and just after 
waking (and therefore anchoring the diurnal variation) may be less distinct. Extensive 
studies of sighted and blind subjects with and without sleep disorders in field conditions 
are needed to confirm this.
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There are methodological problems with the analysis of the mood scales. There are large 
inter-individual differences in the subjective interpretations of the mood scales. These 
are difficult to assess and correct for and may mask more subtle effect changes. 
Therefore caution is required when interpreting such results. The findings that the mood 
scales do not consistently fit a cosine curve may be due to the fact that simple cosinor 
analysis may not the most appropriate method for assessing diurnal variation. More 
detailed methods of analysis, for example complex cosinor or waveform analysis, may 
show a more robust diurnal variation in mood which can then be assessed for changes in 
relation to circadian phase. In order to investigate the apparent lack of mood rhythms in 
these blind subjects with sleep disorders, further studies of sighted and blind subjects, 
both with and without sleep disorders are required. With more data, it may be possible 
to learn whether there are circadian rhythm- and/or sleep-related effects on mood in the 
blind.
This study has investigated for the first time the anecdotal reports of mood changes in 
free-running blind subjects. There is clearly a trend for reduced alertness and increased 
‘tenseness’ when the aMT6s rhythm is maximally out of phase (Figure 9.3). This effect 
of phase is not as marked as for other behavioural parameters (e.g. sleep, naps and 
activity; Section 8.3.2) but this may be due to the method of measuring mood or may be 
due to masking effects as discussed previously. It could also be due to a lack of 
sufficient influence of the endogenous zeitgeber on mood or that mood is differentially 
affected by 24 h social cues or masking effects than other behavioural parameters. 
However, there is a circadian effect on alertness as demonstrated by the association 
between the timing of minimal alertness and the timing of the aMT6s acrophase. 
However, whether alertness is a true circadian rhythm phase-locked to the endogenous 
melatonin rhythm or whether it is an acute effect of endogenous melatonin cannot be 
determined from these results. It is further complicated by the fact that there is a strong 
homeostatic effect on alertness associated with bedtime and wakeup time which clearly 
influences the analysis. Following removal of the ‘minimum’ alertness times that 
occurred at the start or end of the day, a high proportion of the times of minimum 
alertness occurred within a 5-h range before after the estimated daily aMT6s acrophase. 
This result is probably an underestimate of the strength of the association as several
9-11
abnormally entrained and free-running subjects had aMT6s acrophases close to the 
bedtime and wake-up times and therefore the times of minimal alertness associated with 
the acrophase at this time (i.e. at bedtime or wake-up time) were excluded from the 
analyses despite the fact that those times of sleepiness were probably due, at least in 
part, to circadian influences. This relationship is a remarkable finding considering that, 
unlike the timing of naps which showed a similar relationship (Section 7.3.2), the mood 
recordings were not spontaneous. In future, it will be essential to ask subjects to 
formally record periods of extreme sleepiness where naps are not taken. This will help 
to confirm and strengthen the evidence for the relationship between the timing of 
sleepiness and melatonin in field conditions, already established in a free-running blind 
subjects under laboratory conditions (Nakagawa et al., 1992; Section 1.2.2).
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10.1 Introduction
A diurnal rhythm in performance has been established since the last century and has 
been shown to have a sustainable and repeatable ‘time of day’ effect (review, Folkard 
and Monk, 1985; Section 1.1.6). It has been shown that changes in performance persist 
in the absence of time cues (e.g. constant routine, Dijk et al., 1992) and during fractional 
desynchronisation (Wever, 1983). Performance is also mediated by homeostatic 
influences in a similar manner to alertness (Section 1.1.5) and is dependent on the 
length of prior wakefulness (Dijk et al., 1992). It would be expected therefore that any 
phase-shifts in the timing of the endogenous oscillator would shift the rhythm of 
performance. This hypothesis has been extensively studied with regard to phase-shifts 
experienced by shift-workers, especially in the context of accident risk during periods of 
reduced performance and alertness (e.g. Folkard and Totterdell, 1993; Smith et al., 
1994). The majority of previous studies have utilised visual tasks to assess performance 
and there are no reports to date of the effect of a free-running circadian system on 
performance in blind individuals.
Visual psychomotor performance tests show that a serial choice reaction time test 
demonstrates a strong diurnal variation (Rutenfranz et al., 1972; Giloolly et al., 1990) 
that is more reliable than a simple reaction time test (Kleitman, 1963). Visual choice 
reaction time tests are also known to be sensitive to low doses of melatonin (10-80 mg) 
(Dollins et al., 1993a) and moderate nocturnal illumination (1500 lux) (Dollins et al., 
1993b).
Recently, a series of performance tests and mood scales have been developed for use 
with the Psion hand-held personal organiser II (Psion PLC, London, U.K., Model LZ) 
(Totterdell and Folkard, 1992). In conjunction with Professor Simon Folkard 
(University of Wales, Swansea, UK) and Dr. Peter Totterdell (University of Leicester, 
UK), an auditory four-choice serial reaction time test was developed for use with blind
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subjects. Prior to use with the blind, the auditory version was tested in conjunction with 
the equivalent four-choice visual test in 11 sighted subjects (Lockley et al., 1995). The 
results showed that the ASRT test showed a similar diurnal variation to the visual test, 
albeit with some reduction in the robustness of the rhythm.
The rationale for the investigation described in this chapter was to assess whether 
performance changed in relation to aMT6s phase following the findings that sleep, 
activity and to some extent, mood did show phase-related changes. The performance 
rhythms of six free-running subjects were investigated in relation to phase, using aMT6s 
as a phase marker.
10.2 Methods
10.2.1 Subjects
The results of six subjects (SI4, S I8, S20, S31, S33, S36) with rapidly delaying free- 
running aMT6s rhythms (tau > 24.60 h) were analysed. Three had a subjective sleep 
disorder (SI4, S18, S20) and three did not (S31, S33, S36) according to the PSQI. 
Further details of this group are listed in Table 8.1.
10.2.2 Performance test
All subjects were asked to complete the auditory four-choice serial reaction time test 
(ASRT) (Section 3.1.2.5) every two hours whilst awake during the weekly 48 h urine 
sampling periods for at least four weeks. Briefly, the test consisted of four separate 
auditory stimuli presented 40 times each in a random order. Each of the four sounds 
corresponded to four different buttons on the Psion. Subjects were required to press the 
correct button as quickly as possible in response to the sound. Subjects were strongly 
encouraged to practice the test as often as possible prior to the first 48 h urine sampling 
period.
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The results derived from the test for each hand consisted of mean reaction time 
(milliseconds (ms)) for all responses, mean reaction time (ms) for correct and incorrect 
responses, percent incorrect responses and the percent of responses that were longer 
than 1 second (percent ‘gaps’). Before any analysis was performed the following 
parameters for each test were calculated for both hands for all responses: an overall 
mean reaction time (ms), an overall mean inaccuracy (% incorrect) and an overall mean 
value for gaps (% responses > 1 s). Using these overall values, a daily mean and an 
overall mean was calculated for each subject. Observation of the raw data plots revealed 
that two subjects (SI4, S20) had a distinct practice effect during the first 48 h sampling 
period. These data were removed and the mean values were recalculated for these 
subjects.
In order to investigate any effect of circadian phase on daily mean performance 
(reaction time, % accuracy and % gaps), the daily means for each individual were 
expressed with respect to their own overall mean and then divided according to the 
corresponding daily aMT6s acrophase (Section 5.2.4.2). These data were grouped 
according to whether the aMT6s acrophase was normally phased (aMT6s acrophase,
24.00 - 06.00 h) or abnormally phased (aMT6s acrophase, 06.00 - 24.00 h) and analysed 
using Student’s t-test. The data were also grouped according to four circadian phases 
(24.00 - 06.00, 06.00 - 12.00, 12.00 - 18.00, 18.00 - 24.00 h) and into hourly bins and 
analysed by one-way ANOVA (phase or hour as factor). Significant differences were 
assessed by post-hoc analysis using Duncan’s multiple range test. These analyses were 
only performed on grouped data as there were insufficient days to perform the analysis 
on individual data.
The performance data were also subjected to cosinor analysis for 24 h and 48 h 
windows to reveal the acrophase, mesor and amplitude of any rhythm.
10.3 Results
Analysis of the performance data with respect to a normal or abnormal circadian phase 
(24.00 - 06.00, 06.00 - 24.00 h, respectively) revealed that there were no significant
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differences in any of the performance parameters. However, with respect to the four 
circadian phases, there was a significant effect of phase on % gaps (p > 0.05) (Figure 
10.1C), with post-hoc analysis showing that the errors were greatest when the aMT6s 
acrophase occurred within the 18.00-24.00 h. There were no significant differences 
between the phases for reaction time or % accuracy (Figures 10.1 A, B) although there 
was a non-significant trend for increased reaction time during the 18.00 - 24.00 h phase 
(p = 0.09).
Due to insufficient performance data, there were six hourly aMT6 bins without any data 
(15.00-16.00, 20.00-22.00, 2.00-3.00, 5.00-6.00, 10.00-11.00 h) and therefore 
assessment of performance by hourly phase could not be completed. In order to 
maintain the comparison with other behavioural parameters, two- or three-hourly bins 
were not considered appropriate.
Cosinor analysis of individual performance data (reaction time, % accuracy, % gaps) 
revealed very few significant cosine fits. Overall, the analysis of 24 h windows had only 
9.6%, 1.9% and 5.8% of total days (n = 50) with significant cosine fits for reaction time, 
accuracy and % gaps, respectively. The corresponding percentages for analysis of 48 h 
windows were 3.7%, 3.7% and 11.1%, respectively.
10.4 Discussion
This chapter represents the first attempt to investigate any effect of a free-running 
circadian system on performance in blind individuals attempting to live on a 24 h day. 
As performance is under circadian and homeostatic control, individuals with free- 
running circadian rhythms may be expected to show some variation in performance with 
changes in circadian phase.
The results, however, were not conclusive in establishing a robust diurnal variation in 
performance parameters. The lack of significant cosine fits suggests that either there was 
not a strong circadian rhythm in any of the performance parameters or that performance 
is masked by homeostatic influences. In a manner similar to the mood results (Chapter
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Figure 10.1 shows group changes (n = 6) for mean (± sem) for reaction time (A), 
accuracy (B) and gaps (C) over four circadian phases (12.00-18.00, 18.00-24.00, 24.00- 
06.00, 06.00-12.00 h). The grey area represents the phase over which aMT6s acrophase 
is considered normal. Percent gaps showed a significant change in relation to aMT6s 
phase (*, p < 0.05, one-way ANOVA).
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9), it is possible that the homeostatic and circadian mechanisms influencing 
performance are split thus dampening the amplitude of the diurnal variation. The 
presence of a sleep disorder in three of the subjects (SI4, S I8, S20) may have 
influenced the performance although the remaining three subjects without a sleep 
disorder (S31, S33, S36) did not show any evidence of robust performance rhythms.
The results were also inconclusive in establishing whether there were changes in daily 
mean performance with circadian phase. Only the percent gaps showed significant 
variations in relation to four circadian phases, consistent with worse performance during 
abnormal phases. These preliminary data suggests that percent gaps may be the most 
sensitive performance parameter to circadian phase of those measured in this study.
Despite the lack of evidence for periodic decrements in performance in free-running 
blind subjects, the implications of performance problems for blind subjects are 
important and deserve further investigation. As most of the free-running subjects 
studied are fully employed (14/17) there are obvious concerns about any changes in 
performance which would effect their work. This is of great concern in the blind 
community where employment is often difficult to obtain and the publication of any 
findings showing altered performance resulting from abnormal circadian rhythms must 
be treated sensitively.
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CHAPTER 11 - COMPARISON BETWEEN SUBJECTIVE AND 
ACTIGRAPHIC MEASUREMENT OF SLEEP
11.1 Introduction
The assessment of sleep is often performed in circadian studies. Polysomnography 
(PSG) is considered to be the ‘gold standard’ method for assessing sleep but it is not 
always practical for long-term or field use. Two principal methods have been used that 
are convenient for the subject, require minimal supervision and can easily be maintained 
and are therefore highly suited to measure sleep in field studies. The first technique, 
subjective sleep assessment, consists of daily sleep diaries or logs. Alternatively, wrist- 
worn activity monitors (actigraphs) indirectly assess when sleep occurs from the amount 
of physical activity detected (actigraphy). Via an accelerometer, activity is converted to 
a numerical score which is then summed over a predetermined period (e.g. one minute).
Both methods, however have shortcomings. There is some evidence to suggest that 
people have difficulties assessing their own sleep especially when suffering from 
insomnia (e.g. Carskadon et al., 1976). Although there is obviously some difficulty in 
recollecting exact sleep times or duration, subjects should be able to distinguish between 
major differences in sleep parameters. For example, it would be difficult and of little 
value to distinguish between 5 or 6 minutes of sleep latency in long-term studies 
whereas it would be relatively easy and of much more relevance to distinguish between 
5, 30 or 60 minutes for sleep latency. However, the limitations of sleep logs and the 
confidence limits of the data need to be kept in mind when interpreting the results.
Activity monitors have none of the problems associated with subjective recording but 
difficulty may arise when interpreting activity levels. There may be a tendency for 
monitors to overestimate sleep time; for example, the monitor cannot distinguish sleep 
from inactivity and conversely, may interpret night-time restlessness during sleep as 
night awakening. This may be a greater problem in individuals with sleep disorders who 
spend time lying still but awake in bed, or may sleep restlessly (Sadeh et al., 1995).
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PSG also has some problems of interpretation. The technique usually requires 
individuals to sleep in research laboratories which are known to change habitual sleep 
patterns (Reynolds et al., 1992) and there may be problems with interpretation of 
results. Even though these methods all attempt to measure sleep, they all actually 
measure different things; subjective recollection of sleep, activity or electrical activity of 
the brain.
Activity monitors have been widely used in a variety of clinical investigations including 
identification of sleep disorders and drug treatments (Sadeh et al., 1995). However, 
there has only been limited use of actigraphy in the investigation of chronic non-24-hour 
sleep wake schedules. Actigraphs have been used to assess free-running activity and 
sleep-wake rhythms in sighted humans in laboratory based isolation experiments (e.g. 
Middleton et al., 1996). Blind children, for whom sleep diaries may be less reliable, 
have also been investigated by actigraphy to reveal disordered sleep and daytime 
sleepiness (Tzinschinsky et al., 1991) and improvement in actigraphically-derived sleep 
has been shown following melatonin treatment (Tzinschinsky et al., 1992). This study 
investigates the ability of actigraphy and sleep logs to identify sleep disorders in blind 
individuals who are likely to have disordered non-24 hour sleep-wake schedules (Miles 
et al., 1977; Arendt et al., 1988; Okawa et al., 1987).
The first question this study addresses is whether subjective and actigraphic methods 
give the same absolute values for night and day sleep parameters. As has been noted 
previously (Carskadon et al., 1976; Hauri and Wisbey, 1992; Sadeh et al., 1995), there 
may be a discrepancy in night sleep measured by subjective and objective (actigraphic 
and/or PSG) methods. To our knowledge, there has been no systematic comparison of 
actigraphic and subjective measurement of spontaneous napping under normal 
conditions although the Multiple Sleep Latency Test (MSLT) has been assessed 
simultaneously by PSG and actigraphy (Levine et al., 1986). The second question is 
whether activity monitors and/or sleep logs are able to assess relative changes in sleep 
patterns.
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11.2 Methods
11.2.1 Subjects
The subjective sleep diaries and actigraphic-derived sleep data of all 49 subjects were 
studied (for subject details, see Chapter 4).
11.2.2 Data collection
All subjects completed a subjective sleep and nap diary for the duration of the study 
(Sections 3.1.2.2 and 3.1.2.3). They also wore wrist-worn activity monitors 
(Motionloggers or minimotionloggers. Ambulatory Monitoring Inc., New York, USA) 
that were preset to measure activity in one-minute epochs (the largest epoch that can be 
used for automatic sleep scoring) (Section 3.1.2.1).
11.2.3 Data analysis
11.2.3.1 Sleep assessment
Before statistical comparisons were done, several manipulations were performed on 
both sets of sleep data. Subjective sleep parameters (sleep onset, offset, latency, number 
and duration of night awakenings, sleep quality, number and duration of day-time naps) 
were defined as described in Section 3.2.2.2.
Activity data were edited using the subjects’ activity diary and automatic sleep scoring 
was performed by Action3 software as described in Section 3.2.2.1. The analysis 
revealed actigraphically-derived measures of sleep onset, offset, latency, number and 
duration of night awakenings, sleep efficiency and number and duration of day-time 
sleep episodes. For analysis of night-time sleep, only ‘full’ nights with no actigraphy 
data missing between ‘bedtime’ and ‘get up time’ (as defined by the sleep diary) were 
used. For analysis of day-time sleep, only ‘days’ with at least 67% of data points 
between ‘get up time’ and ‘bedtime’ (as defined by the sleep diary) were used.
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11.2.3.2 Statistical analysis
To assess whether the two methods gave similar absolute values, the following 
calculation was employed. Paired Student’s t-tests were performed between the daily 
subjective and actigraphic measurements of sleep latency, onset, offset, number and 
duration of night awakenings, total night sleep duration and the number and duration of 
day-time naps separately for each individual. For each test, the mean difference between 
the methods was calculated by subtracting the actigraphic score from the subjective 
score.
To assess whether similar trends in the data were observed using the methods, two 
techniques were employed (correlation and regression analysis). Firstly, Pearson 
correlations were performed on each pair of sleep parameters (subjective versus 
actigraphic) for each individual separately. Secondly, daily sleep onset and offset times 
were fitted with best-fit regression lines for each individual separately. The period of 
any free-running rhythm was calculated by adding the slope of the regression line to 24 
(tau (t) = 24.00 + slope (h)) and was considered significant if the 95% confidence limits 
of the regression line did not cross 0 (i.e. 24.00 h). Free-running periods derived by the 
two methods were considered non-significantly different if the 95% confidence limits of 
the two regression lines overlapped. On four occasions there was a clear jump in the 
sleep plots and in these instances, the longest continuous sequence of days without 
abrupt shifts was fitted with the regression line (Section 6.2.2.2).
11.2.3.3 Circadian classification
Urinary aMT6s concentrations were measured and analysed by cosinor analysis to 
reveal the peak or acrophase (phi (cp)) of the aMT6s rhythm. Using these acrophase 
times subjects were classified by their circadian rhythm status into normally entrained 
(NE), abnormally entrained (AE), free-running (FR) or unclassified (UN) (Chapter 5).
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11.3 Results
11.3.1 Measurement of absolute sleep parameters
The mean (± SD) number of nights analysed per subject was 23.3 ± 7.0 (n = 49, range 6 
- 35). At least 1073 nights of data were compared for all six night-sleep parameters 
(range 1073 - 1150). Two subjects (S27, S36) failed to record the minutes of sleep lost 
per night in their sleep logs and therefore a subjective estimate of the total night sleep 
could not be calculated for these individuals. Two subjects (SI3, S27) also failed to 
record sleep latency but did record an estimated sleep onset time. The mean (± SD) 
number of days analysed per subject was 22.7 ± 7.4 (n = 49, range 6 - 36). In total, 1113 
days of data were compared for both nap parameters.
There were considerable differences between the methods. The overall mean differences 
(± SD) for all sleep parameters are shown in Figure 11.1. The figure shows that the 
differences were in the direction of a longer sleep period (i.e. shorter sleep latency 
(Figure lA), advanced sleep onset (Figure 11.IB), delayed sleep offset (Figure 11.ID) 
and longer sleep duration (Figure 11.IE)), greater sleep disturbance (increased night 
awakenings of a longer duration (Figures 11.IG, C)) and greater day-time sleepiness 
(number and duration of naps (Figures 11.1 H, 11.1 F)) by actigraphy.
When the data were analysed individually, inter-subject differences were found in the 
direction and magnitude of the differences between the methods. Figure 11.2 shows the 
mean difference and direction of the difference between the methods for all individuals 
(Figure 11.2).
Figure 11.3 shows the incidence of significant differences for each sleep parameter 
expressed as a percent of the number of subjects with a significant difference between 
the two methods. The largest discrepancy between the methods occurred when 
measuring the number or duration of sleep or wake episodes (duration and number of 
night awakenings, night sleep duration, number and duration of day-time naps) (Figure
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11.3). The size of the difference between the methods is smallest when sleep timings are 
compared (sleep onset, offset, latency) (Figure 11.3).
Figure 11.4 shows representative plots of all the sleep parameters measured by both 
methods in one subject (S48). In all analyses, the two methods gave significantly 
different results. Actigraphy clearly measured an advanced sleep onset (Figure 11.4A), 
increased night sleep duration (Figure 11.4B), a delayed sleep offset (Figure 11.4C), 
shorter sleep latency (Figure 11.4D), increased number and duration of night 
awakenings (Figure 11.4E, 11.4F) and increased number and duration of day-time naps 
(Figure 11.40, 11.4H).
11.3.2 Assessment of daily changes in sleep
11.3.2.1 Correlation analysis
Pearson correlation coefficients (r) were used to compare the values for each sleep 
parameter derived using both methods. Figure 11.5 shows the range of correlation 
coefficients between the two methods for all sleep parameters. Of the night-time sleep 
measurements, sleep onset, offset and duration were generally highly positively 
correlated between the two methods. Sleep latency and the number and duration of night 
awakenings were generally less well correlated. Both day-time sleep parameters 
(number and duration of naps) were generally highly positively correlated between the 
methods, although the number of naps showed better correlations overall.
11.3.2.2 Regression analysis
11.3.2.2.1 Sleep onset
Regression analysis of subjective and actigraphic measures of sleep onset agreed in 38 
subjects with a periodicity not significantly different from 24.00 h (Figure 11.6A). Both 
methods also agreed in four individuals with significant free-running taus. The 
periodicities for subjective and actigraphic analysis, respectively were as follows; S ll ,
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n = 38
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Figure 11.6 shows the period (tau (h)) of sleep onset (A) and sleep offset (B) rhythms 
measured using subjective (black bars) and actigraphic (grey bars) data. 8ubjects are 
listed in the left axis. The n value refers to the number of individuals who exhibited a 
24 h rhythm using both methods. Individuals which showed significant differences 
between the two methods in assessment of the rhythm are shown with subjective data 
shown in black and actigraphic data shown in grey. Where no bar is shown the rhythm 
was 24.00 h.
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24.09 and 24.09 h; S20, 24.04 and 24.04 h; S31, 24.07 and 24.04 h; S37, 23.97 and 
23.96 h (Figure 11.6A). In the 7 subjects where the two methods did not agree, one 
method predicted a free-running rhythm whereas the other method predicted a 24 h 
rhythm. In 5 of these 7 subjects, the tau derived from the subjective data indicated a 
free-running rhythm whereas the tau derived from the actigraph was 24.00 h. In 2 
subjects, this relationship was reversed (Figure 11.6A).
11.3.2.2.2 Sleep offset
Regression analysis of subjective and actigraphic measures of sleep offset agreed in 41 
subjects whose periodicity did not differ significantly from 24 .00 h (Figure 11.6B). 
Both methods also agreed in one individual (S20) with significant free-run determined 
by both methods and the taus for subjective and actigraphic analysis were 24.21 and 
24.17 h, respectively. In one of the 8 subjects where the two methods did not agree 
(SI4), both methods predicted a free-running rhythm but with significantly different 
taus (subjective and actigraphic methods; tau ± 95% limits = 24.07 ± 0.06, 24.22 ± 0.07 
h, respectively) (Figure 11.6B). In the remaining 7 subjects where the two methods did 
not agree, one method predicted a free-running rhythm whereas the other method 
predicted a 24 h rhythm. On 4 of the 7 occasions, the subjective result was free-running 
and the actigraphic result was 24.00 and on 3 occasions, this relationship was reversed 
(Figure 11.6B).
Overall, in the majority of analyses (83/98 or 85%) both methods gave similar 
regression analysis results. Most of these (78/98) were not significantly different from 
24 h. When the methods gave significantly different results from each other (15/98), the 
subjective method indicated a significant free-running rhythm whereas the actigraphic 
method showed entrained sleep in 9 subjects and in 5 subjects, this relationship was 
reversed. One further subject had a free-running sleep offset rhythm with significantly 
different taus measured by both methods. On most occasions, both methods measured 
similar taus and overall there was no significant difference in the taus determined by the 
two methods (paired Student’s t-test, p > 0.05).
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11.3.3 Sleep in relation to circadian status
Tables 5.1 and 5.2 show the circadian typing of subjects according to their aMT6s 
rhythm. The sensitivity of both methods of sleep measurement to the rhythm of aMT6s 
was investigated. Of the 17 NPL individuals with free-running aMT6s rhythms, 5 
subjects had free-running sleep onset times (S20, S23, S31, S46, S48) measured by the 
subjective method and 4 subjects (S14, S I8, S20, S31) according to the actigraphic 
measurements (Figure 11.7A). For sleep offset, there were free-running rhythms in 4 
individuals (SI4, S20, S26, S31) according to the subjective results and in 2 individuals 
(SI4, S20) for the actigraphic values (Figure 11.7B). In all cases, the period of these 
free-running sleep onset and offset rhythms, measured by either method, was shorter 
compared to the aMT6s tau (Figure 11.7). In only one subject (S48), the subjective sleep 
onset rhythm appeared to free-run at a tau of 23.95 h whereas the aMT6s rhythm free- 
ran at 24.41 h (Figure 11.7A).
There were also free-running sleep rhythms in some subjects with normally and 
abnormally entrained aMT6s rhythms. For sleep onset, 4 subjects (SIO, S l l ,  S37, S50) 
had free-running subjective rhythms, 2 of which (Sll ,  S37) also had free-running 
actigraphic rhythms. For sleep offset, there were free-running subjective rhythms in 2 
individuals (S4, S50) and free-running actigraphic rhythms in 3 individuals (S2, S7, 
SI 9).
Subjective and actigraphic results predicted (i.e. for both sleep onset and offset) free- 
running sleep for an individual with free-running aMT6s rhythms in 2/17 (12%) cases 
(subjectively, S20 and S31; actigraphically, S14 and S20) (see Figure 6.7). In non-free- 
running subjects (n = 32), subjective and actigraphic results predicted non-free-running 
sleep for both sleep onset and offset in 27/32 (84%) individuals (see Figure 6.6). The 
methods agreed in 23 of these subjects.
The results demonstrate that when an entrained rhythm in sleep onset was measured, it 
corresponded with an entrained aMT6s rhythm on 70% (subjective, 28/40; objective 
30/43) of occasions for both methods. If an entrained sleep offset rhythm was measured.
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Figure 11.7 shows the relationship between the period (tau (h)) of the aMT6s rhythm and 
the sleep onset (A) and sleep offset (B) rhythms measured using subjective and 
actigraphic data in subjects with a known free-running aMT6s rhythm. Individual subject 
numbers are shown on the left axis. The top half of each panel shows individuals who, 
despite having a free-running aMT6s rhythm, had no free-running sleep parameter by 
either method. The bottom half of each panel shows subjects with at least one free- 
running sleep measurement. The tau of the aMT6s rhythm is shown in black bars with 
the associated actigraphic (grey bars) and subjective (white bars) assessment of sleep
onset (A) and sleep offset (B). Where no bar is shown the sleep rhythm was 24.00 h.
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it corresponded with an entrained aMT6s rhythm on 70% (30/43) and 68% (30/44) of 
occasions for subjective and actigraphic methods, respectively. Conversely, a free- 
running rhythm in sleep onset reflected a free-running aMT6s rhythm in 44% (4/9) and 
67% (4/6) of cases for subjective and actigraphic methods, respectively, whereas a free- 
running sleep offset correctly predicted a free-running aMT6s rhythm on 67% (4/6) and 
40% (2/5) occasions for subjective and actigraphic methods, respectively.
11.4 Discussion
This study compared actigraphic (objective) and subjective measurement of sleep in 
field conditions in blind individuals living in their normal environment. The results 
demonstrate a large margin of error between the methods in the measurement of 
absolute sleep parameters. This discrepancy between the methods is greatest for the 
number of naps, followed by number of night awakenings, night sleep duration, day 
sleep duration, sleep offset, latency, duration of night awakenings and sleep onset.
The greatest inconsistencies between the methods were found in the measurement of the 
duration and incidence of sleep or wake episodes (number and duration of night 
awakenings, duration of night sleep and the number and duration of day-time naps). The 
majority of these differences were due to actigraphy overestimating sleep periods 
(night- and day-time) and night-time disturbance. This overestimation is most likely due 
to the manner in which actigraphs assess sleep, namely by measurement of motor 
activity. The results suggest that activity monitors are misinterpreting inactivity during 
wakefulness, both prior to and after the actual night sleep period and during the day, as 
sleep. In addition, they interpret night-time activity during sleep as waking periods. 
There appears to be less inconsistency between the measurements of night-time sleep 
onset and offsets between the methods, although there were still large discrepancies, in 
either direction, in some individuals. However, even the most consistent parameter (i.e. 
sleep onset) still showed a significant difference in 39% of individuals (Figure 11.3).
In general, actigraphic recording reveals a shorter sleep latency, advanced onset time, 
increased number and duration of night awakenings, delayed offset, increased night
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sleep duration and increased number and duration of naps compared to subjective logs. 
The extent and magnitude of these discrepancies makes sole use of activity monitors 
inappropriate to assess night or day sleep in studies where absolute values for sleep 
periods, duration and disturbance are required. The even higher degree of significant 
error in the assessment of day-time naps indicates that the activity monitor is unsuitable 
for measurement of day-time sleep. The direction and extent of these differences 
between the methods is not predictable and does not appear to be strongly related to any 
variable in these subjects. Even within a subject, the direction and significance of 
differences was not consistent in all the sleep parameters measured.
The study was not specifically designed to test the assessment of sleep by subjective 
sleep logs or by activity-derived automatic sleep scoring and therefore no ‘gold 
standard’ PSG was used as a control. However, despite this, information from the sleep 
and nap logs can be used as an indirect control for the actigraphic measure. For 
example, in our experience, blind people often go to bed and lie listening to the radio or 
audiotapes before going to sleep. By asking individuals to note the ‘bedtime’ and the 
‘time of trying to fall asleep’ separately, it can be determined whether the time spent in 
bed is spent awake or asleep. The results show that activity-derived sleep latency is 
short and sleep onsets are advanced compared to the sleep logs and therefore actigraphs 
are likely to be interpreting the whole ‘in bed’ period as sleep. Similarly, subjective 
sleep offset times are likely to be accurate (individuals know when they woke up) and 
again, activity-derived offsets were delayed relative to the subjective measure. The nap 
diary is designed so that subjects only make an entry in the nap diary when a nap has 
occurred and therefore the periods of day-time sleeps recorded are reliable. Activity- 
derived naps were much more frequent and of a longer duration than the subjective 
diary.
Whilst comparison of absolute sleep measurements between the two methods is 
unreliable, there exist strong correlations between the methods. This suggests that 
actigraphy has a consistent flaw in its ability to interpret activity levels in relation to 
sleep or wake. One way to avoid this may be to reset the sleep-wake scoring algorithm 
to make it more difficult to predict switches between sleep and wake states and therefore
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reduce the sensitivity of the interpretation of activity or inactivity. However, extensive 
validation of any new algorithm would be required in a variety of populations prior to 
its routine use.
Most previous studies have concentrated on validating actigraphy against PSG 
recordings in an attempt to substitute actigraphy sleep measurement when PSG is not 
possible (review, Sadeh et al, 1995). The main conclusions of previous work were that 
actigraphs were only marginally acceptable when attempting to measure the exact time 
an individual was asleep (especially for subjects who may lie awake motionless i.e. 
insomniacs) but were appropriate for documenting longitudinal changes in sleep 
patterns or schedules. Hauri and Wisbey (1992) compared actigraphy, PSG and sleep 
logs in 36 subjects. Over three nights of laboratory recordings, the actigraph 
overestimated sleep duration in 56% of subjects and underestimated sleep duration in 
42% of subjects compared to PSG. The average error between the methods was 49 
minutes (range 0 - 2 1 7  minutes). Individual data were not shown for sleep log 
measurements. The discrepancies were reported not to be random; the majority of the 
overestimations occurred in insonmiacs with psychophysiological insomnia or insomnia 
associated with a mental disorder whereas the majority of underestimations occurred in 
individuals with sleep state misperception. Grouped analysis of sleep duration of the 
subjects, divided according to six insomnia diagnostic groups revealed that significant 
differences between PSG and sleep logs (PSG > sleep logs) were only found in one 
group (sleep state misperception). However, significant differences between both PSG 
and actigraphs (PSG > actigraphy) and sleep logs and actigraphs (actigraphy > sleep 
logs) occurred in two diagnostic groups (sleep state misperception/idiopathic insomnia 
and insomnia associated with mental disorder/psychophysiologic insomnia, 
respectively). Further analysis of these data by Chambers (1994) suggested that 
actigraphy was no better than sleep logs in estimating total sleep time. Similarly, in a 
study of the effects of behavioural treatment on insomnia, Schmidt-Nowara et al. (22) 
(1992) measured improvements in sleep using both actigraphic measurements and sleep 
logs but again, actigraphs detected more night awakenings and a longer sleep duration 
compared to sleep logs. Cole et al. (1992) also concluded that actigraphs significantly 
overestimated sleep duration compared to PSG by an average of 21 minutes in a study
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of both normal subjects and in subjects suffering from psychiatric and sleep disorders. 
In a study measuring night sleep and MSLT of seven subjects for 24 hours, actigraphy 
overestimated day sleep and suprisingly, underestimated night sleep when compared to 
PSG (Levine et al, 1986). Overall, actigraphy tended to be less accurate at times when 
sleep was less likely to occur.
These results confirm and extend these general conclusions. It appears that actigraphs
overestimated sleep duration compared to PSG similarly to these comparisons with
sleep logs. For example, this study showed that in 31 out of 47 individuals (66%),
actigraphs overestimated night sleep duration. This compares to 56% reported by Hauri
and Wisbey (1992). Similarly, the overall error in night sleep duration, regardless of
direction, was 60 minutes in the present study compared to 49 minutes by Hauri and
Wisbey. If the results from the two studies are compared with respect to the direction of
error, Hauri and Wisbey found an average of 41 and 61 minutes for overestimation and
underestimation, resnectively of night sleep duration by actigraphs compared to PSG. 
show
The present findingsy^an average of 58 and 69 minutes for overestimation and 
underestimation by actigraphs (versus sleep logs), respectively. Although Hauri and 
Wisbey only present grouped data for sleep logs, the results also agree with this study. 
In three out of their five diagnostic groups, on average actigraphs overestimated sleep 
duration by between 2 1 -69  minutes (3 groups, n = 31). The findings reported here also 
found that actigraphy overestimated sleep by 58 minutes in the majority of subjects 
(n=31). In two further groups (idiopathic insomnia and periodic limb movements), with 
a very small subject number (n = 5), Hauri and Wisbey found actigraphs underestimated 
sleep compared to sleep logs by, on average, 53 minutes and these results also found a 
minority of subjects (n = 16) to have sleep underestimated by actigraphs by an average 
of 69 minutes. These comparisons suggest that sleep logs may estimate sleep more 
accurately than actigraphs and provide results closer to the expected PSG data.
There thus appears to be general agreement in the direction and extent of error from 
comparisons of PSG data and sleep logs compared with actigraphically determined data, 
actigraphs overestimating sleep duration in both cases. This agreement persists despite 
large differences in the methodology of the different studies. Most previous work has
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been undertaken for short periods (e.g. 2-3 nights) in a laboratory setting which is 
known to affect sleep, usually by advancing the sleep offset time (Reynolds et al, 1992). 
This may explain why the differences in sleep duration found in this study are slightly 
longer than errors recorded in the laboratory. It is likely that individuals waking earlier 
in a laboratory will be more active sooner than in a home environment thus advancing 
the actigraphic sleep offset.
The present systematic comparison of actigraphic and daily sleep logs for prolonged 
periods (up to 5 weeks) has not been previously reported. However, further work is 
required to study PSG, actigraphy and sleep logs over prolonged periods in a field or 
home environment. A preliminary trial of individuals with sleep disordered breathing to 
compare PSG and actigraphy in a home setting has been completed (Mason and Kripke, 
1995). Actigraphy underestimated sleep duration by 17 minutes non-significantly at 
home in one group but, in a separate set of subjects, actigraphs significantly 
overestimated sleep duration by 42 minutes. Clearly, more work is required before 
either PSG or actigraphy can be relied upon in a field environment.
Results of comparisons between data should be interpreted with caution. For example, 
many authors report >80% agreement between activity-derived sleep and PSG when 
compared on an epoch-epoch basis (e.g. Mullaney et al, 1980; Webster et al, 1982; 
Levine et al, 1986; Sadeh et al, 1989; Cole et al, 1992; Hauri and Wisbey, 1992). This 
suggests an acceptable agreement between the methods but no information concerning 
the 20% of inaccurate epochs. Similarly, high correlations are reported between sleep 
parameters assessed by different methods (e.g. Cole et al, 1992; Mason and Kripke,
1995). However, whilst such correlations may suggest a strong directional relationship 
between the data, they give no indication of how similar the actual raw data are. This 
study suggests that despite good correlations between the data, there may still be a 
significant difference between the absolute measurements. This must be kept in mind if 
absolute, rather than relative sleep data are required.
This study also investigated the ability of either method to differentiate between 
subjects with different aMT6s rhythms. There appears to be a negligible difference in
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the ability to correctly predict the circadian status of an individual via analysis of sleep 
patterns. Both methods, regardless of whether sleep onset or offset is considered, 
correctly predicted an entrained aMT6s rhythm in around 70% of occasions. The ability 
to predict free-running aMT6s from sleep measurements varied between method and 
parameter. Although subjective sleep offsets and actigraphic sleep onsets correctly 
predicted free-running aMT6s on 67% of occasions. In all cases, taus for sleep rhythms 
were considerably lower than those for aMT6s rhythms presumably due to masking of 
endogenous behavioural rhythms by a 24-hour lifestyle. Thus sleep assessment, by 
either method, is not ideal for predicting the endogenous circadian type.
With regard to measuring changes in sleep over time, both methods show significant 
changes in both day- and night-time sleep in relation to a free-running aMT6s rhythm 
(Section 8.3.3). For example, actigraphically-derived and subjective measures of sleep 
offset, night sleep duration and nap duration showed similar significant variations with 
respect to aMT6s acrophase (Figures 8.5 and 8.6). There was also some similarity 
between the methods in the relationship between the timing of sleep and age in 
entrained subjects (Section 6.3.4.1). These findings, in addition to the analysis of free- 
running sleep rhythms, suggest that actigraphs may be more suitable for assessing 
relative alterations of sleep, for example over time or during treatments, where absolute 
values are not required. However, the results also suggest that actigraphs are not 
appropriate or reliable for sole use in sleep assessment if absolute values of sleep 
parameters are required.
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CHAPTER 12
GENERAL DISCUSSION
CHAPTER 12 - GENERAL DISCUSSION
12.1 Rationale
The initial rationale of this thesis was to conduct an extensive investigation into the 
circadian rhythms of blind subjects. Previous work had established that totally blind 
subjects were susceptible to circadian rhythm disorders and that the type of disorder 
may vary (Section 1.2.2.4). The circadian rhythms of totally blind subjects had been 
classified as normally entrained, abnormally entrained, fi*ee-rurming or arrhythmic based 
on measurements of plasma melatonin profiles in 20 subjects (Sack et al., 1992). The 
extent to which these types of circadian rhythm disorders were present in blind 
individuals with some degree of light perception was not known. As the phase-shifting 
effects of light are intensity-dependent (Section 1.1.1.2.1), it was theoretically possible 
that individuals with very low levels of light perception could be subject to circadian 
rhythm disorders. A further question concerned the possible association of a particular 
type of disease or form of visual loss with specific categories of rhythm disorder. Such 
information may help to identify individuals likely to benefit from chronobiotic 
treatment and may contribute to our knowledge of retinal circadian photoreception 
(Section 1.2.1).
Disorders in sleep, mood and performance have been reported in a minority of blind
subjects with fi*ee-running circadian rhythms studied under field and laboratory 
(Section
conditions/;T .2.2). However, these reports are sparse, only a small number of 
individuals were studied and in general behaviour was not investigated in a systematic 
manner. Epidemiological data suggest that blind subjects experience more sleep 
disorders than sighted individuals (Section 1.2.3) suggesting that behaviour is altered in 
individuals with circadian rhythm disorders resulting fi*om reduced light perception. 
Therefore the aims of the thesis were to establish the incidence of sleep disorder within 
the blind community, to investigate whether the sleep disorders resulted from a 
circadian rhythm disorder and whether it was related to the degree of visual loss. In 
addition, the research aimed to investigate the relationship between the strongly
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endogenous circadian rhythm of melatonin and behavioural rhythms such as sleep, 
activity, mood and performance.
12.2 Sleep disorders in the blind
The epidemiological study performed in conjunction with Moorfields Eye Hospital, 
London, UK, confirmed the high incidence of sleep disorders in registered blind 
subjects (n = 388) (Chapter 2). Fifty-eight percent of those interviewed had some degree 
of sleep disorder as assessed by the PSQI. This study provided the first extensive 
investigation of sleep disorder in subjects undergoing a full clinical ophthalmologic 
examination and allowed for the first time a comprehensive assessment of the severity 
of sleep disorder in relation to visual disease. The findings showed that the incidence 
and severity of sleep disorder increased as the severity of visual loss increased. Sleep 
disorder was significantly greater in subjects with no conscious light perception (NPL, n 
= 58) compared to those with some degree of light perception (LP, n = 330) who in turn 
had a higher incidence and severity of sleep disorder than sighted controls (n = 44). 
There was no significant relationship between PSQI score and the duration, onset, 
rapidity and field loss of the visual defect or between PSQI score and whether the sight 
loss was congenital or acquired. Although the numbers were too small to draw any firm 
conclusions, the results also showed that subjects with bilateral enucleation (n = 19) and 
uveitis (n = 6) had more severe sleep disorders. Both of these conditions are implicated 
in disruption of the RHT; enucleations remove the eye and therefore any retinal photic 
signal and uveitis may affect photic signalling (Section 2.4), possibly via the RHT.
However, sleep disorders are multifactoral in origin. Presumably, not all of the sleep 
problems observed in these subjects were due to abnormal circadian rhythms. It is not 
known to what degree circadian rhythm disorders account for sleep problems reported in 
the blind and whether there is a relationship between rhythm disorder and the degree of 
visual loss. In order to address this question, further investigations were undertaken to 
establish the incidence of circadian rhythm-related sleep disorders in a population of 
blind subjects with reported sleep disorder and with a wide variety of severity of visual 
loss.
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12.3 Circadian disorders in the blind
A detailed four-week study of 49 subjects with varying degrees of visual loss was 
conducted to measure the rhythms of melatonin, sleep, activity, mood and performance. 
Using aMT6s rhythmicity as a phase marker, this thesis has established that the majority 
of NPL subjects (23/30, 77%) had abnormal aMT6s rhythms compared with 5/19 (26%) 
LP subjects (Chapter 5). Free-running aMT6s rhythms (n = 17) were only observed in 
NPL subjects, the incidence of which was greater in those who were uni- and bilaterally 
enucleated. This confirms that light is a major environmental zeitgeber in humans and 
that total loss of light perception is more likely to cause abnormalities in the timing of 
circadian rhythms.
The abnormalities in circadian rhythmicity are presumably caused by a disruption of the 
photic signalling pathway (retina - RHT - SCN), it being dysfunctional in the NPL 
subjects with free-running rhythms (n = 17). It is not surprising that ten of the eleven 
subjects with bilateral enucleations had free-running aMT6s rhythms: evidently removal 
of the eyes would remove any retinal signal. The remaining bilaterally enucleated 
subject was diagnosed as anophthalmic (eyeless) but appeared to have a normally 
entrained aMT6s rhythm. This result may be explained by subconscious light perception 
via vestigial eyes (cryptophthalmos) that can remain in an anophthalmic individual 
(Prof. A.C. Bird, personal communication) or by a very slow free-running rhythm, 
undetectable over the four week study period. Seven NPL subjects appeared to be 
normally entrained and this could be explained either by subconscious (hypothalamic) 
light perception (Czeisler et al., 1995a), entrainment by non-photic time cues or by 
having an endogenous tau of 24 h. The remaining five NPL subjects had abnormally 
entrained rhythms all of which had both eyes present which may indicate an 
abnormality in the processing of light information rather than a lack of subconscious 
light perception.
Both free-running (5/7) and normally entrained (2/7) aMT6s rhythms were observed in 
unilaterally enucleated subjects. These results suggest that in the free-running
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individuals, the remaining eye is unable to transmit photic signals to the SCN. In the 
normally entrained subjects, unilateral subconscious light perception may be sufficient 
for entrainment. Alternatively, there is the possibility that non-photic time cues are 
entraining the rhythm or that the endogenous free-running tau is 24 h. There was a wider 
range of aMT6s rhythm types in the 12 NPL subjects with both eyes present; four were 
normally entrained, five were abnormally entrained, two were free-running and one was 
unclassified.
This thesis also investigated the circadian rhythms of LP subjects with varying degrees 
of visual loss. Most LP subjects (14/19, 74%) had normally entrained rhythms 
presumably due to sufficient light perception for entrainment at the level of the SCN. 
Four LP subjects exhibited abnormally entrained aMT6s rhythms. Their degree of visual 
loss varied widely (from > 3/60 - PL) so it is unlikely that reduced light perception itself 
was the cause of the problem: again an abnormality in processing the light information 
via circadian pathways may be invoked. From the results, it is clear that the degree of 
sight loss (> 3/60, CF, HMO, PL) or the disease type does not provide a reliable 
indication of the presence or type of rhythm abnormality on an individual basis. 
However, there are associations between the likelihood of a rhythm abnormality and 
loss of light perception and between bilateral enucleation and free-running rhythms.
The effects of specific visual diseases on light processing for human circadian function
are unknown. Studies by Foster and colleagues (Section 1.2.1) have failed to find any
abnormalities in the circadian response to light in retinally degenerate mice who lack
et al.,
rods or in transgenic mice that lack rods or cones (Foster/^ 1997). In humans, preliminary 
studies of colour-blind subjects, who had deficient red/green cone function, showed no 
abnormality in light suppression of melatonin (Ruberg et al., 1996). The present finding 
that the majority of individuals with a form of retinitis pigmentosa (n = 14), a group of 
diseases that primarily affects rods or mid-peripheral rods and cones, have normally 
entrained rhythms (Section 5.3.2.3) support these findings that neither rods nor cones 
are necessary for circadian photoreception. However, the possibility remains that 
functional rods and/or cones may still be present in small but sufficient numbers to 
mediate circadian responses to light. The alternative hypothesis that a novel ‘circadian’
12-4
photoreceptor may exist has gained support from the recent discovery of a novel retinal 
photopigment in salmon (Soni and Foster, 1997).
In order to establish whether subconscious photic entrainment could occur, a melatonin 
light suppression test (Lewy et al., 1980; Bojkowski et al., 1987a) could be performed in 
those NPL subjects with normally entrained aMT6s rhythms. This would show whether 
or not the RHT-SCN-pineal pathway mediating light effects was functional. A positive 
light suppression test may not, however, prove that light was entraining the melatonin 
rhythm as the intensity of light required to suppress melatonin is lower than that 
required to entrain the rhythm (Nelson and Takahashi, 1991; Hashimoto et al., 1996). 
Confirmation of photic entrainment in these subjects could be achieved either by 
keeping the individual in constant darkness or by blindfolding, and observing whether 
the melatonin rhythm begins to free-run.
This hypothesis of entrainment of circadian rhythms by subconscious light perception, 
i.e. via the RHT direct to the SCN, is not exclusive. There is evidence in animals that 
there are direct retinal projections to hypothalamic areas other than the SCN (Johnson et 
al., 1988a; Levin et al, 1991), particularly the supraoptic nuclei mediating rhythmic 
production of vasopressin and oxytocin (Cui et al., 1997). In addition, there is indirect 
photic input to the SCN via the RHT-IGL-GHT-SCN pathway. As the neural 
connections between other hypothalamic areas and the SCN are extensive, and these 
extra-SCN areas receive direct photic input, it is possible that the SCN receives photic 
information indirectly from these other brain areas.
The isolation of factors involved in non-photic entrainment in humans is much more 
difficult to achieve. Currently, it is assumed that non-photic zeitgebers are entraining the 
melatonin rhythm of blind subjects who show a negative light suppression test for 
melatonin or those bilaterally enucleated subjects who have entrained rhythms (Czeisler 
et al., 1995a). The nature of this non-photic input is not established although keeping a 
strict 24 h social routine can entrain melatonin, cortisol and sleep rhythms in humans 
living in constant low light (< 500 lux) in an Antarctic winter (Section 1.1.1.2.2). 
Evidence in animals suggests that the non-photic phase-shifting system requires arousal
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or activity to exert an effect (Section 1.1.1.2.2). In humans, we lack knowledge of non- 
photic neural pathways to the SCN (Section 1.1.3.2). It is thought that NPY, the primary 
neurotransmitter between the IGL and the SCN (Mrosovsky, 1995) and/or serotonergic 
systems (Sumova et al., 1996) are involved.
This thesis did not directly address the role of non-photic time cues in human circadian 
rhythms but several conclusions can be drawn from the results. Virtually all of the free- 
running individuals (14/17) were fully employed during the study with conventional 
working hours and therefore had to keep quite strict social routines during working days 
(e.g. waking times, mealtimes, travelling times). It is apparent that these non-photic time 
cues were unable to entrain the aMT6s rhythm in these individuals. Given that activity 
and arousal are implicated in mediating non-photic entrainment in animals, it is difficult 
to envisage how these findings can be applied to humans and why there appears to be 
little effect of non-photic zeitgebers in these freè-running subjects. However, the present 
results do not deny an effect of non-photic time cues on the period of the free-running 
rhythm. It may be that the non-photic influences the subjects are exposed to are 
insufficient to fully entrain the aMT6s rhythm. A way of confirming any social effects 
would be to keep free-running subjects in temporal isolation and investigate whether 
there is any change in tau compared to living in the field. If a difference was found, 
different social cues, specifically timed with a range of periods, could be introduced 
under laboratory conditions to measure the effect on tau. This would attempt to assess 
the strength of different social zeitgebers. However, such experiments are lengthy, 
difficult to control, extremely expensive and very inconvenient to the subject.
There appears to be a discrepancy between the length of free-running taus in blind 
individuals and sighted subjects living in constant dim light. The average melatonin 
rhythm tau (± SD) assessed in 11 free-running blind subjects was 24.55 ±0.31 h (range 
23.86 - 25.08 h) in a study by Sack et al. (1992) and 24.42 ± 0.45 (range 23.83 - 25.00 
h, n = 5) in a study by Aldhous and Arendt (19911)- These values are similar to the mean 
period of the free-running aMT6s rhythms reported in this thesis (24.50 ± 0.17 h, range 
24.13 - 24.79 h, n = 16). The periods reported in these blind subjects generally appear to 
be longer than corresponding periods for sighted subjects studied in constant dim light
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conditions (Middleton et al., 1996) but concur with the taus measured in sighted 
subjects kept in temporal isolation who were able to self-select their own LD cycles 
(Wever, 1979). A study of aMT6s rhythms by Middleton et al. (1996), which utilised 
the same urine collection periods and aMT6s assay as this thesis, found that the mean 
free-running aMT6s period was 24.26 ±0.11 (range 24.19 - 24.43). Similarly, constant 
routine assessment of tau during a forced desynchrony protocol by Czeisler et al. 
(1995b) has shown mean taus of between 24.1 and 24.2 h (range 23.9 - 24.4 h) in CBT, 
melatonin and cortisol. If  these differences are not due to differences in subject groups, 
methodology or analysis of taus, then it is necessary to consider what other than 
variations in individual endogenous tau, may be responsible for the difference. The 
similarity between the findings of Middleton et al. (1996) and Czeisler et al. (1995b) 
suggest that a knowledge of clock time may have little effect on the endogenous tau. An 
explanation for the longer taus observed when sighted subjects are able to self-select 
their LD cycles is that the relationship the SW cycle takes with CBT (i.e. sleep 
beginning soon before CBT minimum) ensures that the light signal is likely to hit the 
phase-delay portion of the PRC and not the phase-advance portion (Klerman et al.,
1996) therefore delaying the intrinsic period. Another explanation may come from the 
work of Campbell et al. (1993) who found that imposing restrictions on naps under 
temporal isolation lengthened the intrinsic period. However, it is difficult to see how 
any of these explanations account for the long endogenous taus observed in free-running 
blind subjects as presumably, the LD cycle is unable to affect the tau in the blind and 
this thesis has also shown long delays in aMT6s taus in subjects with a high incidence 
of naps (Chapter 7). Another explanation may be the length of time the study is 
conducted. Free-running blind subjects probably have had many years to establish a 
stable periodicity of their melatonin rhythms whereas sighted individuals placed in 
constant dim light or constant routine conditions may take many days before a stable 
period is reached (Klerman et al., 1996). Too short an experiment or the inclusion of the 
days whilst the period is stabilising in the analysis may affect the overall estimated tau. 
It is also possible that non-photic zeitgebers have entrained the rhythms with short 
endogenous taus but not those with taus substantially different from 24 h. This may 
mean that the range and the mean of the endogenous periods observed are artificially
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high and not a true reflection of endogenous tau uninfluenced by environmental time 
cues.
12.4 Interaction between melatonin and sleep and activity
These experiments have allowed for the first time a quantitative analysis of sleep and 
activity in blind subjects and the assessment of the relationship between these 
behavioural parameters and the circadian system, using aMT6s rhythms as a marker. 
There are two lines of evidence that confirm the strong associations between behaviour 
and the endogenous melatonin rhythm. This study has shown that there are specific 
stable relationships between the timing of melatonin and the timing of sleep and activity 
in entrained subjects (Chapter 6) and specific dynamic relationships between the timing 
of melatonin and the timing of sleep and activity in free-running subjects (Chapters 7 
and 8).
The association between the timing of the melatonin acrophase and the timing of sleep 
(and activity) manifests in blind subjects as delayed- or advanced sleep phase syndrome 
(DSPS/ASPS). This is the first quantitative report of these conditions in blind subjects 
although they are extensively documented in sighted subjects (e.g. Weitzman et al., 
1983; Strogatz et al., 1987; Lack et al., 1996). The current explanation of these sleep 
disorders is that they are caused by phase shifts of the endogenous ‘wake maintenance 
zone’ that occurs towards the end of the subjective day (Strogatz et al., 1987; Dijk and 
Czeisler, 1994) thereby preventing sleep at the desired time. These shifts may be due to 
a weakened phase relationship between the oscillator(s) governing sleep and the 
environmental zeitgeber. In blind subjects, this weakening may be due to decreased 
photic input. However, evidence also exists for an advance of the circadian system 
associated with older age (e.g. Czeisler et al., 1992). Although it was not possible to 
achieve in this study because of too few subjects, an age-matched investigation of 
sighted subjects with ASPS showed that advanced sleep timing and insomnia was 
associated with advanced CBT and urinary aMT6s rhythms when compared to normally 
entrained non-insomniacs (Lack et al., 1996). It is likely that a combination of age-
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related and circadian effects are contributing to the relationship between sleep and 
activity and aMT6s.
Free-running subjects exhibited complex relationships between the timing of aMT6s 
and sleep, naps or activity. There were significant positive correlations between the 
period of the aMT6s rhythm and the period of sleep onset, offset and activity rhythms 
(Chapter 6). Not all subjects exhibited free-running behavioural rhythms and those that 
did had periods that were much reduced relative to the aMT6s period (behavioural 
period range 23.95 - 24.26 h, aMT6s period range 24.13 - 24.79 h). This reduction in 
period length could be due to several factors. There may be masking effects imposed on 
the expression of the behavioural rhythms by the 24 h lifestyle that does not affect the 
underlying endogenous aMT6s period. As non-photic time cues have the ability to 
entrain human circadian rhythms (Section 1.1.1.2.2), it is possible that the social cues 
associated with living a 24 h lifestyle are fully or partially entraining the behavioural 
rhythins or shortening tau. As sleep and activity are controlled by both homeostatic and 
circadian mechanisms, it is likely that a combination of masking and entraining effects 
is causing the observed reduction in period of the behavioural rhythms relative to the 
aMT6s period. The relative contribution of homeostatic and circadian influences to 
different endogenous rhythms may reflect the strength of coupling between the rhythms 
and the endogenous oscillator and therefore the observed period.
The results show that of the behavioural measures made during the study, activity was 
the most common free-running behavioural parameter in blind subjects with free- 
running aMT6s rhythms (7/17) and it showed the best correlation with aMT6s period. 
This finding suggests that activity may provide the best behavioural indicator of a free- 
running circadian system compared to subjective or actigraphic sleep onset, sleep offset 
or nap times. The results provide preliminary evidence to suggest that activity is the 
least susceptible to masking or partial entrainment by non-photic time cues.
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12.5 The effect of circadian phase on sleep and activity
Two single case studies have formally described specific relationships between sleep 
and strongly endogenous variables in free-running blind subjects (CBT, melatonin, 
cortisol). Nakagawa et al. (1992) showed a specific relationship between unmasked 
sleep propensity and melatonin and cortisol and Klein et al. (1993) demonstrated a 
strong circadian influence on sleep parameters in relation to CBT and cortisol. Although 
clear phase relationships have been observed in the sleep records of blind subjects living 
in field conditions (e.g. Miles et al., 1977; Arendt et al., 1988; Sack et al., 1992), there 
has been no previous attempt to characterise these changes with respect to a circadian 
phase marker.
Nakagawa et al. (1992) showed that the initiation of sleep propensity (unmasked using 
an ultrashort sleep paradigm (Lavie et al., 1986)), was associated and ran in parallel 
with the melatonin rhythm in a blind subject under clinical conditions. This thesis has 
investigated the relationship between day-time naps, which are a primary complaint of 
blind subjects with sleep disorders, and aMT6s acrophase. The findings show that the 
timing of day-time naps is highly associated with the timing of the aMT6s acrophase in 
abnormally entrained and free-running subjects (Chapter 7). These results agree with the 
findings of Nakagawa and colleagues (1992). There is also evidence that this 
relationship between aMT6s and napping can manifest itself as a free-running nap 
rhythm in individuals with a free-running aMT6s rhythm (Chapter 6). Whether the 
association between naps and aMT6s timing is causative remains an open question. 
There is no consistent pattern in the precise relationship between aMT6s acrophase and 
naps (e.g. naps do not always fall before the aMT6s acrophase) probably because 
subjects are unable to nap at their desired time due to external social pressures. The 
sleepiness-inducing effects of exogenous melatonin (Section 1.1.1.4.5) and further 
examples of strong associations between the timing of sleep and endogenous melatonin 
onset (e.g. Tzischinsky et al., 1993) make melatonin an attractive candidate as an 
endogenous sleep-inducing factor. However, as the phase relationship between 
melatonin and other SEVs, for example CBT or cortisol, are also specifically phase- 
locked, it is possible that melatonin is only a phase marker of an endogenous desire to
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sleep, the promoter of which is unknown. A specific melatonin antagonist would assist 
in defining the role of endogenous melatonin on sleep and naps and blind subjects 
would be a good model to test this.
The clinical case study by Klein and colleagues (1993) investigated the relationship 
between scheduled sleep episodes and CBT phase in a free-running blind man living a 
24 h lifestyle for three months and found that many sleep parameters varied in relation 
to circadian phase (assessed using CBT in a similar manner to sighted subjects in 
temporal isolation (Winfree, 1982)). The findings of this thesis also show significant 
changes in sleep parameters and the timing of sleep in those free-running subjects who 
completed virtually a full circadian cycle during the study with no restrictions placed on 
sleep periods (Chapter 8). It also characterises and quantifies for the first time the 
cyclical sleep disorder that has been previously reported in blind subjects (Section 
1.2.2). With respect to phase, there were significant changes in subjective measures of 
night sleep duration, sleep offset and the number and duration of day-time naps and 
similar non-significant trends in the timing of sleep onset. Some of these changes were 
also reflected in the actigraphic assessment of sleep and in the timing of the activity 
acrophase (Section 8.3.3). The major changes were reductions in the number and 
duration of day-time naps and an increase in night sleep duration when aMT6s 
acrophase approached a normal phase position (2.00 - 6.00 h) and a reverse of these 
changes when the aMT6s was maximally out of phase (14.00 - 18.00 h). There were 
also striking changes in the timing of sleep and activity with relative advances and 
delays in sleep onset, offset and activity acrophase as the aMT6s acrophase became 
relatively advanced and delayed, compared to a normal phase. These findings suggest 
that there is a strong endogenous circadian contribution to the timing and maintenance 
of sleep and wakefulness in individuals with free-running rhythms. This is despite the 
maintenance of a relatively stable sleep pattern (compared to the aMT6s rhythm) 
presumably mediated by homeostatic influences. The inverse relationship between the 
duration of night-time and day-time sleep suggests a combination of circadian and 
homeostatic influences. It could be argued that the sleep deprivation at night is causing a 
compensatory increase in day-time nap duration and this is likely to be partly 
responsible for the relationship. However, the dynamic relationship between the timing
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of naps and aMT6s acrophase suggests that the timing of naps is not random and is 
mediated by a circadian-driven desire to sleep during the day at an appropriate circadian 
time. Sleep initiated at night when the aMT6s is maximally out of phase (according to 
clock time) is being attempted at an incorrect circadian time and therefore the duration 
is reduced. It is likely that the circadian propensity to sleep, reflected in the timing of 
the aMT6s acrophase, is simultaneously influencing both the incidence and duration of 
night-time and day-time sleep.
There were a minority of free-running subjects (2/17, 12%) that failed to nap 
extensively throughout the study, had adequate and normally timed night-time sleep and 
did not report a subjective sleep disorder (PSQI < 5). The strength of the association 
between naps or sleepiness and the free-running aMT6s rhythm may well reflect an 
inter-individual difference in the complex relationship between homeostatic and 
circadian mechanisms involved in determining sleep (Section 1.1.5). Subjects with 
normal night-time sleep and few day-time naps may have sleep relatively more 
controlled by homeostatic mechanisms and those subjects with phasic changes in the 
SW cycle and prevalent naps may be more influenced by the circadian system. It is 
likely that homeostatic influences are dominant in influencing sleep under field 
conditions as all of the free-running subjects maintained a level of night-time sleep 
throughout all phases of the circadian cycle, despite a circadian influence on sleep 
timing and duration. If the circadian effect were dominant, there would have been very 
little night-time sleep whilst aMT6s acrophase was maximally out of phase. It is also 
likely that 24 h non-photic time cues and masking effects contributed to maintaining an 
approximately normally timed night-sleep period throughout all circadian phases. To 
investigate the relative contribution of homeostatic and circadian influences, well 
designed laboratory studies are required that remove the non-photic social cues and 
masking. However, the finding that the relationship between naps and aMT6s acrophase 
persists in field conditions is important as it means that most NPL subjects with free- 
running aMT6s cannot override the circadian component of SW control, therefore 
causing them to nap.
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The relationship between the timing of naps and aMT6s acrophase in free-running and 
abnormally entrained subjects and the changes in the number and duration of naps in 
relation to a free-running aMT6s acrophase, suggests that the presence of naps may be a 
useful marker of circadian desynchrony in NPL subjects. The value of a nap diary 
would be enhanced if subjects also recorded times when they have an overwhelming 
desire to nap but are unable to do so for external reasons, as there is also preliminary 
evidence for an association between times of minimum alertness and aMT6s acrophase 
in these subjects (Chapter 9).
12.6 Modelling relative co-ordination
The present findings have led to a preliminary model on which to base the phenomenon 
of relative co-ordination observed in the SW cycle of free-running blind subjects living 
in a 24 h society in this study and others (e.g. Arendt et al., 1988; Sack et al. 1992). It is 
based on the finding that sleep onset and sleep offset do not change in parallel in 
relation to the free-running aMT6s acrophase and that the phase angle difference 
between the two parameters exhibits a distinct relationship with circadian phase 
(Chapter 8). It is proposed that these changes in the phase angle between sleep onset and 
offset are due to differences in the amplitude of each rhythm. These differences cause 
changes in the timing of sleep and its duration appearing as relative co-ordination. Such 
a hypothesis may also explain the apparently contradictory observation that sleep is 
biphasic under free-running conditions (Czeisler et al., 1980; Winfree, 1980). The 
timing of each episode is associated with both the minimum and maximum of CBT 
(Zulley and Campbell, 1985). These results are difficult to explain in terms of a 
causative effect of CBT on sleep as it is unlikely that such opposite CBT signals could 
initiate similar sleep effects. If sleep onset and offset are controlled by independent but 
phase-locked oscillators (cf. Ilnerova, 1991), their relationship may appear as relative 
co-ordination. However, as free-running subjects still manage to maintain some 
consolidated sleep whilst the timing of sleep onset and offset changes, it suggests that 
homeostatic effects are dominant. This dynamic relationship between the timing of 
sleep onset and offset in the determination of a main sleep period, coupled with the 
endogenous influence of the free-running system on initiating nap periods, may help to 
explain multi-phasic sleep patterns.
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There is supporting evidence that separate morning and evening oscillators exist from 
the reports describing the control of NAT activity onset and offset in rats and that these 
oscillators have differing amplitudes (Section 1.1.2.2). Whether these oscillators are 
distinct oscillators of a multi-oscillator system or are due to changes in the coupling 
between a single central oscillator and effector mechanisms is unknown. The results of 
the thesis are unable to distinguish between either theory. The existence of multiple 
periodicities in the measured circadian rhythms in free-running blind subjects suggests 
that they may be controlled by distinct oscillators which are differentially affected by 
zeitgebers or masking (Wever, 1979; 1983). Conversely, the difference in rhythm 
periods may be due to differences in the coupling between the overt rhythms observed 
and the central oscillator - SEVs are tightly coupled to the central oscillator (Type I 
oscillator) and other rhythms are less strongly coupled (Type II oscillator). The 
difference in the coupling strength allows the rhythms to be differentially affected by 
zeitgebers which manifests as distinct periodicities (Daan et al., 1984; Daan and 
Beersma, 1992). Proving either hypothesis by observing rhythm function is very 
difficult as the rhythms are not a direct reflection of the oscillator itself but are 
‘downstream’ representations of the endogenous period. Anatomical and neurological 
studies of rhythmic function in animals following removal of the SCN, considered the 
site of the primary oscillator (Section 1.1.3), have provided some evidence of the role of 
extra-SCN oscillator sites on overt rhythmicity (Section 1.1.2.1).
12.7 Mood and performance
Unlike previous findings in sighted subjects (Section 1.1.6), preliminary analysis of 
mood and performance rhythms show that they are not robust in blind subjects with and 
without circadian rhythm disorders, as assessed by cosinor analysis. This may be linked 
to the fact that most of the subjects had a subjective sleep disorder (86%). More analysis 
is required to assess whether a consistent diurnal variation exists that does not fit a 
cosinor curve in these subjects. Only then can conclusions be drawn as to whether there 
is a detrimental effect of either sleep disorder and/or circadian rhythm disorder on mood 
and performance. In most of the subjects, the sleep disorder itself may change the 
relationship between the homeostatic and circadian influences. Additionally, the
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amplitude of mood and performance in free-running subjects may be damped by the 
splitting of the homeostatic and circadian mechanisms controlling sleep and arousal. 
Evidence for this splitting is observed in the napping behaviour of free-running and 
abnormally entrained individuals (Chapter 7) and is partially observed in the timing of 
minimum alertness once the homeostatic influence had been removed (Chapter 9). 
There is evidence that increased age is associated with an alteration in coupling between 
homeostatic and circadian mechanisms (Czeisler et al., 1992) and this is thought to be 
responsible for a reduction in the robustness of diurnal variation in mood and 
performance observed in the elderly (Monk et al., 1992). A similar effect may be 
responsible for the lack of diurnal variation observed in the blind but in this study the 
number of significant cosine fits was too low to enable an assessment of the effect of 
age on mood.
The findings that sleep, mood, and to a small extent performance, alter in relation to 
circadian phase has important implications for other circadian rhythm disorders 
experienced in field conditions, for example, shifr-workers. The deleterious effects on 
sleep and mood reported by shift-workers (e.g. Akerstedt, 1984), are often difficult to 
study and measure in the field. This thesis adds to the evidence that a circadian system 
out of synchrony with the environment strongly influences individuals’ behaviour in 
‘real-life’ situations. This study has the advantage that the complicated phase-shifting 
and masking effects of light on circadian rhythmicity are removed in free-running blind 
subjects. The study therefore provides evidence for a true circadian effect on behaviour 
that may explain the deleterious effects on behaviour experienced by shift-workers.
12.8 Methodological aspects
Several methodological points have been raised in the thesis. It has illustrated that the 
length of any study of free-running rhythms is vital and that subsequent studies should 
be conducted for as long as possible. With respect to aMT6s rhythms reported in this 
study, the average period of the free-running subject was 24.43 h. This means that, on 
average a 56 day (8 week) study is required to study the free-running population for a 
full circadian cycle. Ideally the four-week protocol could be used to characterise
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whether or not an individual has a free-running aMT6s rhythm and to determine how
long a second study would need to be in order to cover a full circadian cycle. This is
essential to provide definitive data of the effects of circadian phase on, for example,
sleep. Subjects characterised as having abnormally entrained rhythms may have very
do
slow free-running rhythms and in order to^this, the study length would need to increase 
dramatically.
Another limitation of the study is the use of cosinor analysis to measure diurnal 
variation in mood and performance. There may well be consistent diurnal variation in 
these parameters that do not fit a cosine curve. Extension of the analysis techniques, for 
example using complex cosinor analysis or waveform analysis may reveal more robust 
rhythms in mood or performance that can then be analysed in relation to circadian 
rhythm type.
Another methodological point highlighted by the thesis has been the comparison of 
subjective and actigraphic measurements of sleep (Chapter 11). In some individuals 
there were large inconsistencies in the measurements of absolute sleep parameters 
between the two methods, with actigraphy generally overestimating the number and 
duration of sleep and wake periods compared to subjective diaries, most probably due to 
misinterpretation of measured activity levels (Chapter 11). Subjective diaries therefore 
appear to be more accurate if absolute measurements of sleep are required. However, 
when measuring the timing of sleep and the relationship between sleep parameters and 
aMT6s acrophase over time, both methods gave comparable results.
12.9 Final comments
This thesis has characterised in detail the circadian rhythms of 49 blind subjects with 
varying degrees of visual loss. The results have provided a firm basis for future studies 
to investigate the cause of the observed rhythm type i.e. the influence of photic and non- 
photic zeitgebers. Light suppression tests of melatonin will determine whether 
hypothalamic light perception is entraining the rhythms in normally entrained NPL 
subjects and further work, using different light intensities will determine whether the
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response to light is comparable in the blind with sighted subjects. Further work is 
required to assess the role of non-photic zeitgebers, for example, exogenous melatonin 
or scheduled activity in circadian rhythm entrainment.
The practical application of these findings is the targeting of individuals who are likely 
to have circadian sleep disorders (i.e. NPL subjects, especially those who are bilaterally 
enucleated) and the optimisation of treatment using photic or non-photic time cues. 
Research with blind people may advance the broad base of knowledge that enables the 
prevention and treatment of circadian rhythm disorders in general. It is hoped that there 
will be wider publicity of the potential for sleep problems in blind subjects in order to 
educate the blind population who may be unaware that their sight loss could be related 
to their sleep disorder. Additionally, it is also hoped that wider publicity will aid the 
identification of potential sufferers and allow appropriate treatments of their circadian 
sleep disorder.
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1. Wliat  T im e  do )Oii normally ;;o lo I>cd7 How manv  lioiiis |)cr niglU do you sleep on average?
?.. How long docs il lake you (0 fall sleep? < 10 min  10 - 30 min CD >30 min CD
3. How often do you wake up during (he night? 1 low often do you get vtp during the night and why?
■1. Do you go through pliascs of getting to sleep earlier and earlier or later and later each night? r
5. Do you have any dilTiculty getting up in the m orrungs? W hat kind o f difliculty?
6. Do you fall sleep during the day? How often and for how long?
7. Do you feel that your sleep pattern has changed since the deterioration of your vision?
8. Do you feel you have any problems sleeping?
W hat kind of problems?
Is it recurrent? Can you estim ate how often it recurs? Does it recur regularly?
Do you do an^lhing lo try to overcom e this problem ? (e. g. sleeping pills, relaxation, techniques, m aking 
yourself go to bed at a particular tim e?)
Arc these strategies effective?
D uration of sleep problem; <6 m onths CD 6-12 month CD >12 month  CD
Do you feel it is related to your visual loss? ■
Do you ever skip a night's sleep?
9. Is your sleep pattern different during work-free periods (e.g. holidays, weekends)? If yes, how is it different?
10. Does your sleep pattern affect your social or occupational life? I f  yes, please describe?
A ny fu r th e r  com m ents you h a \e  w ould be \ e ry  w elcom e.
IN C LU D ED  IN .T H E  SLEEP STUDY : YES O NO CD
R E A SO N  F O R  EX CLU D IN G  F R O M  TH E S L E E P  S TU D Y  :
15-2
P i d s b u r g l i  S l e e p  Q u a l i t y  I n d e x  ( P S Q I )
N am e................................... ID #
Instructions
Dale A lie.
The following questions relate to your usual sleep habits during the past month only. Your 
answers should indicate the most accurate reply for the majority of days and nights in the past 
month.
Please answer all questions.
1. During the past month, when have you usually gone to bed at night?
U SU AL BED T IM E   ..... .....................
2. During the past month, how long (in minutes) has it usually taken you to fall asleep
each night?
N UM BER O F M IN U TE S................................ ...............
3. During the past month, when have you usually gotten up in the morning?
U SUA L GETTIN G UP T IM E   ............
4. During the past month, how many hours of actual sleep did you get at night? (This may
be different than the number of hours you spend in bed).
HOURS OF SLEEP PER N IG H T...........
For each o f the remaining questions, check (tick) the one best response. Please answ er all 
questions.
5.
(a )
During the past month, how often have you had trouble sleeping because you. 
Cannot get to sleep within 30 minutes
Not during the 
past m onth.....
Less than 
once a week.
Once or 
twice a week.
Three or more 
times a week.
(b) W ake up in the middle of the night or early morning
Not during the 
past m onth.....
Less than 
once a week.
Once or 
twice a week.
Three or more 
times a week.
(c) Have to get up to use the bathroom (toilet)
Not during the 
past m onth.....
Less than 
once a week.
Once or 
twice a week.
Three or more * 
times a week....
(d) Cannot breathe comfortably
Not during the 
past m onth.....
Less than 
once a week.
Once or 
twice a v/eek.
Three or more 
times a week.
15-3
(e) Cough or snore loudly
Not during the. Less than
past m onth  once a week.
(0  Feel too cold
Not during thq 
past m onth......
(g) Feel too hot
Not during the 
past m onth.....
(h) Had bad dreams
Not during the 
past month.. ...
(i) Have pain
Not during the 
past month......
Less than 
once a week.
Less than 
once a week.
Less than 
once a week.
Less than 
once a week.
(j) O th er reason(s), p lease describe.
Once or 
twice a week.
Once or 
twice a week.
Once or 
twice a week.
Once or 
twice a week.
Once or 
twice a week.
Three or more 
times a week.
I'hree or more 
times a week.
Tltree or more 
times a week.
Three or more 
times a week.
Three or more 
times a week.
How often during the past month have you had trouble sleeping because of this?
Not during the 
past month.....
Less than 
once a week.
Once or 
twice a week.
Three or more 
times a  week.
During the past month, how would you rate your sleep quality overall?
Veiy good 
Fairly good 
Fairly bad 
Very bad
During the past month, how often have you taken medicine (prescribed or "over the 
counter") to help you sleep?
Not during the 
past month....;
Less than 
once a week.
Once or 
twice a week.
Three or more 
times a week.
During the past month, how often have you had trouble staying awake while driving, 
eating meals, or engaging in social activity?
Not during the 
past m onth.....
Less than 
once a week.
Once or 
twice a week.
Three or more 
times a week.
15-4
9. During the past month, how much of a problem has it been tor you to keep up enough 
enthusiasm to get things done?
No problem at all....................... ..............................
Only a very slight problem ......    ^
Somewhat of a problem ..............................
A very' big problem ............ ................
10. Do you have a bed partner or roommate?
No bed partner or roommate  : ............
Partner/roommate in other room 
Partner in same room, but not same bed 
Partner in same bed
15-5
(b)
If you have a roommate or bed partner, ask him/her how often in the past month you 
have had
(a) Loud snoring
Not during the Less than 
once a week.past m onth......
Long pauses between breaths while asleep
Not during the 
past m onth.....
Less than 
once a week.
(c) Legs twitching or jerking while you sleep
Not during the 
past m onth.....
Less than 
once a week.
Once or 
twice a week.
Once or 
twice a week.
Once or 
twice a week.
(d) Episodes of disorientation or confusion during sleep
Not during the 
past m onth.....
Less than 
once a week.
Once or 
twice a week.
(e) O ther restlessness while you sleep; please describe
Three or more 
times a week.
Three or more 
times a week.
Three or more 
times a week.
Three or more 
times a week.
Not during the 
past month...
Less than 
once a week.
Once or 
twice a week.
DJS/jrc/Questionnaire
Three or more 
times a week.
15-6
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